Quarterlytics / Healthcare / Medical - Instruments & Supplies / Invacare

Invacare

ivc · ASX Healthcare
Claim this profile
Ticker ivc
Exchange ASX
Sector Healthcare
Industry Medical - Instruments & Supplies
Employees 1001-5000
← All annual reports
FY2016 Annual Report · Invacare
Sign in to download
Loading PDF…
I

N

V

O

C

A

R

E

L

I

M

I

T

E

D

A

N

N

U

A

L

R

E

P

O

R

T

2

0

1

6

invocare.com.au

2016 Annual Report

 
 
 
 
Contents

1 

2 

4 

Performance Highlights

Chairman’s Message

 Chief Executive Offi  cer’s 
Review

6 

Community Activities

8  Management Team

9 

Financial Report

10  Director’s Report

25 

 Corporate Governance 
Statement

30  Remuneration Report

42 

 Auditor’s Independence 
Declaration

90  Director’s Declaration

91 

Independent Auditor’s Report

96  Shareholder Information

97  Glossary

98 

InvoCare Locations

100  Corporate Information

Our Mission
“We’re here to support our 
clients, their families and 
friends, at a pivotal time in 
their lives. We do this by being 
compassionate, exceeding 
expectations and delivering 
outstanding service.”

Performance highlights

By continuing an unrelenting focus on key strategies, 
operating earnings after tax have increased by 11.9% 
despite a modest 0.3% increase in the number of deaths.

Revenue from external customers 
($ million)

Operating EBITDA
($ million)

2012 

2013 

2014 

2015 

2016 

368.7

385.4

413.0

436.4

450.7

2012 

2013 

2014 

2015 

2016 

93.0

95.1

101.1

105.4

112.3

Operating earnings after tax 
($ million)

Ordinary dividends per share 
(cents per share)

2012 

2013 

2014 

2015 

2016 

42.5

42.5

46.2

49.4

55.2

2012 

2013 

2014 

2015 

2016 

34.0

34.5

36.5

38.0

42.5

Profit after tax attributable to members 
($ million)

2012 

2013 

2014 

2015 

2016 

44.5

48.9

54.5

54.8

70.9

InvoCare Annual Report 2016  |  1

Chairman’s Message

Investing  
to Protect  
and Grow

InvoCare delivered a robust financial 
result for 2016 through an unrelenting 
focus on its proven business strategy.

InvoCare’s operational strategy has 
enabled the Company to continue to 
grow in 2016 and to deliver a strong set of 
financial results. This has contributed to 
total shareholder returns (price movement 
plus cash dividends) since the initial public 
offering in late 2003 remaining above 20% 
compound annual growth.

Operating earnings after tax grew by 11.9% 
to $55.2 million. The key drivers of this 
growth were a continued focus on case 
average and efficient operations, together 
with gains in the cost of debt following 
refinancing. The result was achieved despite 
a lower than expected level of demand and 
a small decline in market share.

Statutory profit after tax increased by $16.1 
million (to $70.9 million). This result includes 
asset sale gains, impairment charges and 
the non-cash impact of movements in 
the value of funds under management for 
prepaid contracts. The gains on prepaid 
funds under management resulted from the 
revaluation, by the independent trustees, 
of property investments in the Sydney 
market. Gains of this nature are cyclical and 
InvoCare remains focused on long term 
returns and the appropriate management of 
risk for these funds.

The operating EBITDA to cash conversion 
ratio of 104% led the Board to approve a 
fully franked final dividend of 25.5 cents 
per share. Total dividends for the year 
amounted to 42.5 cents per share, an 
increase of 11.8% on 2015. The dividend 
payout ratio is 85% (2015: 85%) of operating 
earnings after tax for 2016.

In February 2017, InvoCare announced 

2

to the market its Protect and Grow 
programme to be implemented over the 
next four years. The approximately $200 
million programme of works is focussed 
on investing in our existing assets in core 
markets to set the business up for profitable 
growth over the next 10 to 15 years. The 
programme is structured to enable the 
Company to continue to achieve its primary 
financial objective of delivering year on year 
operating EPS growth of 10%, with stretch 
targets of 12% and beyond, whilst also 
delivering historic levels of return on capital.

The focus of the program is threefold:

•  Network and Brand Optimisation – 

delivering the right product to the 
customer, in the right locations at the 
right price;

•  People and Culture – greater focus on 
entrepreneurial ethos by encouraging 
local leadership;

•  Operational Efficiencies – capture 
operational benefits of scale and 
standardise quality of service provision. 

The programme will be debt funded, but the 
Board and management have implemented 
guidelines to ensure the maintenance of 
a strong and conservative balance sheet 
and a shadow investment grade rating. 
More detail on the funding will be disclosed 
in the third quarter of this year following 
the finalisation of Management’s work to 
determine the optimal approach.

who has been on the Board since 2003 
resigned in February 2017. On behalf of all 
shareholders and the Board, I would like 
to pay tribute to Tina’s commitment and 
her passionate focus on the development 
of InvoCare since 2003. Her positive 
contributions and good humour will 
be missed.

On behalf of the Board and all shareholders 
I would like to express our appreciation to 
the InvoCare team for delivering another 
strong set of financial results, whilst 
ensuring that they also continue to provide 
the highest levels of customer service. 
Over and above their commitment to 
the Company’s day to day operations, 
our people’s involvement with the local 
community is impressive. The Board 
commends their professionalism and 
dedication, as well as their sense of 
vocation and purpose.

I would also like to express the Board’s 
thanks to the Company’s shareholders 
for their continued support. That support 
is important as we guide and encourage 
InvoCare’s executive leadership in the 
delivery of both the financial results to 
shareholders, and equally importantly, 
care, understanding and support to the 
Company’s customers.

Board renewal has continued and we 
welcome Robyn Stubbs to the Board with 
effect from 1 January 2017. Tina Clifton 

Richard Fisher 
Chairman

Operating earnings after tax

Dividends

Cash conversion ratio

11.9% 

Operating earnings 
after tax increased to 
$55 million

11.8% 

Dividends for the year 
increased to 42.5 cents 
per share

104%

Strong cash conversion 
ratio with 104% of 
operating EBITDA 
converted to cash

Five-year Financials

$’000 

 2016 

 2015 

 2014 

 2013 

2012

Revenue from external customers

 450,659 

 436,371 

 413,011 

 385,352 

 368,652 

Operating EBITDA

Operating EBITDA margin

Operating earnings after tax

 112,279 

 105,426 

 101,082 

 95,072 

 93,026 

24.9%

24.2%

24.5%

24.7%

25.2%

 55,233 

 49,366 

 46,192 

 42,498 

 42,479 

Operating earnings per share (cents) 

 50.4 

 45.1 

 42.2 

 38.9 

 38.8 

Profit after tax attributable to members

 70,949 

 54,844 

 54,515 

 48,869 

 44,479 

Earnings per share (cents) 

Dividend paid in respect of the financial year (cents) 

 64.7 

 42.50 

 50.1 

 38.00 

 49.8 

 36.50 

 44.7 

 34.50 

 40.6 

 34.00 

Ungeared, tax free operating cash flow 

 117,023 

 102,618 

 104,721 

 105,170 

 86,416 

Proportion of EBITDA converted to cash

104%

97%

104%

111%

93%

Actual capital expenditure 

 30,321 

 22,035 

 26,665 

 19,264 

 18,412 

Net Debt

 222,927 

 222,093 

 218,862 

 215,057 

 217,136 

Operating EBITDA / Net interest (times) 

Net debt / EBITDA (times) 

Funeral homes (number) 

Cemeteries and crematoria (number) 

Employees (full time equivalents) 

Prepaid contract sales per 100 redemptions 

 10.7 

 2.0 

 225 

 16 

 1,566 

 142 

 8.8 

 2.1 

 231 

 16 

 8.0 

 2.2 

 234 

 14 

 6.8 

 2.3 

 237 

 14 

 6.7 

 2.3 

 232 

 14 

 1,557 

 1,532 

 1,470 

 1,470 

115

108

115

116

Operating earnings after tax excludes the net gain/(loss) on undelivered prepaid contracts, gain/(loss) on sale, disposal or impairment of  
non-current assets and non-controlling interests.

InvoCare Annual Report 2016  |  3

Martin Earp 
Chief Executive Officer

Chief Executive Officer’s Review

Investing 
in long term 
value creation
through the Protect 
and Grow programme

In 2016 the business delivered a strong set of financial results and funded the 
preparatory work required to announce its $200 million Protect and Grow 
investment strategy. This programme of work was announced in February 2017 
and will be rolled out over the next four years in order to deliver long term 
sustainable value for shareholders for the next 10 to 15 years.

Summary of 2016

New Zealand 

InvoCare delivered strong results for financial year 2016, despite 
lower than expected deaths in our markets and a decline in market 
share. Reported profit increased 29.4% ($70.9 million), operating 
earnings increased by 11.9% ($55.2 million) and operating EBITDA 
increased by 6.5% ($122.3 million).

Australia 

In Australia, the highlight of the result was the improvement in the 
Cemeteries and Crematoria division. Despite a reduction in case 
volume of 2.3%, the division was able to increase sales by 10.1%. 
This was driven by a change in organisational structure in 2015 and 
a concerted effort to improve collaboration and accountability. The 
focus on culture, as well as targeting higher value memorialisation 
opportunities, has driven the improvement in performance.

The funeral business experienced lower than anticipated demand, 
but a combination of focusing on case average and cost control, 
delivered a strong result for the division with operating EBITDA of 
$98.3 million, up 6.1% on the previous year.

Singapore 

The business in Singapore improved its operating EBITDA  
2% year on year to SG$8.4 million. Strong competition targeting 
the business’ lower yielding customers saw a drop in market share 
from 10.2% to 9.5%. However, the retention of the higher yielding 
customers meant sales were up 3.9%. 

Singapore remains an attractive market due to the business’ strong 
brand proposition; the excellent central business district location 
of our facility; and a high performing operations team. In 2017 our 
intention is to upgrade the existing location to capitalise on these 
features and to meet demand by creating more space for revenue 
generating activities. This will entail closing the primary location for 
three months during the second half of the year which will impact 
performance for 2017.

4

This business had a difficult year, driven in part by a decline of 2.8% 
in the number of deaths. This, combined with some market share 
reduction, saw sales decline by 1.2%. Careful cost control, along 
with improved performance from the Christchurch memorial parks, 
mitigated the impact and overall operating EBITDA increased by 
2.4% (NZ$9.6 million).

The small size of the market (5,578 InvoCare cases in 2016) means 
it will always be more volatile than Australia, but management 
is focused on increasing market share and case average, whilst 
positioning the cost base to better accommodate fluctuations 
in demand. 

USA 

An increased focus on volume resulted in sales improving 60% and 
an EBITDA improvement of 19.8% (loss US$2.3 million). Despite 
this performance, management determined that the business 
was unlikely to reach viability by mid-2018 within the capital 
parameters set to explore the opportunity. A decision was made 
in February 2017 to close the US funeral business, although the 
Macera Crematory will remain operational.

Pillars of Growth 

InvoCare has created long term sustainable value for shareholders 
over many years by focusing on the key pillars of growth, which 
remain fundamental to the business’ performance.

Deaths 

The long term trend in the number of deaths remains positive 
due to an increasing and ageing population. However, this year 
growth in the number of deaths was less than expected at 0.3%. 
We anticipate growth will revert to the long term average of 1.5% in 
2017, and will continue to increase year on year to 2034.

Market Share 

Overall market share for the group 
was down by 77bps. There are many 
contributing factors to this decline but the 
key issue is that the needs of the customer 
are changing. InvoCare must address and 
cater for these changes and this is the 
impetus behind the development of the 
Protect and Grow investment programme. 
We will refresh and enhance our product 
offering to meet the changing market 
and the needs of our customers and, 
at the same time, seek to entrench our 
competitive advantages. 

Funeral Case Average

Funeral case average continued to increase 
in line with expectations, with an increase 
of 4% year on year. The value proposition of 
the business remains competitive and this 
is demonstrated by strong Net Promoter 
Scores. It is anticipated that with an 
increasing range of products and services 
being demanded by the customer, case 
average will continue to increase at historic 
rates and remain a core driver of value 
creation into the future.

Operational Efficiency 

InvoCare has continued to focus on working 
more efficiently and pleasingly, operating 
margins improved by 70bps to 24.9%. 
Overall operating expenses increased 
by 2.4%, with non-sales personnel costs 
increasing by 4.6%, the lowest increase 
in more than five years. Looking forward, 
InvoCare will invest in systems to achieve 
continued improvements in efficiencies, 
as well as focus on more sophisticated 
procurement practices.

Acquisitions & Greenfield Developments 

During the year InvoCare conducted a 
thorough review of its markets as part 
of its network and brand optimisation 
programme. While the business was 
undertaking this analysis it deliberately 
placed acquisitions and new greenfield 
developments on hold to ensure they were 
consistent with the longer term strategy of 
investment for each region.

Prepaid Funerals

Prepaid funerals secure future market 
share and revenue and it is pleasing to 
report a strong result in 2016. The number 
of contracts sold increased by 25%, 
which was driven by decentralising the 
leadership of the sales team; a targeted 
marketing campaign; and changes to 
the pension assets test. In addition, the 
undelivered prepaid contracts funds 
under management increased by 12% to 
$473 million, underpinned by revaluations 
of the property investments within the Over 
Fifty Guardian Friendly Society. 

Protect and Grow 

Last year I wrote about investing today 
for future returns. The focus for 2016 has 
been on undertaking the detailed planning 
required to successfully implement a 
programme of investment to set the 

business up for long-term value creation. 
Considerable time and effort has been 
spent to understand the needs of our 
customers and future demographics in core 
markets; to conduct detailed competitor 
analysis for each of the regional markets in 
which we operate; as well as to ascertain 
the investment required to improve the 
efficiency of our operations.

This culminated in the announcement in 
February of our $200 million Protect and 
Grow programme to be rolled out over the 
next four years.

This investment programme is divided into 
three distinct categories:

1. 

 Network and Brand Optimisation (‘NBO’) 

2.  Operational Efficiency 

3.  People and Culture 

Network and Brand Optimisation 

The objective of this programme of work is 
to deliver the right product; to operate in the 
right locations; and to offer product at the 
right price. The capital investment for this 
work aims to optimise the current asset base 
in order to underpin growth for the business 
for the next decade. This first part of the 
programme is divided into two distinct areas:

•  Refresh and Enhance – to provide a 

more contemporary look and feel, whilst 
also meeting the customers’ needs for 
a “one-stop-shop”. The high quality 
full service funeral locations (hubs), will 
be served by a network of “satellite” 
shopfronts that will drive utilisation of 
the enhanced full service locations. 
The key deliverable for 2017 will be to 
refresh 22 sites, substantively enhance 
two sites and commence work on a 
further 22 sites.

•  Growth – the market analysis 

highlighted the opportunity for new sites 
to be established within the current 
network. These opportunities include 
both full service and satellite locations. 
Work will commence on establishing 
these greenfield developments in 2017 
and continue through to 2020. This 
organic growth is complementary 
to InvoCare’s traditional acquisition 
strategy, work on which will resume 
following the NBO review.

Operational Efficiencies 

The key objectives of this category of 
the Protect and Grow programme are to 
capture the benefits of InvoCare’s scale 
and to standardise the quality of service 
provision across the group. This will enable 
the business to operate more efficiently 
and to procure more effectively. To this 
end, we will invest in upgraded operational 
centres, business systems and processes, 
all of which will ensure the business is 
well-positioned to cope with the increased 
levels of demand forecast over the next 15 
or more years.

The key deliverables for 2017 are to 
finalise the scope for the replacement 

business system; agree the implementation 
timetable; and commence implementation. 
The second key deliverable is to complete 
the design of standalone operational 
centres and identify the optimal locations 
for regional operational centres. 

People and Culture 

The primary objective of this part of 
the Protect and Grow programme is to 
engender an entrepreneurial ethos in the 
organisation, commencing with measures to 
empower and encourage local leadership. 
We aim to develop a culture that draws on 
the core company values (Collaboration, 
Accountability, Responsiveness and 
Excellence) to deliver both customer needs 
and investor returns. In 2017 a review will 
be completed of the existing culture and a 
tailored culture programme rolled out to the 
broader business.

InvoCare will also complete its regional 
manager restructure with a focus on 
geographic regions rather than brands. This 
has required the appointment of regional 
managers that are both commercial and 
culturally aligned. The business will closely 
monitor net promoter scores, levels of 
collaboration, as well as the traditional 
financial metrics to monitor and determine 
the success of the culture initiative.

Outlook 

The four pillars of growth that underpin the 
InvoCare business remain fundamental to 
achieving long term growth and returns for 
our stakeholders. The work undertaken by 
the management team in 2016 has clearly 
affirmed this view. However, it has also 
identified significant potential within that 
framework to increase market share from 
our substantial scale and assets; to achieve 
operational efficiencies; and to better and 
more productively deploy our capital.

Implementing our Protect and Grow 
programme is the means by which we will 
realise this potential. Bringing a strong 
focus to the way in which and the means by 
which we serve our customers, in the areas 
delineated by the programme, will positively 
impact the group’s financial performance.

We believe market conditions in the near 
to mid-term will be favourable with the 
growth in deaths anticipated to revert to the 
forecast growth trend line. The initial stages 
of the programme are expected to stabilise 
market share in 2017 and improve it in 
2018. Indications are that case averages 
are expected to grow in line with historic 
increases and the programme’s focus on 
operational efficiencies will generate near-
term productivity gains.

The combination of these factors should 
lead to high single digit growth for EBITDA 
in 2017, with EPS growth being mid-
single digits. The EPS result takes into 
account the increase in interest costs and 
depreciation in 2017 due to the additional 
investment under the Protect and Grow 
programme. In the longer term it is 
expected the programme will deliver double 
digit EPS growth.

InvoCare Annual Report 2016  |  5

Bringing 33 Australians 
home to rest

InvoCare was privileged in 2016 to support one of the largest repatriations 
in Australia’s history when 33 deceased servicemen and their dependants, 
who had been buried in military cemeteries in Malaysia and Singapore 
during the Vietnam War, were finally returned home.

Of the 521 Australians who were killed in Vietnam or died of 
wounds sustained in the war, 496 were buried back home in 
Australia. However, 25 had been interred abroad, as the military 
rules at that time meant that families were required to cover the 
cost of repatriation themselves, and some couldn’t afford to do so. 

In 2016 the Australian Government agreed to fund the repatriation 
of these servicemen and their dependants. InvoCare immediately 
offered the Department of Veteran Affairs its full support and 
expertise, which was gratefully accepted, and InvoCare was 
entrusted to assist in all stages of this complex operation, which 
became known as Project Reunite. 

The repatriation of 33 Australians was an exercise to bring 
closure to the family and friends of the 25 soldiers and eight 
dependents who had died during the Vietnam War nearly 50 
years ago. They were finally returned home to rest in peace near 
their loved ones. Participating in this monumental exercise fully 
captured the spirit of the InvoCare team and demonstrated the 
core values of Collaboration, Accountability, Responsiveness and 
Excellence (CARE).

On 2 June 2016, two Royal Australian Air Force C-17A 
Globemasters bearing the returning Australians who had been 
interred at the Terendak Military Cemetery in Malaysia and 
the Kranji Cemetery in Singapore finally landed at RAAF Base 
Richmond in Sydney. Each serviceman and dependant had been 
placed in a specially-designed coffin, crafted from local timbers, 
and draped with the Australian flag. His Excellency Governor-
General Peter Cosgrove and family, friends and former colleagues 
of the deceased attended the ramp ceremony, which was 
conducted with full military honours by Defence Force personnel 
from Australia’s Federation Guard. 

6

This was then followed by a moving and emotional private 
memorial service for the families of the deceased.

The scale of the operation was clearly seen as a 1km funeral 
cortege consisting of 33 InvoCare black hearses then slowly 
travelled 50kms in convoy from Richmond Airbase to the InvoCare 
Operations Centre at Lidcombe under a full police escort. The 
streets were lined with people paying their respects to those who 
had made the ultimate sacrifice to serve their country in Vietnam.

The InvoCare team also coordinated and assisted with the 
reinternment arrangements at cemeteries across Australia and 
the repatriation of one serviceman abroad to the United Kingdom. 
Throughout our involvement the company was committed to 
ensuring that the last stages of the 33 Australians’ long journey 
home were conducted safely, respectfully and peacefully.

Many people within the InvoCare team volunteered their time, 
effort and expertise; not only on the day and in the months 
beforehand, but also in the weeks after, as the deceased made 
their way to their final resting places. 

The InvoCare support was provided at no cost to the families or 
to the Australian Government. Instead, it gave the team a sense 
of immense honour and pride to be the only company that could 
have provided such expertise and assistance. 

It showed what can be achieved to bring some solace and closure 
to so many families, through simply working as one team and 
living the CARE values.

Share the Dignity 
for homeless women

As most people prepared to celebrate the festive season with 
loved ones in 2016, more than 50,000 Australian women and 
teenage girls found themselves homeless, sleeping rough, or 
taking refuge in shelters. 55% of these women were in this 
situation as a result of fleeing domestic abuse in their homes.

InvoCare’s funeral brands White Lady and Mareena Purslowe 
decided to make a difference by extending their partnership 
with Share the Dignity to support the It’s in the Bag 
Christmas campaign.

The campaign follows the well-received sanitary drives initiated 
by Share the Dignity founder, Rochelle Courtenay. It aims to give 
women and girls doing it tough at Christmas a reason to smile 
and feel cared for, as well as restoring some dignity by providing 
them with handbags filled with essential hygiene products they 
desperately need, as well as a few little treats. The White Lady 
Funerals and Mareena Purslowe Funerals locations acted as a 
collection point in the lead up to Christmas.

The InvoCare teams got fully behind the campaign and collected 
more than 9,500 handbags full of items that would be gratefully 

received by a homeless woman at any time of the year. These 
included things such as pads, tampons, deodorants, toothpaste, 
shower gel, socks, a brush, a magazine, anything that would make 
a woman or teenage girl who’s struggling feel special. Individuals 
donating bags were also encouraged to put a thoughtful note 
into the bag, to show these women that someone cares and that 
they matter. The donations reached thousands of women at a 
difficult time.

Celebrating at the InvoCare Awards

The inaugural InvoCare Awards were held 
in 2016 and again in March 2017 to celebrate 
those employees who went above and beyond 
to achieve their business goals and also for 
living the InvoCare values of Collaboration, 
Accountability, Responsiveness and Excellence.

Each year awards are presented in 12 categories which cover Funerals, Cemeteries and Crematoria and 
the CARE Awards. More than 150 employees were invited to the 2016 InvoCare Awards and included three 

finalists in each category – the people who have excelled in providing 

the best possible experience for their client families.

The overall winners were presented with their Awards 

by the Chief Executive Office Martin Earp and Board 
Directors Joycelyn Morton and Richard Davis.

Every day InvoCare employees do amazing 
things for their customers, it’s often the 
little things that make a difference and 
at the InvoCare Awards the team are 

recognised for excelling in each 
category. It’s a great example of the 
business building on a culture which 
is based on people who support 
each other and put the customer at 
the heart of everything they do.

InvoCare Annual Report 2016  |  7

1

3

4

5

6

7

8

2

9

Martin Earp Chief Executive Officer (1), Josée Lemoine Chief Financial Officer (2), Lachlan Sheldon Group Executive Capital Management (3), Graeme Rhind 
Chairman InvoCare New Zealand (4), Wee Leng Goh Chief Executive Officer Singapore (5), Steve Nobbs Group Executive Network & Brand Optimisation (6), 
Fergus Kelly Chief Marketing Officer (7), Keiron Humbler Group Executive Business Operations (8), Greg Bisset Chief Operating Officer InvoCare Australia (9)

Management Team

The InvoCare management team deploy operational excellence and 
technical insights to deliver the best results for the business, customers 
and stakeholders.

CEO Martin Earp also announced a key to success will be a greater 
focus on the entrepreneurial ethos by encouraging local leadership. 
In 2016, this saw the implementation of a regional manager structure 
based on geographic regions rather than by brands, with leaders 
appointed that are commercial and culturally aligned. 

Set for success

2016 saw the appointment of Josée Lemoine to Chief Financial Officer 
after Phillip Friery began a planned transition from being involved in 
the business on a day to day basis but continuing his involvement as 
Company Secretary and adviser to the CEO on strategic projects.  
Phillip’s counsel, leadership and expertise have been paramount to the 
group’s ability to deliver consistently high returns to its shareholders.

Josée joined InvoCare in September after recently working with Telstra as 
Director of Innovation and Business Performance. She has had a finance 
career spanning several blue chip companies across multiple industries, 
with a clear focus on driving businesses to deliver commercial outcomes. 

Steve Nobbs also joined the team in 2016 as Group Executive, Network 
& Brand Optimisation (NBO). As part of the Protect and Grow strategy, 
he will be responsible for the NBO programme of work to deliver the right 
product, to the right locations at the right price. 

These appointments were made to ensure the leadership would continue 
to deliver on the current operational requirements and set the business up 
for long term sustainable growth.

8

Financial 
Report

InvoCare Limited and Controlled 
Entities Annual Financial Report  
for the financial year ended  
31 December 2016

The financial report covers the consolidated financial statements 
for the consolidated entity consisting of InvoCare Limited and its 
subsidiaries. The financial report is presented in Australian currency.

InvoCare Limited (ABN 42 096 437 393) is a company limited by 
shares, incorporated and domiciled in Australia. Its registered office 
and principal place of business is:

Level 2, 40 Miller Street 
North Sydney NSW 2060

A description of the nature of the consolidated entity’s operations 
and its principal activities is included in the Directors’ Report.

The financial report was authorised for issue by the directors on 
23 February 2017. The Company has power to amend and reissue 
the financial report.

Through the use of the internet, InvoCare ensures corporate 
reporting is timely, complete, and available globally at minimum 
cost to the Company. All press releases, financial reports and other 
information are available on the Company’s website:  
www.invocare.com.au

Contents
Directors’ Report

Corporate Governance Statement
Remuneration Report

Auditor’s Independence Declaration
Consolidated Income Statement
Consolidated Statement of Comprehensive Income
Consolidated Balance Sheet
Consolidated Statement of Changes in Equity
Consolidated Statement of Cash Flows
Independent Auditor’s Report
Notes to the Financial Statements
Note 1
Note 2
Note 3
Note 4
Note 5
Note 6
Note 7
Note 8
Note 9
Note 10
Note 11
Note 12
Note 13
Note 14
Note 15
Note 16
Note 17
Note 18
Note 19
Note 20
Note 21
Note 22
Note 23
Note 24

Summary of Significant Accounting Policies
Financial Risk Management
Segment Information
Revenue from Continuing Operations
Expenses
Income Tax
Key Management Personnel Disclosures
Share-based Payments
Remuneration of Auditors
Dividends
Earnings per Share
Cash and Cash Equivalents
Trade and Other Receivables
Inventories
Prepaid Contracts
Interests in Other Entities: Subsidiaries
Interests in Other Entities: Associates
Property, Plant and Equipment
Intangible Assets
Derivative Financial Instruments
Trade and Other Payables
Borrowings
Provisions for Employee Benefits
Current Liabilities expected to be settled 
in twelve months
Contributed Equity
Reserves and Retained Profits
Non-controlling Interests
Capital and Leasing Commitments
Business Combinations 
Contingent Liabilities and Contingent Assets
Cash Flow Information
Deed of Cross Guarantee
Events after the Balance Sheet Date
Related Party Transactions
Parent Entity Financial Information
Economic Dependence
Critical Accounting Estimates and Judgements
Company Details
Authorisation of the Financial Report

Note 25
Note 26
Note 27
Note 28
Note 29
Note 30
Note 31
Note 32
Note 33
Note 34
Note 35
Note 36
Note 37
Note 38
Note 39
Directors’ Declaration

10
25
30
42
43
44
45
46
47
91

48
54
61
62
63
64
66
67
68
69
69
70
70
70
71
72
73
74
76
77
77
77
78
78

79
81
82
82
83
83
84
85
87
87
88
89
89
89
89
90

InvoCare Annual Report 2016  |  9

Directors’ Report

The directors submit their report on the consolidated entity 
consisting of InvoCare Limited (the “Company”) and the entities 
it controlled at 31 December 2016. InvoCare Limited and its 
controlled entities together are referred to as “InvoCare”, the 
“Group” or the “consolidated entity” in this Directors’ Report.

Directors

The following persons were directors of InvoCare Limited during the 
whole of the financial year and until the date of this report:

Richard Fisher (Chairman) 
Martin Earp 
Christine Clifton 
Richard Davis 
Joycelyn Morton 
Gary Stead

Robyn Stubbs was appointed as an independent Non-executive 
Director on 1 January 2017 and is a Director at the date of 
this report.

Principal activities

The Group is the leading provider of services in the funeral industry 
in Australia, New Zealand and Singapore with smaller operations in 
Hong Kong and the USA. Other than disclosed in this report there 
were no significant changes in the nature of these activities during 
the year.

Significant changes in the state of affairs 

There have been no significant changes in the state of the Group’s 
affairs during the financial year.

Operating results

The operating earnings after tax for the year was $55,233,000 
(2015: $49,366,000) as reconciled on page 11. The consolidated 
after tax profit of the Group attributable to shareholders was 
$70,949,000 (2015: $54,844,000). More detailed information is 
included in the operating and financial review set out in the report.

Dividends

The Directors have recommended a final, fully franked dividend 
of 25.50 cents per share payable on 7 April 2017. Total full year 
dividends are 42.50 cents, being 4.50 cents or 11.8% higher than 
2015. The full year dividend payout ratio is 85% (2015: 85%) of 
operating earnings after tax.

Dividends to ordinary shareholders of the Company have been paid 
or recommended as follows:

Interim ordinary dividend of 17.00 cents (2015: 15.75 cents) per fully paid share paid  
on 7 October 2016

Final ordinary dividend of 25.50 cents (2015: 22.25 cents) per fully paid share has been  
recommended by directors on 23 February 2017 to be paid on 7 April 2017

Total ordinary dividends of 42.50 cents (2015: 38.0 cents)

All dividends are fully franked at the company tax rate of 30%.

2016 
$’000

2015 
$’000

18,706

17,330

28,058

24,482

46,764

41,812

The Dividend Reinvestment Plan (“DRP”) was available for the 2016 interim dividend and $16,842,000 (2015: $14,855,000) was paid in cash 
and $1,863,000 (2015: $2,475,000) through the issue of 134,327 (2015: 226,049) shares purchased on market at $13.87 (2015: $10.95) per 
share via the DRP. The shortfall in the DRP take-up was not underwritten in 2016 and shares were not issued at a discount. The DRP will 
apply to the final 2016 dividend, which is not being underwritten and no discount to the market price will apply.

10

Operating and Financial Review 

Result highlights:

Total sales to external customers

Other revenue

Operating expenses (i)

Operating EBITDA (i)
  Operating margin

Depreciation and amortisation

Finance costs

Interest income

Business acquisitions costs

Operating earnings before tax (i)
Income tax on operating earnings (i)

Effective tax rate

Operating earnings after tax (i)
  Operating earnings per share (i)

Net gain on undelivered prepaid contracts after tax (i)

Asset sales losses after tax (i)

Impairment (loss)/gain after tax (i)

Non-controlling interest

2016

$’000

2015

$’000

450,659

436,371

10,175

9,570

(348,555)

(340,515)

112,279

24.9%

(21,335)

(13,555)

964

(79)

78,274

(23,041)

29.4%

55,233

105,426

24.2%

(20,180)

(14,786)

722

(70)

71,112

(21,746)

30.6%

49,366

Change

$’000’s

14,288

605

(8,040)

6,853

(1,155)

1,231

242

(9)

7,162

(1,295)

5,867

50.4 cents

45.1 cents

5.3 cents

16,050

(124)

(111)

(99)

5,269

(6)

340

(125)

10,781

(118)

(451)

26

Net profit after tax attributable to ordinary equity holders of InvoCare

70,949

54,844

16,105

Basic earnings per share

Diluted earnings per share

Interim ordinary dividend per share

Final ordinary dividend per share

Total ordinary dividend per share

(i) Non-IFRS financial information.

64.7 cents

50.1 cents

14.6 cents

64.6 cents

50.1 cents

14.5 cents

17.00 cents

15.75 cents

1.25 cents

25.50 cents

22.25 cents

3.25 cents

42.50 cents

38.00 cents

4.50 cents

%

3.3%

6.3%

(2.4%)

6.5%

0.8%

(5.7%)

8.3%

33.5%

(12.9%)

10.1%

(6.0%)

(1.2%)

11.9%

11.8%

29.4%

29.1%

28.9%

7.9%

14.6%

11.8%

Operating EBITDA and operating earnings are financial measures that are not prescribed by Australian equivalents to International Financial 
Reporting Standards (“AIFRS”) and represent the earnings under AIFRS adjusted for specific non-cash and significant items. The table 
above summarises the key reconciling items between net profit after tax attributable to InvoCare shareholders and operating EBITDA and 
operating earnings before and after tax. The operating EBITDA and operating earnings before and after tax information included in the 
table above has not been subject to any specific audit or review procedures by our auditor but has been extracted from the accompanying 
financial report.

InvoCare Annual Report 2016  |  11

 
Directors’ Report continued

Business model

Results overview

InvoCare’s business model is based upon earnings growth from the 
following pillars:

Comparable business operating earnings after tax for 2016 was up 
by 9.6% or $5.1 million to $53.6 million on 2015.

•  Annual sales revenue growth from:

 о Ageing population trends with an approximate 1% annual 

increase in deaths;

 о Consistent annual 3-4% pricing increments;

 о Market share improvements, including new funeral 

locations, generating 1% revenue growth;

•  Prepaid contracts providing families emotional and financial 
peace of mind as well as securing future market share 
for InvoCare;

•  Business acquisitions, which have contributed more than half of 
InvoCare’s compound annual sales growth since listing; and

Operating leverage improvement, through delivery of revenue 
growth pillars and cost control so that annual EBITDA growth is 
greater than annual sales growth.

Most pillars contributed positively to 2016 results as depicted in 
the following table. More detail is provided throughout this report, 
including in the Outlook section on page 20.

Favourable demographics

Pricing / average contract values

Market share improvements

Prepaid contracts

New locations/business acquisitions

-

Operating leverage improvement 

Including the start-up USA operations and acquisitions in New 
Zealand, operating earnings after tax for the total Group was up by 
11.9% or $5.8 million to $55.2 million (2015: $49.4 million).

Statutory reported profit after tax for the comparable business was 
up 26.1% or $15.4 million to $74.5 million (2015: $59.1 million). The 
total Group reported profit after tax was up 29.4% or $16.1 million 
to $70.9 million (2015: $54.8 million). Reported after tax profits were 
impacted by increased gains on undelivered prepaid contract than 
the previous year.

Total Group sales revenue was up 3.3% or $14.3 million 
to $450.7 million (2015: $436.4 million). The increase was 
due to a combination of higher average contract values, 
increased memorialisation sales in the cemeteries and 
crematoria, contributions from new businesses and favourable 
currency movements. 

Overall numbers of deaths in InvoCare’s core markets increased by 
approximately 0.8% compared to 2015. Small market share losses 
were detected in most markets owing to significant competition 
from smaller operators.

Comparable Group EBITDA was up $5.7 million or 5.2% to $114.9 
million (2015: $108.8 million). The foreshadowed negative EBITDA 
for the start-up USA operation of USD2.3 million (or AUD3.1 million), 
offset by $0.5 million from acquisitions, resulted in total Group 
EBITDA increasing by 6.5% or $6.9 million to $112.3 million (2015: 
$105.4 million).

As a percentage of sales, comparable EBITDA margins improved 
from 25.1% in 2015 to 25.7% in 2016. Most of this improvement 
occurred in the second half where margins rose from 27.3% in 2015 
to 28.1%. By comparison, first half margins increased 0.3% from 
22.7% in 2015 to 23.0%.

Cash flows remained strong for the year. Ungeared, tax free 
operating cash flow was 104% of EBITDA (2015: 97%), underpinning 
the ability to pay a fully franked final dividend of 25.50 cents per 
share, which is 3.25 cents up on last year. This is in addition to 
the 17.00 cent interim dividend paid in October 2016, taking total 
dividends declared for the year to 42.50 cents (2015: 38.00 cents).

12

Directors’ Report continuedSales, EBITDA, margins and major profit & loss line items

The following table summarises sales revenue, EBITDA and margins by country segments.

1H16 
$’000

1H15 
$’000

Var 
%

2H16 
$’000

2H15 
$’000

Var 
%

FY16 
$’000

FY15 
$’000

Var 
%

Sales Revenue

Australia

New Zealand

Singapore

184,581

178,124

20,050

21,326

8,386

8,169

Comparable business

213,017

207,619

USA & Acquisitions

1,492

498

3.6%

(6.0%)

2.7%

2.6%

202,745

196,234

23,021

22,665

8,850

8,356

234,616

227,255

1,534

999

3.3%

1.6%

5.9%

3.2%

387,326

374,358

43,071

17,236

43,991

16,525

447,633

434,874

3,026

1,497

3.5%

(2.1%)

4.3%

2.9%

Total

EBITDA

Australia

New Zealand

Singapore

Comparable business

USA & Acquisitions

Total

Margin on sales

Australia

New Zealand

Singapore

Comparable business

USA & Acquisitions

Total 

214,509

208,117

3.1%

236,150

228,254

3.5%

450,659

436,371

3.3%

56,635

52,610

41,617

40,029

3,464

3,899

48,980

(1,708)

47,272

22.5%

17.3%

46.5%

23.0%

3,144

3,909

47,082

(1,907)

45,175

22.5%

14.7%

47.9%

22.7%

4.0%

10.2%

(0.3%)

4.0%

4,977

4,257

65,869

(862)

4.6%

65,007

-

2.6%

(1.4%)

0.3%

27.9%

21.2%

48.1%

28.1%

5,377

4,062

62,049

(1,798)

60,251

26.8%

23.7%

48.6%

27.3%

7.7%

(7.4%)

4.8%

6.2%

98,252

92,639

8,441

8,156

8,521

7,971

114,849

109,131

(2,570)

(3,705)

6.1%

(0.9%)

2.3%

5.2%

7.9%

112,279

105,426

6.5%

1.1%

(2.5%)

(0.5%)

0.8%

25.4%

19.4%

47.3%

25.7%

24.7%

19.4%

48.2%

25.1%

0.7%

-

(0.9%)

0.6%

22.0%

21.7%

0.3%

27.5%

26.4%

1.1%

24.9%

24.2%

0.7%

The following table shows the EBITDA performance of the business by halves, discussed in the following sections of the report.

1 H16 
$’000

1 H15 
$’000

Var 
%

2 H16 
$’000

2 H15 
$’000

Var 
%

FY 16 
$’000

FY 15 
$’000

Var 
%

Total – all lines of business

Sales Revenue

Other revenue

Expenses:

Cost of goods sold

Personnel

214,509

208,117

3.1%

236,150

228,254

4,787

3,792

26.2%

5,388

5,778

(60,011)

(60,347)

(75,263)

(69,685)

Advertising & promotions

(8,731)

(8,497)

Occupancy & facility expenses

(14,325)

(14,236)

Motor vehicle expenses

Other expenses

Operating expenses

Operating EBITDA

Operating margin %

(3,785)

(9,909)

(4,159)

(9,810)

(172,024)

(166,734)

47,272

45,175

22.0%

21.7%

0.6%

(8.0%)

(2.8%)

(0.6%)

9.0%

(1.0%)

(3.2%)

4.6%

0.3%

(67,014)

(65,098)

(75,495)

(72,646)

(7,799)

(8,218)

(14,129)

(13,919)

(4,096)

(7,998)

(4,665)

(9,235)

(176,531)

(173,781)

65,007

60,251

27.5%

26.4%

3.5%

(6.7%)

(2.9%)

(3.9%)

5.1%

(1.5%)

12.2%

13.4%

(1.6%)

7.9%

1.1%

450,659

436,371

10,175

9,570

3.3%

6.3%

(127,025)

(125,445)

(150,758)

(142,331)

(16,530)

(16,715)

(28,454)

(28,155)

(7,881)

(8,824)

(17,907)

(19,045)

(348,555)

(340,515)

112,279

105,426

24.9%

24.2%

(1.3%)

(5.9%)

1.1%

(1.1%)

10.7%

6.0%

(2.4%)

6.5%

0.8%

InvoCare Annual Report 2016  |  13

Directors’ Report continued

A summary of the comparable business operating EBITDA by major income statement line item by halves is presented in the following table. 

1 H16 
$’000

1 H15 
$’000

Var 
%

2 H16 
$’000

2 H15 
$’000

Var 
%

FY 16 
$’000

FY 15 
$’000

Var 
%

Total – all lines of business

Sales Revenue

Other revenue

Expenses:

Cost of goods sold

Personnel

213,017

207,619

4,712

3,779

(60,065)

(60,251)

(73,777)

(68,413)

Advertising & promotions

(7,640)

(7,828)

Occupancy & facility expenses

(14,113)

(14,163)

(3,676)

(9,478)

(4,114)

(9,547)

2.6%

24.7%

0.3%

(7.8%)

2.4%

0.4%

10.6%

0.7%

Motor vehicle expenses

Other expenses

Operating expenses

Operating EBITDA

Operating margin %

Number of deaths and cases

(168,749)

(164,316)

(2.7%)

(173,743)

(170,925)

48,980

47,082

23.0%

22.7%

4.0%

0.3%

65,869

62,050

28.1%

27.3%

234,616

227,254

3.2%

447,633

434,873

4,996

5,721

(12.7%)

9,708

9,500

(67,142)

(65,288)

(74,050)

(71,368)

(7,049)

(7,123)

(13,907)

(13,728)

(4,014)

(7,581)

(4,592)

(8,826)

(2.8%)

(3.8%)

1.0%

(1.3%)

12.6%

14.1%

(1.6%)

6.2%

0.8%

(127,207)

(125,539)

(147,827)

(139,781)

(14,689)

(14,951)

(28,020)

(27,891)

(7,690)

(8,706)

(17,059)

(18,373)

(342,492)

(335,241)

114,849

109,132

25.7%

25.1%

2.9%

2.2%

(1.3%)

(5.8%)

1.8%

(0.5%)

11.7%

7.2%

(2.2%)

5.2%

0.6%

The number of deaths continues to be a very significant driver of InvoCare’s performance. The ageing of the population in InvoCare’s 
markets and the long-term trend of increasing numbers of deaths are major pillars of growth for the Group. However, short-term fluctuations 
in the numbers of deaths do occur such that in any year the number can be up to 5% above or below the trend line, as shown in the 
following graphs for both Australia and New Zealand.

The Australian graph incorporates the most recent long-term death projections released in November 2013 by the Australian Bureau of 
Statistics. Projections for New Zealand have been sourced from the latest data supplied by Statistics New Zealand.

Actual and Projected Calendar and Fiscal Year Deaths – Australia

325

300

275

250

225

200

175

150

125

100

)

0
0
0
’
(

r
e
b
m
u
N

1990

1995

2000

2005

2010

2015

2020

2025

2030

2035

2040

2045

2050

Actual national rolling annual deaths per ABS

Trend plus/minus 5%

ABS projected deaths 2012 Series B

Estimated national rolling annual deaths per ABS

Actual and Projected Calendar and Fiscal Year Deaths – New Zealand

57.5

52.5

47.5

)

0
0
0
’
(

14

42.5

r
e
b
m
u

N

37.5

32.5

27.5

22.5

1990

1995

2000

2005

2010

2015

2020

2025

2030

2035

2040

2045

2050

Actual rolling annual deaths per Statistics NZ Series 3

Trend plus/minus 5%

NZ projected deaths 2016 (base)-2068

Directors’ Report continued 
 
Actual and Projected Calendar and Fiscal Year Deaths – Australia

325

300

275

250

225

200

175

150

125

100

)

0

0

0

’

(

r

e

b

m

u

N

1990

1995

2000

2005

2010

2015

2020

2025

2030

2035

2040

2045

2050

Actual national rolling annual deaths per ABS

Trend plus/minus 5%

ABS projected deaths 2012 Series B

Estimated national rolling annual deaths per ABS

Actual and Projected Calendar and Fiscal Year Deaths – New Zealand

57.5

52.5

47.5

42.5

37.5

32.5

27.5

22.5

)

0
0
0
’
(

r
e
b
m
u
N

1990

1995

2000

2005

2010

2015

2020

2025

2030

2035

2040

2045

2050

Actual rolling annual deaths per Statistics NZ Series 3

Trend plus/minus 5%

NZ projected deaths 2016 (base)-2068

The table below illustrates the trends in InvoCare’s funeral case volumes over the last 24 months, clearly demonstrating how the volumes 
have changed from period to period.

Australia

New Zealand

Singapore

Total comparable business

Total Group (incl. USA & acqns)

2016 vs 2015

2015 vs 2014

Half 1

(1.6%)

(4.3%)

(9.0%)

(2.2%)

(1.2%)

Half 2

(1.8%)

(4.5%)

(2.7%)

(2.2%)

(1.5%)

Full Year

Half 1

(1.7%)

(4.3%)

(5.5%)

(2.2%)

(1.4%)

2.4%

3.0%

4.8%

2.5%

3.6%

Half 2

0.9%

(1.2%)

7.4%

0.8%

2.2%

Full Year

1.6%

0.7%

6.0%

1.6%

2.8%

1. Comparable businesses in the table comprise a different mix in 2016 from 2015. The 2015 percentages are as presented in the FY2015 results presentation. 

Commentary on the period since 31 December 2016 is set out in the Outlook section on page 20. 

Sales

Key components of the comparable sales movements are summarised below:

•  Australian funeral sales increased 1.5% or $4.3 million to $301.8 million (2015: $297.5 million).

 о Average revenue per funeral contract, excluding disbursements and delivered prepaid impacts, increased 4.1% (2015: 2.7%) and 
contributed an estimated $9.0 million to sales growth. Contributing to the average revenue were the combined effects of price 
increases (averaging between 3% and 4%) and strong performance in markets that have historically yielded high average revenue 
per contract such as Victoria.

 о The number of funeral services performed was down on the previous year by 1.7%. InvoCare’s market intelligence indicates that 

across its overall markets the number of deaths increased by approximately 0.8%. Market share losses in Queensland, New South 
Wales and Western Australia were mitigated to some extent by gains made in other states. Management has been actively pursuing 
strategies to address market share with more details provided in the Outlook section of this Directors’ Report on page 20.

 о The number of new prepaid funeral contracts sold for comparable Australian business increased by 24.9% on the previous year 
and exceeded the number of prepaid services performed by 42.0% (2015: 14.8%). Strong customer demand for prepaid funeral 
contracts before the new age pension entitlement rules came into effect on 1 January 2017 and an effective marketing campaign 
accounted for most of the increase. Prepaid funerals performed in the year were 14.3% (2015: 13.8%) of comparable at need 
funerals.

•  Australian cemeteries and crematoria sales were up 10.1% or $9.0 million to $97.7 million (2015: $88.7 million). Services performed 
decreased by 2.3% in line with the case volume decrease experienced by the funeral business, price increases were similar to the 
funeral business and memorialisation sales were strong. The net increase in the deferred revenue pool of unconstructed memorials was 
approximately $2.0 million (2015: $3.4 million) taking the pool to approximately $16.9 million (2015: $14.9 million) that will be constructed 
and included in sales revenue in future periods. New contracts added to the pool amounted to $6.0 million (2015: $7.8 million) and the 

InvoCare Annual Report 2016  |  15

 
 
Directors’ Report continued

amount constructed and included in sales was $4.0 million (2015: $4.3 million). In addition, deferred revenue includes $46.5 million 
(2015: $44.0 million) of pre-sold plaques, ash containers and other miscellaneous items deliverable and recognisable in sales revenue at 
the customer’s future time of need.

•  Comparable New Zealand sales (in NZD) were down 3.1% or $1.5 million to $45.9 million (2015: $47.4 million). Case volumes were 

down 4.3% due to combination of a 3.0% decline in numbers of death and, minor, market share losses across InvoCare’s market in 
New Zealand. Funeral case averages increased 2.5%. Case averages benefited from price increases (2-3%) at the beginning of each of 
January and July but were impacted by customers seeking low priced offerings and wanting less service from funeral directors. In AUD 
New Zealand sales were down 0.2% to $44.2 million (2015: $44.3 million) which included favourable FX movements of $0.4 million.

•  Singapore funeral sales (in SGD) increased by 3.9% to $17.7 million (2015: $17.0 million). Case volume decrease of 5.5% was offset by 

a 9.5% increase in case averages driven by customer demand for high value funeral offerings. Majority of the case volume decrease 
stemmed from the low cost segment of the market where management made a strategic decision to not compete. In AUD Singapore 
sales increased 4.3% to $17.2 million (2015: $16.5 million), which included favourable FX movements of $0.1 million. 

• 

Intra-group elimination of cemeteries and crematoria sales to InvoCare owned funeral homes amounted to $12.8 million (2015: 
$12.4 million).

•  USA operations, set up in early 2015, generated revenues of US$1.4 million (A$1.9 million). Over 700 funeral cases and over 2,400 
cremations were performed during the year. Funeral case averages achieved were over US$1,200 and cremation case averages 
achieved were over US$250. Subsequent to the balance date, a strategic decision was made to execute an orderly closure of the 
Group’s USA funeral operations after a detailed review of its performance to date. It is expected that the closure will cost approximately 
$700,000. 

Acquired businesses, being two cremation memorial parks in Christchurch (New Zealand) in July 2015 contributed, (in NZD), $2.2 million 
to sales in 2016, before the elimination on consolidation of sales of $0.9 million by the acquired Christchurch memorial parks to InvoCare 
owned funeral homes in Christchurch.

Other revenue

Other revenue increased by $0.6 million to $10.2 million (2015: $9.6 million). Other revenue mainly comprises administration fees upon 
initial sale of prepaid funeral contracts and trailing commissions on prepaid funds. The increase in 2016 was mainly attributable to higher 
administration fees on prepaid funeral contracts following the strong sales growth recorded in the year.

Operating expenses and EBITDA1

Operating expenses (excluding depreciation, amortisation, acquisition related and finance costs) for the comparable operations increased 
$7.2 million or 2.2% to $342.5 million. Tight cost management, particularly during the second half, resulted in the Operating EBITDA1 to 
sales margin increasing to 25.7%, from 25.1% in 2015. The second half margin was 28.1%, compared to 27.3% in the second half of 2015.

Australia recorded a strong EBITDA growth with New Zealand and Singapore businesses recording a slight EBITDA decline and growth 
respectively. Growth in EBITDA to sales margin was achieved in Australia and New Zealand whereas Singapore business recorded a slight 
decline mainly due to increased marketing expense to combat strong competition.

After including expenses of the USA operation of $5.4 million and from new business acquisitions of $0.6 million, the total Group operating 
expenses increased by 2.4% or $8.0 million and margins improved by 0.8% to 24.9%. 

Favourable FX movements benefited Operating EBITDA by $0.1 million, as the NZD and SGD strengthened against the AUD.

Depreciation and amortisation expenses

Depreciation and amortisation expenses were up $1.1 million in 2016 to $21.3 million (2015: $20.2 million). This increase included $0.4 
million associated with the USA and other acquired businesses.

Finance costs

Finance costs declined by $1.2 million to $13.4 million (2015: $14.8 million). Lower interest rates and expiry of some higher fixed cost 
swaps were the main contributors to lower debt interest. More information about the Group’s debt facilities is set out under the Capital 
Management section.

Acquisition related costs

Acquisition costs of $0.1 million were in line with those incurred in 2015.

Share of associate

After writing down InvoCare’s investment in online memorial associate to $nil, equity accounting of the associates losses is no longer 
required. The associate, in which InvoCare has a 35% interest, continues to record losses during its start-up phase.

1  Operating EBITDA is non-IFRS financial information.

16

Directors’ Report continuedUndelivered prepaid contract gains

Net gains on undelivered prepaid contracts were $22.9 million (2015: $7.5 million). The current year gain comprised of a $39.4 million 
increase in the fair value of funds under management offset by $16.5 million growth in the future liability to deliver prepaid services.

The fair value uplift of $39.4 million in funds under management was $19.6 million higher than PCP due to returns on the main Guardian 
Fund being impacted by positive revaluations of unlisted property investments.

During the year the preneed liability was increased to progressively recognise the impact of expected price increases. This resulted in 
liability growth of $16.5 million which was up on last year’s $12.3 million. 

Please refer to the accompanying financial statements for detailed Consolidated Income Statement and Consolidated Balance Sheet 
impact of undelivered prepaid contract performance. 

Approximately 80% of InvoCare’s prepaid funds under management are with the Over Fifty Guardian Friendly Society. Asset allocations 
for this fund remained relatively steady over the year with strong returns delivered from direct property investments. The trustees of the 
Guardian fund continued to evaluate asset allocation strategies that will deliver required returns with acceptable levels of risk and volatility. 
This may see a further shift in asset classes should the right opportunities be identified.

Asset allocations, which are being closely reviewed as equity markets remain volatile, are set out below:

Equities

Property

Cash and fixed interest

Asset sales

31 Dec 2016 
%

30 June 2016 
%

31 Dec 2015 
%

13

32

55

15

27

58

17

26

57

Minor after tax gains and losses on asset sales were recorded in both 2016 and 2015.

Impairments

All of the Group’s previously impaired assets, being memorial parks and the Group’s investment in its associate, were assessed during 2016 
and no change to the impairment provision was deemed necessary (2015: after tax impairment gain of $0.3 million).

Income tax expense

Income tax expense on reported profit was $27.8 million (2015: $26.7 million), representing an effective rate of 29.2% (2015: 32.7%). The 
effective rate represents a return to trend as 2014 had an effective rate of 29.3%. The major cause of the increase in 2015 was adjustments 
to prior periods covering a total of four years. An analysis of tax paid, based on tax residency status, for Australia and the Group is set 
out on the following page.

InvoCare Annual Report 2016  |  17

Directors’ Report continued

Profit before tax

Tax at nominal rate in relevant country

Increase / (decrease) due to non-temporary differences

Non-deductible expenses

Foreign exempt dividends

Capital gains offset against previously unrecognised capital losses

Impairment of financial assets

Revenue tax losses not recognised

Other items

Increase / (decrease) due to temporary differences

Depreciation and amortisation

Unrealised prepaid contract funds under management gains and losses

Accruals and creditors

Provisions

Deferred expenses

Gains / (losses) on the sale of fixed assets

Impairment of cemetery land

Other items

Income tax paid or payable

Income tax paid1

Australia

Group

2016 
$’000

96,928

29,078

139

(837)

(118)

-

-

-

1,008

(6,357)

(77)

(13)

(136)

205

-

367

23,259

24.0%

2015 
$’000

82,553

24,766

2016 
$’000

100,372

29,173

147

(1,815)

-

790

-

-

1,017

(1,965)

377

703

(254)

(95)

(1,620)

204

22,255

27.0%

176

-

(118)

43

794

30

1,239

(6,357)

(85)

(38)

(136)

190

-

433

25,344

25.2%

2015 
$’000

81,715

23,669

226

-

-

790

948

(132)

1,343

(1,965)

371

759

(254)

(103)

(1,620)

177

24,209

29.6%

1.  Calculated as the total amount of income tax paid divided by the Profit before Tax.

The governance of the tax functions of the Group have been delegated by the Board to the Audit, Risk & Compliance Committee who 
adopt a conservative approach when considering tax planning initiatives. Tax planning initiatives are not implemented until they receive 
approval from the Audit, Risk & Compliance Committee. Additionally, the committee receives a regular report on the Group’s tax 
compliance activities.

The Group has a limited number of international related party arrangements in place. An Australian subsidiary receives dividends from 
Singapore Casket Company, which is resident in Singapore, and the New Zealand group is charged management fees based on time spent 
for management, administration, accounting and other services provided by the Australian operation.

In addition to income tax paid the Australian group pays payroll tax, $5,716,000 in 2016 (2015: $5,533,000), fringe benefits tax, $2,264,000 
in 2016 (2015: $2,701,000) and land tax on owned buildings, $3,544,000 in 2016 (2015: $3,159,000), to various state governments. Council 
and water rates paid to various authorities totaled $1,901,000 in 2016 (2015: $1,807,000).

18

Directors’ Report continuedCash flow highlights

Net cash provided by operating activities

Asset sale proceeds

Asset purchases

Purchase of subsidiaries and businesses

Payments to funds for pre-paid contract sales

Receipts from funds for pre-paid contracts performed

Net cash used in investing activities

Dividends paid to InvoCare shareholders

Net increase in borrowings

Other movements

Net cash used in financing activities

Net increase / (decrease) in cash during year

Cash at start of year

Exchange rate effects

Cash at end of the year

2016 
$’000

2015 
$’000

78,496

4,510

(30,321)

(1,270)

(46,669)

39,253

(34,497)

(43,188)

2,235

(123)

64,631

1,138

(22,035)

(7,076)

(35,338)

37,022

(26,289)

(40,157)

70

(118)

(41,076)

(40,205)

2,923

8,679

(74)

11,528

(1,863)

10,488

54

8,679

The operating EBITDA conversion to cash ratio for the period was 104% which was up compared to the 97% achieved in 2015 as shown in 
the table below.

Operating EBITDA

Cash provided by operating activities

Add finance costs

Add income tax paid

Less interest received

Ungeared, tax free operating cash flow

Proportion of operating EBITDA converted to cash

Capital expenditure related to:

Property, refurbishments and facility upgrades

Motor vehicles

Information Technology

Other assets

Total capital expenditure

2016 
$’000

2015 
$’000

112,279

105,426

78,496

13,233

25,319

(25)

117,023

104%

2016 
$’000

11,028

6,832

7,504

4,957

64,631

14,380

23,690

(83)

102,618

97%

2015 
$’000

6,446

7,320

4,322

3,947

30,321

22,035

Purchase of businesses included $1.3 million deferred purchase consideration paid in relation to historical acquisitions.

Dividends paid in the year totalled $43.2 million (2015: $40.2 million), including $4.5 million (2015: $6.6 million) for the on-market purchase of 
shares for the dividend reinvestment plan.

There were no shares required to be purchased during 2016 and 2015 by the InvoCare Deferred Employee Share Plan Trust in connection 
with the long-term, share-based incentives scheme. Share grants in 2016 were made using unvested, forfeited shares from prior 
years’ grants.

Capital management

At 31 December 2016, the Group had drawn down $235 million borrowings (from total $290 million debt facilities) compared to $252 million 
at 30 June 2016 and $232 million at 31 December 2015. Net debt at 31 December 2016 was $223 million, which compared to the balance 
at 30 June 2016 of $239 million and 31 December 2015 of $223 million. 

InvoCare Annual Report 2016  |  19

Directors’ Report continued

The Group has $290 million bi-lateral, multi-currency, revolver facilities which comprise five-year tranche of $170 million, maturing in 
December 2018, and a five-year tranche of $120 million, maturing in December 2020. 

The five-year tranche maturing in December 2018 is provided in equal $42.5 million proportions by Australia and New Zealand Banking 
Group Limited (“ANZ”), Commonwealth Banking Group Limited (“CBA”), Westpac Banking Corporation (“Westpac”) and HSBC Bank 
Australia Limited (“HSBC”) or their New Zealand affiliates. The five-year tranche maturing in December 2020 is provided by ANZ 
($45 million), CBA ($45 million) and HSBC ($30 million). The Group intends to renegotiate the tranche falling due in 2018 in the latter part 
of  2017.

The current facilities’ drawings comprise AUD164.0 million, SGD27.0 million and NZD44.5 million. The foreign currency drawings naturally 
hedge investments in foreign Singapore and New Zealand markets.

Financial covenant ratios on the borrowing facilities are a Leverage Ratio (being Net Debt to EBITDA adjusted for acquisitions) which must 
be no greater than 3.5 and an Interest Cover Ratio (being EBITDA to net interest) which must be greater than 3.0. Both these ratios continue 
to be comfortably met at 31 December 2016, being 1.98:1 and 10.05:1 respectively. 

To maintain certainty over cash flows, the Group has policies limiting exposure to interest rate fluctuations. In accordance with the policy, 
at balance date, 78% of Australia and New Zealand debt principal was covered by floating to fixed interest rate swaps. Due to the level of 
stability of Singapore interest rates and their quantum Singapore debt is not covered by interest rate swaps.

The overall average effective interest rate is currently 4.6% (2015: 5.4%), inclusive of fixed rates on hedged debt, floating rates on unhedged 
debt, margins (based on tranche tenor and leverage – currently averaging around 150bps), undrawn commitment fees and amortisation of 
establishment fees. 

Headroom on the debt facilities of $55.0 million, and cash of $11.5 million, provide $66.5 million in available funds at 31 December 2016. 
This amount together with operating cash flows will provide further capacity to fund near-term growth opportunities.

Outlook

Re-Cap of 2015 Strategic Review 

During 2015, the Board reviewed the Group’s strategy and concluded that:

•  Business fundamentals in core markets remain strong;

•  Potential to drive greater operational efficiencies;

•  On-going opportunities for market share improvements from existing assets;

•  Opportunities for more efficient deployment of capital; and

•  Acquisition opportunities still exist in Melbourne, Adelaide and Singapore.

Planning work undertaken in 2016 

During 2016 the CEO and the executive team undertook detailed planning work to identify the key projects that will deliver the key strategic 
actions identified above. The key areas of work that have been undertaken are summarised below:

•  Customer – detailed research into the evolving customer needs;

•  Demographics – assessment of current and future demographics of core markets; 

•  Brands – review of both InvoCare’s and Competitors brand relevance and physical product;

•  Network – identification of optimisation opportunities (growth, disposal and consolidation); 

•  Operational Efficiency – assessment of current operations, identification of key areas of opportunities and detailed planning for 

projects that will deliver improvements;

•  Culture – developed clarity on key behaviours required to deliver the strategic objective of local leadership within a strong business 

system framework;

•  Organisational Structure – identification of appropriate structure to assist support the cultural objectives.

20

Directors’ Report continuedThe outlook for 2017 is for a continued improvement in the Groups 
operating EBITDA growth with high single digit growth anticipated 
for 2017. The operating EPS growth for 2017 is expected to be 
slightly lower due to additional costs of debt impacting in 2017, 
whilst the main benefits associated with the capital will start coming 
on line in 2018 and beyond.

Total sales revenue for the month of January 2017 was up 
approximately 9% on January 2016, due mainly to case volume 
growth in all three core markets. Consistent with past practice, 
funeral prices were increased as planned in late 2016 and cemetery 
and crematoria prices are scheduled to be increased during the first 
quarter of 2017.

The outlook for 2017 is highly dependent on the number of deaths 
that occur in 2017, and as has been seen in the past this can cause 
short-term volatility, despite the positive longer-term trend.

The longer-term outlook is for continuing improvement in operating 
EBITDA performance and for operating EPS growth to reliably 
deliver double-digit growth.  

Significant events after the balance date

Subsequent to the balance date a strategic decision was made to 
execute an orderly closure of the Group’s USA funeral operations 
after a detailed review of its performance to date. Other than this, 
there have been no significant events occurring after balance 
date which have significantly affected or may significantly affect 
either InvoCare’s operations or the results of those operations or 
InvoCare’s state of affairs in future financial years.

Environmental regulation and performance

InvoCare is committed to the protection of the environment, the 
health and safety of its employees, customers and the general 
public, as well as compliance with all applicable environmental 
laws, rules and regulations in the jurisdictions in which the 
consolidated entity operates its business. The consolidated entity 
is subject to environmental regulation in respect of its operations, 
including some regulations covering the disposal of mortuary 
and pathological waste and the storage of hazardous materials. 
InvoCare has appropriate risk management systems in place at 
its locations.

There have been no claims during the year and the directors believe 
InvoCare has complied with all relevant environmental regulations 
and holds all relevant licences.

2020 Plan: Protect and Grow 

The outcome of this work has been consolidated into a four year 
plan named “Protect and Grow” estimated to cost $200 million. 
The focus of this plan is to ensure that the strong operational 
platform developed over 20 years is maintained and improved, and 
that growth by acquisition is augmented by the opening of new 
locations within existing core markets. 

The Protect and Grow plan has three core programmes of work:

•  Network and Brand Optimisation – refresh and enhance 
existing facilities to better meet the evolving needs of 
customers, and growth through the opening of new locations 
within and adjacent to the existing network.

•  People and Culture – ensure that InvoCare provides the 

highest level of responsiveness to customer needs and further 
strengthens the culture of accountability and collaboration. In 
order to promote collaboration the structure of how InvoCare 
operates will shift to managing locations by geography rather 
than by brands and empowering local leaders. 

•  Operational Efficiencies – will be driven by a major project 
of renewing InvoCare’s business systems and operational 
practices. In addition, InvoCare will invest in standalone 
operational centres that will ensure it is positioned to cope with 
the increased level of demand that will be driven by favourable 
demographics and increased market share.

The implementation is planned to be undertaken over a four year 
period to allow the company to monitor the performance of the 
investments and make adjustments to future investments where 
required. It is expected that the ramp-up period for the benefits 
associated with these investments will be from 2018 through to 
2022. The expected returns from this investment program will be 
consistent with what the Group has earned over previous years.

Funding the 2020 Plan 

InvoCare has always maintained an extremely robust balance sheet 
with strong credit metrics that is managed within a strong financial 
framework and this will continue. Whilst the intention is to fund 
the $200m plan using a combination of operation cash flow and 
additional debt, the company will seek to maintain a shadow credit 
rating that is equivalent to that of Investment Grade.

The sourcing of debt will be undertaken in two tranches. Firstly 
during 2017 InvoCare will increase its existing facilities to $350m  
(up from $290m). This will fund the initial work and provide a 
sensible amount of headroom to allow for opportunistic acquisitions 
and maintain a conservative liquidity buffer. The longer term funding 
requirements (2018-20) will be put in place by the end of 2017 
following a review to identify the best mix of maturities, funding 
instruments and facility pricing. 

The core pillars of growth are summarised below:

•  Demographics – a revision to the long-term growth trend  

(1.5% increase in deaths per annum);

•  Market Share – stabilised in 2017, improving in 2018 

and beyond;

•  Case Average – growth consistent with recent history;

•  Operating Expenses – continued efficiency gains;

•  Acquisitions / New Developments – increased activity in both 
new developments and acquisitions following the network and 
brand review. 

InvoCare Annual Report 2016  |  21

1

2

3

4

5

6

7

Mr Richard Fisher (1), Mr Martin Earp (2), Mr Richard Davis (3), Ms Joycelyn Morton (4), Ms Robyn Stubbs (5), Mr Gary Stead (6), Dr Christine (Tina) Clifton (7)

Information on directors

Mr Richard Fisher AM MEc LLB 
Chairman of the Board 
Chair of Nomination Committee 
Member of People, Culture & Remuneration Committee 
Age 67 years 
Appointed October 2003

Richard Fisher is General Counsel to The University of Sydney 
and is an Adjunct Professor in its Faculty of Law. Richard is the 
immediate past Chairman of Partners at Blake Dawson (now 
Ashurst) and specialised in corporate law. He has been a director 
of InvoCare Limited since 24 October 2003. He is also a director of 
Sydney Water. Richard is formerly a part-time Commissioner at the 
Australian Law Reform Commission, an International Consultant for 
the Asian Development Bank and a Member of the Library Council 
of NSW. Richard holds a Master of Economics from the University 
of New England and a Bachelor of Laws from the University 
of Sydney.

Interest in shares: 17,914 ordinary shares in InvoCare Limited

Mr Martin Earp MSc, BSc (Hons), MBA 
Chief Executive Officer 
Age 48 years 
Appointed April 2015

Martin Earp joined InvoCare on 30 March 2015, was appointed 
as a Director on 13 April 2015 and assumed the role of CEO and 
Managing Director on 1 May 2015. 

Prior to joining InvoCare Martin was the CEO of Campus Living 
Villages and was responsible for the strategic direction and 
operational leadership of the company. He worked for Transfield 
Holdings for over twelve years in a number of operational roles 

22

including CEO of the Australian Biodiesel Group (ASX listed 
company), General Manager Airtrain (where he also served as 
a Director for eight years) and Business Development Manager 
for Airport Rail Link. Prior to this he worked for a London based 
transport consultancy advising on large infrastructure and 
investment deals.

Martin holds an MBA from the Australian Graduate School of 
Management, a Masters in Traffic Engineering and a degree in 
Transportation Management and Planning.

Interest in shares: 29,545 ordinary shares in InvoCare Limited / 
160,313 options in InvoCare Limited

Dr Christine (Tina) Clifton MB BS (Hons) BHA 
Non-executive Director 
Chair of People, Culture & Remuneration Committee 
Member of Audit, Risk & Compliance Committee 
Member of Nomination Committee 
Age 61 years 
Appointed October 2003

Tina Clifton is a registered medical practitioner. Tina has been a 
director of InvoCare Limited since October 2003. She has also 
been a Director of various public and private companies over the 
last 15 years. Prior to 2001, Tina held various positions in the public 
and private healthcare sectors including Chief Executive Officer 
of the Sisters of Charity Health Service in New South Wales and 
deputy Chief Executive Officer of the Northern Sydney Area Health 
Service. From 1980 to 1988 Tina was a general practitioner. Tina 
holds degrees in medicine and health administration and obtained a 
specialist qualification in medical administration. 

Interest in shares: 112,961 ordinary shares in InvoCare Limited

Directors’ Report continuedMr Richard Davis BEc 
Non-executive Director 
Member of People, Culture & Remuneration Committee 
Member of Finance, Capital & Investment Committee 
Member of Nomination Committee 
Age 61 years 
Appointed February 2012

Mr Gary Stead BCom LLB MBA 
Non-executive Director 
Chair of Finance, Capital & Investment Committee 
Member of Audit, Risk & Compliance Committee 
Member of Nomination Committee 
Age 59 years 
Appointed September 2014

Richard Davis was appointed a non-executive director of InvoCare 
Ltd on 21 February 2012. Richard previously retired as InvoCare’s 
Chief Executive Officer and Managing Director on 31 December 
2008 after 20 years with InvoCare. For the majority of that time, 
he held the position of Chief Executive Officer and successfully 
initiated and managed the growth of the business through a 
number of ownership changes and over 20 acquisitions, including 
Singapore Casket Company (Private) Limited, the Company’s first 
international acquisition.

Richard is currently serving as Chairman of Singapore Casket 
Company (Private) Limited. Prior to joining the funeral industry, 
Richard worked in venture capital and as an accounting partner of 
Bird Cameron. Richard holds a Bachelor of Economics from the 
University of Sydney. 

Other Public Company Directorships held in the last three years:

Australian Vintage Limited (appointed non-executive director in May 
2009 and chairman in May 2015)

Monash IVF Group Limited (appointed non-executive director and 
chairman in June 2014)

Interest in shares: 521,607 ordinary shares in InvoCare Limited

Ms Joycelyn Morton BEc FCA FCPA FIPA FGIA FAICD 
Non-executive Director 
Chair of Audit, Risk & Compliance Committee 
Member of Finance, Capital & Investment Committee  
Member of Nomination Committee  
Age 57 years 
Appointed August 2015

Joycelyn Morton was appointed a director of InvoCare Limited on 
19 August 2015. She has more than 37 years experience in finance 
and taxation having begun her career with Coopers & Lybrand 
(now PwC), followed by senior management roles with Woolworths 
Limited and global leadership roles in Australia and internationally 
within the Shell Group of companies.

Joycelyn was National President of both CPA Australia and 
Professions Australia, she has served on many committees and 
councils in the private, government and not-for-profit sectors.

Former ASX listed non-executive director roles include Crane Group 
Limited, Count Financial Limited, and Chair of Noni B Limited. 
Effective 1 January 2017 Joycelyn joined the Board of ASC Pty Ltd, 
Australia’s largest specialised defence shipbuilding organisation. 
Joycelyn holds a Bachelor of Economics from the University 
of Sydney. 

Other Public Company Directorships held in the last three years:

Thorn Group Limited (appointed non-executive director in October 
2011 and Chair in 2014)

Argo Investments Limited (appointed non-executive director in 
March 2012)

Argo Global Listed Infrastructure Limited (appointed non-executive 
director in 2015).

Interest in shares: 8,205 ordinary shares in InvoCare Limited

Gary Stead was appointed a non-executive director of InvoCare 
Limited on 1 September 2014. Gary is currently Managing Director 
of HPS Investment Partners, LLC based in Sydney, Australia. 
Prior to his current role, Gary was the Managing Director and 
Co-Head of Olympus Capital Asia Credit and previously founder 
and Managing Director of Australia-focused structured credit fund, 
Shearwater Capital and Chief Executive of Fortress Investment 
Group Australia, where he established its Australian operations in 
2004. Gary’s prior experience included 13 years at Merrill Lynch, 
where he held various leadership positions, including Co-Head of 
Investment Banking in Japan, Vice Chairman of Investment Banking 
in Australia, and Head of Mergers and Acquisitions in Australia, 
Asia-Pacific and Japan, following earlier roles at both Schroders in 
Australia and Salomon Brothers in New York.

After starting his working career as a solicitor with degrees in 
law and commerce from the University of New South Wales, he 
subsequently completed an MBA at Wharton Graduate School of 
Business at the University of Pennsylvania before commencing a 
30-year investment banking career.

Interest in shares: 6,615 ordinary shares in InvoCare Limited

Ms Robyn Stubbs BBus MSc GAICD 
Non-executive Director 
Age 53 years 
Appointed January 2017

Robyn Stubbs was appointed a director of InvoCare Limited on 1 
January 2017. She has more than 25 years experience in senior 
marketing, sales, leasing and broader management roles with large 
and complex organisations, including Stockland, Ten Network, 
Fairfax Media, Lend Lease and Unilever.

Robyn is a non-executive director of the responsible entity for ASX 
listed Aventus Retail Property Fund and is a Board Member of 
Lifeline Northern Beaches Incorporated and Harness Racing New 
South Wales.

Robyn holds a Bachelor of Business from the University of 
Technology Sydney, is a graduate of The Australian Institute of 
Company Directors and has completed an MSc in coaching 
psychology from the University of Sydney.

Other Public Company Directorships held in the last three years:

Aventus Retail Property Fund (appointed non-executive director 
from 16 October 2015)

Interest in shares: Nil ordinary shares in InvoCare Limited

InvoCare Annual Report 2016  |  23

Directors’ Report continued

Company Secretary 
Mr Phillip Friery BBus CA

Phillip Friery was appointed Company Secretary in January 2007 
and Chief Financial Officer in March 2007. He retired as Chief 
Financial Officer effective 8 September 2016. Prior to joining the 
Group in 1994 as Accounting Manager, Phillip spent approximately 
19 years with Coopers & Lybrand (before its merger with Price 
Waterhouse) in external audit, technical advisory and financial 
management consulting roles. He holds a Bachelor of Business 
from the New South Wales Institute of Technology (now University 
of Technology Sydney) and is a member of the Institute of 
Chartered Accountants Australia and New Zealand.

Interest in shares: 51,874 ordinary shares in InvoCare Limited / 
33,441 options in InvoCare Limited

Chief Financial Officer 
Ms Josée Lemoine BCom / Chartered Professional Accountants 
of Canada 

Josée was appointed Chief Financial Officer on 8 September 
2016. Josée has had a finance career spanning several blue chip 
companies across multiple industries and geographies, with a clear 
focus on driving businesses to deliver commercial outcomes.

Josée’s most recent role was with Telstra, having led the Finance 
transformation program as part of her broader portfolio. Prior to 
this, Josée held senior leadership roles at Rio Tinto Alcan, Fairfax, 
Boral and Arnott’s. She started her career at KPMG where she 
worked in Canada, New Zealand and Hungary.

Josée holds a Bachelor of Commerce from the Hautes Etudes 
Commerciales (HEC) at the University of Montréal and is a member 
of the Chartered Professional Accountants of Canada (formerly 
known as the Canadian Institute of Chartered Accountants).

Interest in shares: 2,931 ordinary shares in InvoCare Limited / 
14,754 options in InvoCare Limited

Meetings of directors

Details of the meetings attended by each director during the year ended 31 December 2016 are set below.

Non-executive Directors

Richard Fisher

Christine Clifton

Richard Davis

Gary Stead

Joycelyn Morton

Executive Director

Martin Earp 

A = number of meetings attended.

Board

Audit, Risk & 
Compliance 
Committee

Finance, Capital  
& Investment 
Committee

People, Culture & 
Remuneration 
Committee

Nomination 
Committee

A

11

9

11

10

11

11

B

11

11

11

11

11

11

A

6*

4

6*

6

6

6*

B

-

6

-

6

6

-

A

6*

3*

7

7

6

7*

B

-

-

7

7

7

-

A

6

5

7

3*

6*

5*

B

7

7

7

-

-

-

A

3

2

3

3

3

-

B

3

3

3

3

3

-

B = number of meetings held during the time the director held office or was a member of the committee during the year.

* = includes meetings attended as an invited guest of the committee where the director was not a member of the relevant committee.

Robyn Stubbs was appointed a Director effective from 1 January 2017.

The composition of the Board and Board Committees is a minimum of three directors. Board Committees consist entirely of independent 
non-executive directors. The CEO may attend all Board Committee meetings by invitation. Other senior management attend Board and 
Committee meetings by invitation.

24

Directors’ Report continuedCorporate Governance Statement

The Directors’ Report continues with the Corporate 
Governance Statement.

InvoCare Limited (the “Company”) and the Board of Directors 
(the “Board”) are committed to achieving and demonstrating the 
highest standards of corporate governance. The Company and 
its controlled entities together are referred to as “InvoCare” or the 
“Group” in this statement.

This statement outlines the main corporate governance practices 
in place throughout the financial year, which comply with the ASX 
Corporate Governance Council’s principles and recommendations 
as issued in March 2016. The Other Key Management Personnel 
(“Other KMP”) comprise:

•  Greg Bisset, Chief Operating Officer Australia (“COO Australia”);

•  Graeme Rhind, Chief Operating Officer New Zealand (“COO 

New Zealand”);

•  Wee Leng Goh, Chief Executive Officer of Singapore Casket 

Company (“CEO Singapore”); 

•  Phillip Friery, Chief Financial Officer: stepped down as CFO on 

8 September 2016 (“CFO”) but remains Company Secretary; and

•  Josée Lemoine, Chief Financial Officer: effective  

8 September 2016 (“CFO”).

For further information on the corporate governance policies 
adopted by InvoCare Limited, refer to the Company’s website: 
www.invocare.com.au

Principle 1 – Lay Solid Foundations  
for Management and Oversight

Functions of the Board and senior executives

The Board of InvoCare Limited is responsible for guiding and 
monitoring the Group on behalf of the shareholders by whom they 
are elected and to whom they are accountable.

The Board seeks to identify the expectations of the shareholders, 
as well as other regulatory and ethical expectations and obligations. 
In addition, the Board is responsible for identifying areas of 
significant business risk and ensuring arrangements are in place to 
adequately manage those risks.

The responsibility for the operation and administration of the Group, 
including day-to-day management of the Group’s affairs and the 
implementation of the corporate strategy and policy initiatives, 
is delegated by the Board to the CEO, other Senior Executives 
(being the direct reports of the CEO including the Other KMPs), 
and other management. Delegations are set out in the Group’s 
delegations policy and are reviewed regularly. Delegations, within 
defined authority limits, relate to various operational functions, 
including areas such as expenditure and commitments, employee 
matters (e.g. recruitment, termination, remuneration, discipline, 
training, development, health and safety), pricing, branding, investor 
and media communications. The Board ensures that the senior 
executives and the management team are appropriately qualified 
and experienced to discharge their responsibilities and has in 
place procedures to assess the performance of the CEO and the 
senior executives.

In deciding which functions and activities the Board reserves to 
itself, it is guided by the overarching principle that the Board is 
charged with strategic responsibility, along with a management 
oversight function, and that the executive management have an 
implementation function. In fulfilling these functions, the directors 

seek to enhance shareholder value and protect the interests of 
stakeholders.

The Board Charter is available on the Company’s website:  
www.invocare.com.au

Board and senior executive appointments

Prior to the appointment of a new director or senior executive, 
thorough background checks are undertaken to ensure that the 
individual has the appropriate background to hold their position 
with the Company. For directors, information about these checks 
is included in the Notice of Meeting when the individual stands for 
election. For senior executives, information about the checks is held 
by the Company Secretary. All Board members have formal letters 
of appointment which clearly articulate the roles, responsibilities, 
expectations and remuneration of directors. All senior executives 
have agreed formal contracts stipulating the terms of their 
employment including duties, obligations and conditions. 

Company Secretary

Created in September 2016 the Company Secretary is a dedicated 
part-time position that works closely with the Chairman of the 
Board and various committees to ensure that all directors receive 
the information they require to fully discharge their duties which 
includes facilitating external advice to directors where appropriate. 
Some aspects of these functions are supported by other senior 
staff specialists where appropriate and these interactions are free 
of executive management oversight to ensure that directors are 
fully informed.

Diversity

InvoCare released its Inclusion Policy during February of 2016, 
which is available on its website: www.invocare.com.au. 
The Inclusion Policy provides a framework that reinforces the 
Company’s long held commitment to diversity, with a focus on 
creating an inclusive organisational culture where all individuals feel 
respected and valued for their uniqueness. The nature of InvoCare’s 
businesses means that its employees come into daily contact with 
families from every walk of life and facet of society so a focus on 
inclusion makes a direct contribution to the business’s ongoing 
success, as well as being in line with community and stakeholder 
expectations. From a gender perspective, women currently 
comprise 43% (2015: 33%) of the Board, 36% (2015: 25%) of the 
group executive and 40% (2015: 35%) of Australian management. 
InvoCare’s current focus is on specific actions that will achieve 
overall gender equality at the Australian management level by the 
end of 2020, that is, a minimum of 45% management roles will be 
held by either gender. The Australian entity is a relevant employer 
under the terms of the Workplace Gender Equality Act.

Directors’ performance evaluation

The Board, through its Nomination Committee, undertakes an 
annual performance review of the full Board, its Committees and 
of the Chairman. The Chairman performs individual appraisals of 
each director.

The evaluation process, which was completed late in 2016, involves 
an assessment of Board and committee performance by each 
director completing a confidential questionnaire. The questionnaire 
covers such matters as the role of the Board, the composition and 
structure of the Board and committees, operation of the Board, 
Group behaviours and protocols and performance of the Board and 
committees, and invites comments from each director.

The results of the questionnaire are aggregated and discussed 
by the Board as a basis for collegiate consideration of Board 
performance and opportunities for enhancement.

InvoCare Annual Report 2016  |  25

Corporate Governance Statement 
continued

The individual appraisals between each director and the Chairman 
provide an opportunity for consideration of individual contributions, 
development plans and issues specific to the director.

The evaluation process provides the Board an opportunity to make 
an informed assessment of the skills of each individual director, 
reflect on how those skills are meeting the needs of the Company 
and consider Board succession planning.

Senior executive evaluation

After the conclusion of each financial year the CEO evaluates 
and documents the performance of each member of the Group 
Executive (senior executives including Other KMPs). The results 
of the achievement of targeted key performance indicators are 
reviewed by the People, Culture & Remuneration Committee along 
with market remuneration data for each role type. The Committee 
and the Board also review and determine each senior executive’s 
key performance indicators and remuneration for the ensuing year.

The People, Culture & Remuneration Committee evaluate the 
performance of the CEO against annual key performance indicators 
and reports to the Board its recommendations on performance 
appraisal and remuneration.

In addition to a review of monthly financial results, the Board 
monitors the key performance indicators and strategic plan for the 
Group, at least quarterly, which provides the opportunity to more 
regularly evaluate the performance of senior executives outside the 
annual review process. 

Principle 2 – Structure the Board to Add Value

Board composition

The Board currently comprises seven directors, being six non-
executive directors (including the Chairman) and one executive 
director, being the CEO. Any director appointed to fill a casual 
vacancy, except for the CEO, must stand for election by 
shareholders at the next Annual General Meeting. In addition, one-
third of the non-executive directors, and any other director who 
has held office for three years or more since last being elected, 
must retire from office and, if eligible, may stand for re-election. The 
CEO is exempt from retirement by rotation and is not counted in 
determining the number of directors to retire by rotation.

The composition of the Board and Board Committees is a 
minimum of three directors. Board Committees consist entirely 
of independent non-executive directors. The CEO may attend 
all Board Committee meetings by invitation. The other Senior 
Executives or managers attend Board and Committee meetings 
by invitation.

At the date of this report, the composition of the Board Committees 
is as follows:

Audit, Risk & 
Compliance 

People, 
Culture & 
Remuneration

Finance, 
Capital & 
Investment

Nomination

Chair

Chair

Director

Richard Fisher

Christine Clifton

Richard Davis

Joycelyn Morton

Chair

Gary Stead

Robyn Stubbs

Nomination Committee

Chair

The Nomination Committee critically reviews on an annual basis 
the corporate governance procedures of the Group and the 
composition and effectiveness of the Board. The Committee 
currently consists of the six independent non-executive directors of 
the Board. The Committee is chaired by Richard Fisher. 

In addition to its role in proposing candidates for director 
appointment for consideration by the Board, the Nomination 
Committee reviews and advises the Board in relation to CEO 
succession planning, Board succession planning, and Board and 
committees’ performance appraisals.

In 2014, the Committee assisted the Board in making the decision 
not to renew the former CEO’s contract at the end of its term on 30 
April 2015. Martin Earp was appointed as CEO following an external 
search conducted with the Committee’s oversight. Although the 
replacement CEO was appointed as recently as 1 May 2015, there 
is an ongoing focus on CEO succession.

In terms of Board succession planning and composition, there have 
been two new directors appointed in the last eighteen months. 
These appointments were made to provide additional expertise 
and / or replace the skills of departing directors. In addition, 
Christine Clifton has foreshadowed her intention to retire before the 
next Annual General Meeting. Similar Richard Fisher has advised 
the Board he will retire in the course of 2018. Planning for their 
succession is now underway. Moreover, with the appointment of 
Robyn Stubbs to the Board it has been possible to refresh the 
membership of the Board’s Committees and Robyn has been 
appointed to each of the People, Culture & Remuneration, the 
Finance, Capital & Investment and the Nominations committees.

InvoCare may utilise the professional advice of external consultants 
to find the best person for the position of director of the Company. 
These advisors seek applicants according to the Board’s skills 
requirements. The Board also acknowledges the benefits of a 
diverse Board and requires the advisors to present candidates 
with equal numbers of suitably qualified men and women and with 
some diversity in cultural background and age. The Board then 
selects the most suitable candidate(s) for the consideration of the 
shareholders. The Board is looking to achieve an appropriate mix of 
skills and diversity amongst directors. 

The Committee Charter is available on the Company’s website: 
www.invocare.com.au

26

Directors’ Report continuedBoard skills matrix

When considering the appointment of a new director the Board, through the Nomination Committee, considers the desirable skills mix 
for the Board and focusses its search on potential candidates who complement the existing skill set of the Board. The current matrix is 
summarised in the following table:

Business 
Management

Legal

Accounting / 
Finance

Funeral Industry

Health

International 
Business

Director / Skill Set

Richard Fisher
Tina Clifton
Richard Davis
Joycelyn Morton
Gary Stead
Robyn Stubbs
Martin Earp

Board independence

Directors’ induction 

The majority of the Board must be independent directors, one of 
whom is the Chairman. A director is deemed to be “independent” 
if independent of management and free of any business or other 
relationship that could materially interfere with, or could reasonably 
be perceived to materially interfere with, the exercise of unfettered 
and independent judgement. 

The Board has assessed, using the criteria set out in the ASX 
Corporate Governance Principles and Recommendations, the 
independence of non-executive directors in light of their interests 
and relationships and considers them all to be independent. The 
Company will provide immediate notification to the market where 
the independence status of a director changes.

When appointed to the Board, all new directors receive an induction 
appropriate to their experience, which is designed to quickly allow 
them to participate fully and productively in Board decision-making. 

The induction programme covers the Group’s structure and goals, 
financial, strategic, operational and risk management positions, 
the rights and duties of a director and the role and operation of the 
Board Committees. The Nomination Committee is responsible for 
reviewing the effectiveness of the director induction programme. 
New directors are given an orientation regarding the business, 
including corporate governance policies, all other corporate policies 
and procedures, Committee structures and responsibilities and 
reporting procedures.

The skills, experience and expertise relevant to the position of each 
director and their term of office are set out starting on page 22 of 
the Directors’ Report.

Directors’ access to independent professional advice and 
Company information

To assist in the effective discharge of their duties, directors may, in 
consultation with the Chairman, seek independent legal or financial 
advice on their duties and responsibilities at the expense of the 
Company and, in due course, make all Board members aware of 
both instructions to advisers and the advice obtained. 

All directors have the right of access to all relevant Company 
information and to seek information from the Company Secretary 
and other senior executives. They also have a right to other 
records of the Company subject to these not being sought for 
personal purposes. 

All directors and former directors are entitled to inspect and copy 
the books of the Company for the purposes of legal proceedings, 
including situations where the director is a party to proceedings, 
where the director proposes in good faith to bring proceedings 
and where a director has reason to believe proceedings will be 
brought against him or her. In the case of former directors, this right 
of access continues for a period of seven years after the person 
ceases to be a director. 

Prior to each Board meeting, the Board is provided with 
management reports and information in a form, timeframe, and 
quality that enables them to discharge their duties. If a board 
member considers this information to be insufficient to support 
informed decision-making, then they are entitled to request 
additional information prior to, or at, Board or committee meetings. 

Directors’ continuing education 

Directors are expected to undertake continuing education both 
as regards the normal discharge of their formal director duties, as 
well as ongoing developments within the Group and its operating 
environment. Directors typically attend courses and seminars 
relevant to the effective discharge of their duties. 

Principle 3 – Act Ethically and Responsibly

Code of Conduct

The Board, in recognition of the importance of ethical and 
responsible decision-making, has adopted a Code of Conduct 
for all employees and directors, which outlines the standards of 
ethical behaviour which are essential to maintain the trust of all 
stakeholders and the wider community. This code also mandates 
the avoidance of conflicts of interest and requires high standards 
of personal integrity, objectivity and honesty in the dealings of all 
directors and employees, providing detailed guidelines to ensure 
the highest standards are maintained.

InvoCare recognises that its clients may be vulnerable due to a 
recent bereavement and it requires all employees to be aware 
of their ethical and legal responsibilities. Accordingly, InvoCare 
requires all employees to behave according to this code, to 
maintain its reputation as a good corporate citizen. Such 
behaviours extend to areas such as confidentiality, Privacy Act 
obligations, communications with the media, work health and safety 
and drugs and alcohol.

This code is provided to all directors and employees as part of their 
induction process and compliance is reviewed on a regular basis. It 
is subject to ongoing review and assessment to ensure it continues 
to be relevant to contemporary conditions.

The code is available on the Company’s website:  
www.invocare.com.au

InvoCare Annual Report 2016  |  27

Corporate Governance Statement 
continued

Principle 4 – Safeguard Integrity  
in Corporate Reporting

Audit, Risk & Compliance Committee

The Audit, Risk & Compliance Committee provides assistance to 
the Board in fulfilling its corporate governance, risk management 
and oversight responsibilities in relation to the Group’s financial 
reporting, internal control structure, interest rate and foreign 
currency risks and the internal and external audit functions.

It is the responsibility of the Committee to maintain free and open 
communication between the Committee, the external auditor, the 
internal auditor and management of the Group. Both the internal 
and external auditors have a direct line of communication to the 
Chairman of the Audit, Risk & Compliance Committee.

The Audit, Risk & Compliance Committee comprises three 
independent non-executive directors and is chaired by Joycelyn 
Morton. Ms Morton is an FCPA, FCA and FGIA and brings a wealth 
of financial and taxation experience to the Committee. Other 
members are Christine Clifton and Gary Stead. The number of 
meetings held during the year and the individual attendances at 
those meetings is set out in the Information on Directors section of 
the Directors’ Report on page 24.

The external auditor met with the Audit, Risk & Compliance 
Committee during the year without management being present.

The Committee Charter is available on the Company’s website: 
www.invocare.com.au

Assurance

Prior to finalising the release of half-year and full-year results and 
reports, the Board receives assurance from the CEO and CFO 
in accordance with s295A of the Corporations Act 2001 and 
Recommendation 4.2 of the ASX Corporate Governance Principles 
and Recommendations. These assurances also provide the Board 
with information in relation to internal control and other areas of risk 
management. These officers receive similar assurance from the 
key financial and operational staff reporting to them in relation to 
these matters.

Auditor attendance at the Annual General Meeting

The Company’s external auditor attends the Annual General 
Meeting and is available to answer shareholder questions about 
the conduct of the audit and the preparation and content of the 
auditor’s report.

Principle 5 – Make Timely and Balanced Disclosure

The Company has appropriate mechanisms in place to ensure 
all investors are provided with timely, complete and accurate 
information affecting the Group’s financial position, performance, 
ownership and governance.

The Chairman, CEO, CFO or Company Secretary are responsible, 
as appropriate, for communication with shareholders and the 
Australian Securities Exchange (“ASX”). This includes responsibility 
for ensuring compliance with the continuous disclosure 
requirements in the ASX listing rules and overseeing and co-
ordinating information disclosure to the ASX, analysts, brokers, 
shareholders, the media and the public. Continuous disclosure 
obligations are well understood and upheld by the Board and senior 
executives. Formal and informal discussion and consideration of 
these obligations occurs as and when the need arises. The Group’s 

28

shareholder communication strategy is designed to ensure that 
all relevant information, especially market sensitive information, is 
made available to all shareholders and other stakeholders as soon 
as possible. InvoCare’s website is structured to ensure information 
is easily located and logically grouped. Those shareholders who 
have made the appropriate election receive email notification of all 
announcements.

The Continuous Disclosure Policy and Shareholder Communication 
Strategy are available on the Company’s website:  
www.invocare.com.au

Principle 6 – Respect the Rights of Shareholders

The Board of Directors aims to ensure that the shareholders are 
informed of all major developments affecting the Group’s state of 
affairs.

The Company uses its website to complement the official release 
of material information to the ASX. Shareholders may elect to 
receive email alerts when Company announcements are made. 
Notice of Annual General Meeting, half-year and annual results 
announcements and financial reports, investor presentations, 
press releases and other ASX announcements can be found on the 
Company’s website: www.invocare.com.au 

Additionally, all shareholders have the right to access details  
of the holdings, provide email address contacts and make  
certain elections via the Company’s share registry Link Market  
Services Limited by accessing the web site  
www.linkmarketservices.com.au. Shareholders have the option 
of receiving all or a selection of communication electronically.

The Company encourages full participation of shareholders at the 
Annual General Meeting. The Chairman of the meeting encourages 
shareholders to ask reasonable questions at the Annual General 
Meeting. The Board makes itself available to all shareholders both 
before and after the Annual General Meeting.

The next Annual General Meeting is scheduled to be 
held at 11.00am on Friday, 19 May 2017 at the offices of 
PricewaterhouseCoopers, One International Towers, Waterman 
Quay, Barangaroo.

Shareholders are also able to direct any questions relating to 
the Company’s securities to the share registry, Link Market 
Services Limited.

Principle 7 – Recognise and Manage Risk

The Board, through the Audit, Risk & Compliance Committee, 
reviews and oversees the Group’s risk management systems. 

Audit, Risk & Compliance Committee

The Audit, Risk & Compliance Committee determines the Group’s 
risk profile and is responsible for overseeing and approving risk 
management strategy and policies, internal compliance and internal 
control. The Committee does not have responsibility for strategy, 
which is a Board responsibility. The Board has reviewed the 
Group’s risk management framework during the year and confirmed 
that it remains sound.

The Company’s approach to managing risk draws from the 
International Standard ISO 31000 for Enterprise Risk Management. 
The Group does not have any material exposure to economic, 
environmental and social sustainability risks.

Each senior executive, with input and assistance from their direct 
reports, identifies key risks for their areas of responsibility and 
function, which are in turn aggregated into an overall corporate risk 

Directors’ Report continuedregister. Each risk is assessed and assigned an inherent risk rating. 
The risk register is continuously reviewed and maintained as new 
risks are identified or incidents occur, or mitigating controls change.

Extracts of the risk register are provided to the Audit, Risk & 
Compliance Committee at each of its meetings, together with 
specific commentary or information on significant changes to the 
risks or the ratings. Specific major risks or incidents are reported, 
as and when they occur, to the CEO and other Senior Executives 
who are responsible for escalating these to the Audit, Risk & 
Compliance Committee and Board, where necessary, if the event 
occurs outside the regular cycle of Committee meetings. The 
Committee is informed of the effectiveness of actions to mitigate 
the impact of risk events. In addition, the Committee considers 
developments or improvements in risk management and controls, 
including the adequacy of insurance programmes.

Separate records and registers are maintained for other more 
common or recurring risks; for example, arising from customer 
complaints and workplace health and safety issues. These are 
managed and reported to the Committee by the Group Executive 
Business Operations. In this context, the Committee monitors 
complaints handling and also has a strong focus on ensuring 
suitable work practices and employee learning and development 
programmes are developed and delivered.

The Audit, Risk & Compliance Committee Charter is available on 
the Company’s website: www.invocare.com.au

Internal control

The Group maintains a register of delegated authorities, which 
is designed to ensure that all transactions are approved at the 
appropriate level of management and by individuals who have no 
conflicts of interest in relation to the transaction.

An internal audit function is established and has developed a 
self-assessment questionnaire, which is distributed to operational 
management. This questionnaire serves to build higher awareness 
and understanding of business risks and how to manage and 
control them. 

Principle 8 – Remunerate Fairly and Responsibly

Non-executive directors are remunerated by way of directors’ fees, 
which may be sacrificed by payment into superannuation plans or 
by allocation of ordinary shares. They do not participate in schemes 
designed for the remuneration of employees, and do not receive 
retirement benefits, bonus payments or incentive shares.

Senior executive remuneration and other terms of employment are 
reviewed annually by the Committee, having regard to individual 
and Group performance, contribution to long-term growth, relevant 
comparative information, and independent expert advice. As well 
as a base salary, remuneration packages include superannuation, 
performance-related bonuses, long-term incentives and fringe 
benefits. The Remuneration Report which begins on page 30 
provides detailed information about the current remuneration 
practices and the levels of remuneration, including recent changes 
to long term incentive arrangements.

Share Trading Policy

The Company’s share trading policy is designed to minimise the 
risk that InvoCare, its directors and its employees will breach the 
insider trading provisions of the Corporations Act or compromise 
confidence in InvoCare’s practices in relation to securities trading. 
The policy prohibits directors and employees from trading in 
InvoCare securities when they are in possession of information not 
generally available to the investment community, and otherwise 
confines the opportunity for directors and employees to trade in 
InvoCare securities to certain limited periods. The policy specifically 
bans the use of techniques or products to limit the economic risk 
associated with holding the Company’s securities.

This policy applies to all senior staff, particularly managers and 
other senior employees, such as finance team members, who have 
access to information that is not generally available. In addition, it 
applies to all associates of these individuals. The policy prohibits 
trading in the Company’s shares except within narrow and specific 
windows when the Group believes the market is fully informed. 
There are limited procedural exceptions to the policy and in certain 
circumstances the Chairman has the ability to approve trading 
outside the policy prescriptions. 

The share trading policy is available on the Company’s website: 
www.invocare.com.au

People, Culture & Remuneration Committee

The Directors’ Report continues with the Remuneration Report.

InvoCare’s remuneration policy ensures that remuneration 
packages properly reflect employees’ duties and responsibilities, 
and that remuneration is competitive in attracting, retaining and 
motivating people of appropriate calibre. The People, Culture & 
Remuneration Committee reviews and makes recommendations to 
the Board on senior executive remuneration and appointment and 
on overall Group remuneration and benefits policies.

The People, Culture & Remuneration Committee comprise three 
independent non-executive directors with Christine Clifton as Chair 
and Richard Fisher and Richard Davis as members. The number 
of meetings held during the year and the individual attendances at 
those meetings is set out in the Information on Directors section of 
the Directors’ Report on page 24.

The People, Culture & Remuneration Committee Charter is available 
on the Company’s website: www.invocare.com.au

Remuneration structure

Remuneration for senior executives typically comprises a package 
of fixed and performance-based components. The Committee may, 
from time to time, seek advice from special remuneration consulting 
groups so as to ensure that the Board remains informed of market 
trends and practices.

InvoCare Annual Report 2016  |  29

The Remuneration Report

B.  Executive remuneration policy and framework

The Remuneration Report summarises the key compensation 
policies and practices for the year ended 31 December 2016, 
highlights the link between remuneration and corporate 
performance and provides detailed information on the 
compensation for non-executive and executive directors and other 
key management personnel.

The Remuneration Report is set out under the following main 
headings:

a.  Directors and key management personnel disclosed in this 

report

b.  Executive remuneration policy and framework

c.  Relationship between remuneration and InvoCare’s 

performance

d.  Non-executive director remuneration policy

e.  Details of remuneration

f.  Service agreements

g.  Share-based compensation

h.  Use of remuneration consultants

The information provided in this Remuneration Report has been 
audited as required by section 308(3C) of the Corporations Act 2001.

A.  Directors and key management personnel

Policy

The guiding principle underlying InvoCare’s executive remuneration 
philosophy is to ensure rewards are fair and reasonable, having 
regard to both internal and external relativities, appropriately 
balanced between fixed and variable components, and that all 
variable components are commensurate with performance and 
results delivered.

InvoCare’s remuneration policy is that:

• 

• 

for each role, the balance between fixed and variable 
components should reflect market conditions;

individual objectives should reflect the need for sustainable 
outcomes;

•  all variable pay should be tightly linked to measurable personal 

and business performance; 

• 

• 

total compensation should be market competitive and be 
reviewed annually, with no component guaranteed to increase; 
and

the CEO’s and Senior Executives’ total remuneration is 
benchmarked to comparable positions in comparable size 
companies (taking into account sales revenue, market 
capitalisation and industry), with the value of the incentives 
included in total remuneration based on amounts that can 
be achieved when individual and overall Group performance 
targets are met.

For the purposes of this report, the key management personnel 
(“KMP”) are those persons having authority and responsibility for 
planning, directing and controlling the activities of the Group or a 
major operation within the Group and are as follows:

Commencing January 2016, the Group will seek to clawback all 
or part of an executive’s incentives that has already been paid 
to ensure the executive has not been inappropriately awarded in 
circumstances including:

Non-executive directors

Richard Fisher (Chairman)

Christine Clifton

Richard Davis

Joycelyn Morton

Gary Stead

Other key management personnel

Martin Earp (Managing Director and Chief Executive Officer)

Josée Lemoine (Chief Financial Officer from 8 September 2016)

Phillip Friery (Chief Financial Officer until 8 September 2016 and 
Company Secretary)

Greg Bisset (Chief Operating Officer Australia)

Wee Leng Goh (Chief Executive Officer Singapore)

Graeme Rhind (Chief Operating Officer New Zealand)

A Group Executive Team (“GET”) comprising Martin Earp’s direct 
reports continues to operate. The Board has determined that 
not all members of the Group Executive Team are considered 
KMP, as they do not have responsibility for planning, directing 
and controlling a substantial part of the operations of InvoCare. 
Periodically changes are made to the Group Executive Team to 
reflect the evolving strategy and structure of the Company. The use 
of the term Senior Executives in this report means members of the 
Group Executive Team.

30

•  a material misstatement or omission in the Group’s 

financial statements;

• 

if actions or inactions seriously damage the Group’s reputation 
or put the Group at significant risk; and / or

•  a material abnormal occurrence results in an unintended 

increase in the award.

In accordance with InvoCare’s Share Trading Policy, senior 
managers are prohibited from trading the Company’s shares 
other than during specified trading windows, or with approval in 
exceptional circumstances, provided they do not possess inside 
information. In addition, senior managers are not permitted to enter 
into transactions in products associated with their shareholding 
in the Company which operate to limit the economic risk of their 
shareholding (e.g. hedging or cap and collar arrangements), 
which includes limiting the economic risk of holdings of unvested 
entitlements associated with LTI shares.

Remuneration structure 

The compensation of the CEO and other Senior Executives is 
comprised of payments and / or allocations under the following 
categories:

• 

total fixed remunerations including base salary and benefits, 
annual leave, superannuation and other incidental benefits;

•  short-term incentives (“STI”) in the form of annual cash 

bonuses; and

• 

long-term incentives (“LTI”) in the form of share-
based compensation.

Directors’ Report continuedThe target remuneration mix for the CEO and other KMP, as 
depicted in the following graph (and averaged for the other KMP), 
is set to place a considerable portion of executive remuneration 
at risk so as to align remuneration with both Group performance 
and the individual’s personal influence and contribution to the 
Group performance.

CEO – 2016

47%

24%

29%

CEO – 2015

51%

28%

21%

Other key 
management 
personnel – 2016

Other key 
management 
personnel – 2015

60%

60%

18%

22%

20%

20%

0%

20%

40%
■ TFR  ■ STI potential  ■ LTI potential

60%

80%

100%

During 2016 Senior Executives and many of their direct reports 
were transitioned to Total Fixed Remuneration (“TFR”) rather than a 
“Base plus superannuation” description. The intent is to implement 
this, more current practice across all levels of management 
during 2017.

No director or other key management personnel has, at 
31 December 2016 or during or since the end of the financial 
year, had any loans to or from the Group. The CEO and Senior 
Executives hold options over unissued shares in the Company 
under the terms the LTI scheme introduced during 2016. Section G 
provides detail for each KMP.

Short-term incentives (“STI”)

STIs are awarded for achievement of pre-determined financial and 
non-financial objectives. For Senior Executives, the target criteria 
and possible bonus levels are defined each year by the People, 
Culture & Remuneration Committee and Board, in consultation with 
the CEO. For other executives, the Senior Executives determine 
the objectives and reward levels within the constraints of a Board 
approved budget.

Each executive has a target STI opportunity depending on the 
accountabilities of the role and impact on Group performance. The 
STI opportunity for 2016 was up to a maximum of 51.4% of TFR 
for the CEO and from 24.8% up to a maximum of 44.7% for the 
other Senior Executives. The target criteria for Senior Executives 
is heavily weighted to overall financial performance, measured 
by EBITDA, being 50% of the potential STI opportunity for the 
CEO other Senior Executives, but is also tailored to the relevant 
circumstances of each executive. In the case of the EBITDA target 
50% of the STI amount is paid when 95% or more of the target is 
achieved. If 100% or more of the target is achieved the STI amount 
is limited to 100% of the target STI. The Group seeks to reward 
executives for sustained outperformance and this is reflected in 
the design and vesting arrangements in the LTI Plan, as well as an 
increased weighting to LTI incentive opportunities from 2016.

In summary, the criteria used to determine short-term bonuses for 
Senior Executive are aligned with InvoCare’s strategic and business 
objectives and include:

•  group, specific country or specific business EBITDA growth 
targets, with EBITDA being a key financial measure of the 
success of operations;

•  absolute case volume and Group, specific country or specific 
market share growth, which are cornerstones of the past and 
future growth of the business; and

•  other operational targets specific to the particular role including 
items like ERP implementation or decrease employee initiated 
turnover by 10% in Australia.

Other levels of staff also received short-term objective based 
compensation based on measurable and pre-determined targets. 
In addition to complementing the targets applying to more senior 
executives, for example these objectives include key performance 
indicators such as average revenue per case, sales of prepaid 
contracts, the management of labour costs, client survey results 
and debtors’ days outstanding.

Bonuses are payable in cash in the first quarter of each year 
after the completion of the audit of the results for the previous 
year ended 31 December. The People, Culture & Remuneration 
Committee considers that STI bonuses are awarded for 
achievement of key performance criteria for a particular financial 
year, without payment for outperformance, and that no part of 
the bonus should be deferred for payment in a later year. The 
Committee is of the view that the share-based LTI, described in 
more detail below, provides incentive for outperformance over the 
longer term, encourages executives to remain employed with the 
Group, and ensures alignment with shareholder interests.

Long-term incentives (“LTI”)

During 2015 the People, Culture & Remuneration Committee 
reviewed the design and operation of the LTI arrangements. As a 
consequence, a new LTI plan was introduced from January 2016 to 
eligible participants. It is referred to as the Performance Long Term 
Incentive Plan (PLTIP) and is aimed at attracting, rewarding and 
retaining high performing executives who contribute to the overall 
medium and long term success of InvoCare.

Key features of the PLTIP:

•  participants will be restricted to the CEO, the other Senior 

Executives, operational General Managers and selected high 
performing or high potential senior managers by invitation and 
as approved by the Board;

• 

• 

the awards are performance shares rights (“PSRs”) or options;

there is a return on capital gateway before any awards meeting 
performance conditions will vest;

•  no dividends will be paid on unvested awards; and

• 

there will be no voting rights.

For offshore employees participating in the PLTIP, any vested 
awards may be settled in cash instead of equity.

During 2007, a share-based compensation scheme, the InvoCare 
Deferred Employee Share Plan (“DESP”), was introduced under 
which the Board may offer selected senior managers incentive 
shares (“Deferred Shares”), or, in the case of foreign managers 
who may not be able to participate in Australian share offers, share 
equivalents (“Deferred Rights”). No consideration is payable by the 
employee for the DESP offer, but they are subject to continuous 
service and, for senior management, performance conditions. 
Deferred Shares are purchased on-market and hence the DESP 
is operated on a non-dilutive basis. Share equivalents for offshore 
employees are settled in cash.

Participants in the PLTIP are not eligible for grants under the 
existing DESP. This existing plan will be retained and continue 
for remaining participants and, at the CEO’s discretion, future 
participants. From January 2016, awards under the DESP will vest 
subject to continuous service only and recognise the contribution 
of primarily middle level managers over time through the granting of 
modest amounts of equity.

InvoCare Annual Report 2016  |  31

Remuneration report continued

In determining the amount of an offer to an individual manager, 
consideration is given to factors including market benchmarks, skill 
and experience, expected and actual performance over time and 
promotion and succession potential.

finance costs and after deducting tax) divided by the average 
invested capital during the year (being the average of the beginning 
and end of year balances of total assets less surplus cash less non-
interest bearing liabilities).

“Normalised earnings” means reported profit as adjusted:

A tiered arrangement by level applies to offers under the PLTIP:

•  CEO – of the maximum LTI award, 75% is in options and 25% 

in PSRs;

• 

• 

to remove the impacts of any gains or losses arising from the 
sale, disposal or impairment of non-current assets;

to maintain consistency in accounting policies across the 
respective vesting periods for each grant; and

• 

for PLTIP awards from February 2016:

 о to reflect constant currency; and

 о to remove impacts of non-cash movements in prepaid 
contracts and associated funds under management.

In the case of the CEO, CFO and Group Executive Capital 
Management, the non-cash movements for Guardian Plan prepaid 
contracts and funds under management will be included in the EPS 
figure utilised in calculating vesting for PLTIP.

Compound growth per annum of normalised EPS share was 
selected at the time of establishment of the DESP as the most 
suitable and reliable measure of organisational performance, based 
on independent advice and analysis by the Board. As part of the 
review of LTI arrangements during 2015, the People, Culture & 
Remuneration Committee re-affirmed the appropriateness of the 
EPS absolute measure, including by comparison to the commonly 
used Total Shareholder Return (“TSR”) relative metric. The reasons 
for this conclusion include:

• 

• 

• 

• 

InvoCare is a stable business without a true comparator peer or 
group to benchmark performance against within Australia;

relative TSR incentives tend to favour executives in companies 
with higher levels of inherent share price volatility than InvoCare, 
which has lower volatility in both share price and earnings than 
other ASX listed entities or market indices;

InvoCare has relatively small market capitalisation and its 
growth may appear constrained relative to an index or selected 
peer group;

the vagaries of equity markets are not controllable by InvoCare’s 
Board or its executives and introducing TSR would detract from 
the clear and proven organisational performance culture which 
already exists within InvoCare; and

•  earnings per share growth is aligned with InvoCare’s strategic 
objectives and, together with the introduction of a ROIC 
gateway, more closely reflects management performance and 
success in incrementally creating value through good decision 
making and sustained and improving performance over time.

Subject to the ROIC gateway condition, the EPS performance 
conditions applying for PLTIP awards in 2016 and 2017 are as set 
out below:

•  GET Participants – 75% in options and 25% in PSRs; and

•  Other Participants – 50% in options and 50% in PSRs.

The value of LTI award offered in 2016 was up to a maximum of 
60% of TFR for the CEO and up to a maximum 41.3% for the other 
Senior Executives.

The number of PSRs was calculated at the date of issue by dividing 
the value of LTI to be awarded in PSRs by the face value of an 
InvoCare share. The face value is based on the 10-day VWAP for 
InvoCare shares starting from the first day of the Trading Window 
immediately following the announcement of the full-year result.

The number of options was calculated based upon the value of 
LTI to be awarded in options divided by the option valuation at the 
award date. This option value was determined by an independent 
actuary using a Black Scholes valuation methodology. The valuation 
for allocation excludes dividends and does not incorporate any 
discount relating to the performance and tenure conditions. 

Under the DESP, the number of Deferred Shares or Deferred Rights 
is calculated by dividing the value of the LTI award by the on-market 
acquisition cost of InvoCare shares on the 10-day VWAP at the date 
of the grant if sufficient shares are available in the trust to satisfy 
the grant.

Vesting of the LTI awards under the PLTIP and DESP will be in three 
equal tranches in February of each of the second, third and fourth 
subsequent years after the year of offer. This is to allow for the 
impact that the number of deaths has on the Group’s annual result, 
which is outside the control of management particularly given the 
fixed cost nature of the business. Vesting of the first LTI tranche 
two years out from the initial grant, in part compensates for the fact 
STIs are capped and there is no additional reward for short term 
outperformance. Over the longer term, sustained levels of short-
term outperformance should translate into higher LTI rewards. 

Upon vesting of Deferred Shares under the DESP, the employee 
has the discretion to leave the Deferred Shares in trust, withdraw 
or sell any number of them. Upon vesting of Deferred Rights 
under the DESP, the employee will be paid in cash an amount 
equivalent to the number of vested Deferred Rights multiplied by 
the value of those rights derived by reference to the market value of 
InvoCare shares.

Upon vesting of PSRs under the PLTIP, the employee will be 
provided with InvoCare shares, satisfied either by a new issue or 
by on-market purchase. In the case of vested options, the exercise 
period is from the date of grant until 10th anniversary of the grant (eg 
for 2016 awards the end of option life will be February 2026).

Both schemes use the compound growth per annum in normalised 
Earnings per Share (“EPS”) over the vesting period. However, a 
‘gateway’ condition must be met before any PLTIP awards can vest. 
The gateway requires a minimum level of Return on Invested Capital 
(“ROIC”) greater that the Weight Average Cost of Capital (“WACC”). 
This is a safety net to ensure that capital is being employed 
efficiently and earnings growth is translating to shareholder value. 
ROIC is defined as the annual operating earnings (excluding net 

32

Directors’ Report continuedNormalised reported earnings per share (“EPS”)  
compound growth per annum from 1 January in the year of offer 

Proportion of each one-third tranche of LTI shares that will vest

12% or more

11% or more but less than 12%

10% or more but less than 11%

9% or more but less than 10%

8% or more but less than 9%

7% or more but less than 8%

Less than 7%

100%

86% plus 1.4% for each 0.1% EPS over 11% 

72% plus 1.4% for each 0.1% EPS over 10%

58% plus 1.4% for each 0.1% EPS over 9%

44% plus 1.4% for each 0.1% EPS over 8%

30% plus 1.4% for each 0.1% EPS over 7%

Nil

For DESP grants made in 2015, 2014 and 2012 the EPS performance vesting conditions are:

Normalised reported earnings per share (“EPS”)  
compound growth per annum from 1 January in the year of offer 

Proportion of each one-third tranche of LTI shares that will vest

10% or more

9% or more but less than 10%

8% or more but less than 9%

7% or more but less than 8%

Less than 7%

100%

77% plus 2.3% for each 0.1% growth in EPS over 9%

53% plus 2.4% for each 0.1% growth in EPS over 8%

30% plus 2.3% for each 0.1% growth in EPS over 7%

Nil

For DESP grants made in 2013 the EPS performance vesting conditions are:

Normalised reported earnings per share (“EPS”)  
compound growth per annum from 1 January in the year of offer

Proportion of each one-third tranche of LTI shares that will vest

12% or more

11% or more but less than 12%

10% or more but less than 11%

9% or more but less than 10%

8% or more but less than 9%

7% or more but less than 8%

Less than 7%

100%

80% plus 2.0% for each 0.1% EPS over 11% 

65% plus 1.5% for each 0.1% EPS over 10%

55% plus 1.0% for each 0.1% EPS over 9%

50% plus 0.5% for each 0.1% EPS over 8%

30% plus 2.0% for each 0.1% EPS over 7%

Nil

If the compound EPS growth performance conditions are not met at the vesting date, the unvested LTI awards remain available until 
February in the fifth year after grant and may vest based on the compound annual growth from the base date for the grant to 31 December 
of the previous year. Unvested awards at the fifth anniversary of the grant are automatically forfeited.

To receive 100% of the LTI awards, the Senior Executive or manager must remain employed during the vesting period and InvoCare’s 
compound EPS growth must equal or exceed the maximum target growth percentage. The employee remains exposed over this timeframe 
to the consequences of the Group’s results, their own individual performance impacting that result and the market movements in InvoCare’s 
share price.

In general, should a participant cease employment as a result of resignation or termination in circumstances the Board determines as 
related to their performance, all unvested equity awards held by the participant will lapse. In exceptional circumstances, the Board has the 
discretion to determine the extent to which all or part of any unvested equity may vest and the specific performance testing to be applied.

In circumstances where a termination is for reasons including retirement, death, total and permanent disablement, and bona fide 
redundancy, the Board may, at its sole discretion, allow all or part of the unvested equity awards to continue on foot and vest subject to the 
original terms and performance and service conditions set out in the letter of offer and plan rules at the time of award.

In the event of a change in control or other circumstances where the Board determines it is not practical or appropriate for the unvested 
equity to continue on foot, the Board has the discretion to determine the extent to which all or part of any unvested equity may vest and the 
specific performance testing to be applied. 

If no determination is made by the Board, all equity awards held by the participant will lapse upon termination of employment.

The Board has the discretion to determine that any LTI benefit payable in the above termination circumstances can be settled in cash.

The following table summarises the performance to date for the grants made since 2012 which impact remuneration in the current or a 
future financial year.

InvoCare Annual Report 2016  |  33

Remuneration report continued

LTI share 
grant year

Target annual compound 
normalised EPS growth 
from 1 January of grant year

Normalised EPS 
on 1 January of 
grant year

2012

7% to 10%

34.4 cents

2013

7% to 12%

38.7 cents

2014

7% to 10%

39.7 cents

2015

7% to 10%

49.1 cents

2016

7% to 12%

49.8 cents

2017

7% to 12%

61.6 cents

Performance condition testing date and vesting outcome

February 2014 – 39% of the first 1/3rd tranche vested 
February 2015 – 100% vesting of second and unvested first tranches 
February 2016 – 91% vesting of third 1/3rd tranche vested 
February 2017 – 100% of all unvested shares vest

February 2015 – 100% of first 1/3rd tranche vested 
February 2016 – 54% of second 1/3rd tranche vested 
February 2017 – 100% vesting of third tranche and unvested second tranche shares 
February 2018 – not required

February 2016 – 100% of first 1/3rd tranche vested 
February 2017 – 100% of second 1/3rd tranche vested 
February 2018 – to be determined 
February 2019 (if required)

February 2017 – 100% of first 1/3rd tranche vested 
February 2018 – to be determined 
February 2019 – to be determined 
February 2020 (if required)

February 2018 – to be determined 
February 2019 – to be determined 
February 2020 – to be determined 
February 2021 (if required)

February 2019 – to be determined 
February 2020 – to be determined 
February 2021 – to be determined 
February 2022 (if required)

Future offers of LTI awards may be made at the discretion of the Board and the service and performance conditions for any future offers 
may vary from previous LTI offers.

Further details of LTI awards are set out under the heading “G. Share-based Compensation”.

C.  Relationship between remuneration and InvoCare’s performance

The overall level of executive reward takes into account the performance of the Group over a number of years, with at risk remuneration 
linked to that performance. The remuneration approach, elements and mix has delivered an annualised 21.3% return for shareholders 
between listing in December 2003 and the end of 2016. As depicted by the following graph, the growth of an investment of $1 in InvoCare 
at listing exceeds the ASX200 growth over that period.

Growth of $1 in IVC with all dividends reinvested vs ASX 200 accumulation index 
Since IVC listing December 2003

IVC with divs reinvested 

ASX 200 Accumulation index 

$14.00 

$12.00 

$10.00 

1
$
n
o
n
r
u
t
e
R

$8.00 

$6.00 

$4.00 

$2.00 

$0.00 

34

3
0
0
2
-
c
e
D

4
0
0
2
-
r
p
A

4
0
0
2
-
p
e
S

5
0
0
2
-
b
e
F

5
0
0
2
-
l
u
J

5
0
0
2
-
c
e
D

6
0
0
2
-
y
a
M

6
0
0
2
-
t
c
O

7
0
0
2
-
r
a
M

7
0
0
2
-
g
u
A

8
0
0
2
-
n
a
J

8
0
0
2
-
n
u
J

8
0
0
2
-
v
o
N

9
0
0
2
-
r
p
A

9
0
0
2
-
p
e
S

0
1
0
2
-
b
e
F

0
1
0
2
-
l
u
J

0
1
0
2
-
c
e
D

1
1
0
2
-
y
a
M

1
1
0
2
-
t
c
O

2
1
0
2
-
r
a
M

2
1
0
2
-
g
u
A

3
1
0
2
-
n
a
J

3
1
0
2
-
n
u
J

3
1
0
2
-
v
o
N

4
1
0
2
-
r
p
A

4
1
0
2
-
p
e
S

5
1
0
2
-
b
e
F

5
1
0
2
-
l
u
J

5
1
0
2
-
c
e
D

6
1
0
2
-
r
p
A

6
1
0
2
-
p
e
S

Directors’ Report continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Based upon achievements in 2016, the People, Culture & Remuneration Committee determined the CEO and Senior Executives achieved 
an average 80% of their target STI opportunity. The percentage of the available STI cash bonus that was payable for the financial year and 
the percentage that was forfeited because the person or the consolidated entity did not meet the service and performance criteria is set 
out below:

Name

Martin Earp

Josée Lemoine

Phillip Friery

Greg Bisset

Wee Leng Goh

Graeme Rhind

Average

Cash STI bonus

Payable %

Forfeited %

92

88

88

65

83

39

80

8

12

12

35

17

61

20

The following factors were among those considered by the People, Culture & Remuneration Committee in making its assessment on the 
achievement of the STI opportunity:

•  EBITDA;

•  Key operational projects;

•  Market share;

•  New business acquisitions; and

•  Culture initiatives.

When assessing the non-numeric targets the Board had the benefit of a detailed review undertaken by Executive Governance.

In addition to STI, upon satisfying service and performance conditions, the Senior Executives also received the benefit of the vesting of LTI 
awards made in prior years. Further details are set out on page 40 under the heading “G. Share-based Compensation”.

The table below shows measures of the Group’s financial performance over the last five years, including those required by the Corporations 
Act 2001. However, these are not necessarily consistent with the measures used in determining the at-risk incentive components of 
Senior Executives’ remuneration. As a consequence, there may not always be a direct correlation between the statutory key performance 
measures and the variable remuneration awarded.

Reported profit after tax

Basic earnings per share

Operating earnings after tax – note 1

Normal dividends 

Normal dividends per share

Dividend payout of operating earnings

Total return per share – note 2

Total shareholder return – note 2

Share price – 31 December

2016

$70.9m

64.7¢

$55.2m

$46.5m

39.3¢

85%

$2.25

20%

$13.87

2015

$54.8m

50.1¢

$49.4m

$40.2m

38.0¢

85%

$0.28

2%

$12.01

2014

$54.5m

49.8¢

$46.2m

$40.1m

36.5¢

95%

$1.41

13%

$12.10

2013

$48.9m

44.7¢

$42.5m

$37.9m

34.5¢

90%

$2.60 

30%

$11.04

2012

$44.5m

40.6¢

$42.5m

$37.4m

34.0¢

88%

$1.39

18%

$8.78

1.  Operating earnings after tax is a financial measure, which is not prescribed by Australian equivalents to International Financial Reporting Standards (“AIFRS”), 

and represent the earnings under AIFRS adjusted for specific non-cash and significant items.

2.  Total return per share is the share price movement plus in year cash dividends paid. The total shareholder return percentage is the total return per share divided 

by the share price at the beginning of the year.

D.  Non-executive director remuneration policy

Non-executive directors

Fee pool and other fees

Non-executive directors’ base fees for services as directors are determined within an aggregate directors’ fee pool limit, which is 
periodically approved by shareholders. At the date of this report, the pool limit is $1,250,000, being the amount approved by shareholders 
at the Annual General Meeting held on 22 May 2015.

InvoCare Annual Report 2016  |  35

Remuneration report continued

This remuneration of the non-executive directors is determined by the Board. During the 2016 financial year, annual fees for non-executive 
directors were $264,000 for the Chairman of the Board and $132,000 for each of the other non-executive directors with an additional 
$11,000 for the Chairman of the Audit, Risk & Compliance Committee.

Using market information, the Board has determined 2017 fees will be increased to $270,600 for the Chairman and $135,300 for each of the 
other non-executive directors. The Chair of the Audit, Risk & Compliance Committee will be paid an additional annual fee of $11,275 for the 
additional work associated with the Committee. The aggregate of these fees is below the current pool limit.

The base fees exclude any remuneration determined by the directors where a director performs additional or special duties for the 
Company. If a director performs additional or special duties for the Company, they may be remunerated as determined by the directors 
and that remuneration can be in addition to the limit mentioned above. No fees for additional or special duties were paid to non-executive 
directors holding office during the years ended 31 December 2016 and 31 December 2015 other than Richard Davis who received $8,624 
in 2015.

Directors are entitled to be reimbursed for all reasonable costs and expenses incurred by them in the performance of their duties 
as directors.

Equity participation

Non-executive directors may receive options as part of their remuneration, subject only to shareholder approval. No options are held by any 
non-executive director at the date of this report.

Non-executive directors may participate in the Company’s DESP or PLTIP on a fee sacrifice basis. No shares or options have been issued 
or allocated to non-executive directors under either plan.

During 2009, the Board resolved that with effect from 1 January 2009, non-executive directors of InvoCare Limited be required to acquire 
a minimum equity interest in the Company equivalent in value to 50% of their annual director’s fee applying at the time of their appointment 
as a director of the Company and that directors be allowed up to three years to accumulate the required shareholding. At the date of this 
report, all non-executive directors, with the exception of Robyn Stubbs who was appointed on 1 January 2017, have equity interests in the 
Company meeting this requirement.

Directors’ equity holdings are set out under the heading “Information on directors” starting on page 22 of the Directors’ Report and in Note 
7: “Key Management Personnel Disclosures” on page 66 of the notes to the financial statements.

Retiring allowances

No retiring allowances are paid to non-executive directors.

Superannuation

Where relevant, fees paid to non-executive directors are inclusive of any superannuation guarantee charge and, at the discretion of each 
non-executive director, may be paid into superannuation funds.

36

Directors’ Report continuedE.  Details of Remuneration

Details of the remuneration of the directors and the executive key management personnel of the Group are set out in the following table.

Short-term employee benefits

Cash salary 
or fee 
Note 1

Short-
term cash 
bonus 
Note 2

Non- 
monetary 
benefits 
Notes 3

Post 
employment 
benefits

Other 
long-term 
benefits

Share-based payments

Super- 
annuation 
Note 4

Long service 
leave  
Note 5

LTI shares 
at risk 
Note 6

LTI shares 
forfeited 
Note 7

Total Statutory 
Remuneration 
Note 8

Executives’ 
Actual 
Remuneration 
Note 9

Non-executive directors

Year

$

2016

2015

2016

2015

2016

2015

2016

2015

2016

2015

2016

2015

2016

2015

2016

2015

2016

Richard Fisher 

(Chairman)

Christine Clifton

Richard Davis

Aliza Knox

(resigned 31 August 
2015)

Joycelyn Morton

(appointed  
19 August 2015)

Roger Penman

(resigned  
15 December 2015)

Gary Stead

(appointed  
01 September 2014)

Executive directors

Martin Earp 

(appointed  
30 March 2015)

Andrew Smith  
(note 12)

(contract ended  
30 April 2015)

Phillip Friery

Greg Bisset

Josée Lemoine

Wee Leng Goh 
(note 10)

Graeme Rhind 
(note 11) 

2016

2015

2016

2015

2016

2015

2016

2015

2016

$

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

$

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

$

 22,904 

 20,041 

 11,452 

 10,932 

 11,452 

 10,932 

 - 

 - 

 12,406 

 4,034 

 - 

 - 

 11,452 

 10,932 

$

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

$

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

241,096 

 210,959 

 120,548 

115,068 

 120,548 

 115,068 

 - 

84,000 

130,594 

42,464 

 - 

34,125 

120,548 

115,068 

$

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

 - 

$

$

 264,000 

 231,000 

 132,000 

 126,000 

 132,000 

 126,000 

 - 

 84,000 

 143,000 

 46,498 

 - 

 34,125 

 132,000 

 126,000 

 1,567,593 

 1,259,146 

 1,001,071 

 920,067 

 - 

 - 

 560,879 

 1,612,326 

764,991  405,211 

 55,170 

 26,941 

 5,351 

 309,929 

572,739  295,326 

 26,531 

 22,730 

 2,630 

 81,115 

 - 

 - 

 - 

 - 

 - 

 - 

2015

231,756 

44,072 

12,409 

 8,667 

 4,419 

 259,556 

Other key management personnel

 306,510  120,097 

 35,730 

 17,877 

 14,222 

 138,695 

 - 

 633,131 

 561,952 

 369,123  158,636 

 35,801 

 19,205 

 8,507 

 104,351 

(128,636) 

 566,987 

 701,518 

 389,297  125,704 

 26,723 

 30,001 

 12,987 

 166,832 

 751,544 

 689,546 

 361,581  168,612 

 27,393 

 30,003 

 12,447 

 136,291 

(108,700) 

 627,627 

 779,967 

 139,499 

 66,428 

 7,298 

 8,651 

 680 

 29,652 

 - 

 - 

 - 

 - 

 274,704 

 50,679 

 5,790 

 14,573 

 259,579 

 56,343 

 5,753 

 14,481 

 223,544 

 35,417 

 20,339 

 11,376 

 - 

 - 

 - 

 - 

 - 

 91,006 

 - 

 - 

 - 

 252,208 

 217,894 

 - 

 - 

 436,752 

 403,290 

 68,358 

(81,827) 

 322,687 

 416,251 

 93,861 

 - 

 384,537 

 336,357 

2015

 232,993 

 13,451 

 13,305 

 12,978 

 - 

 51,791 

 - 

 324,518 

 335,041 

InvoCare Annual Report 2016  |  37

Remuneration report continued

Notes to Remuneration Table:

1.  The total cost of fees and salary, including annual leave taken and the increase or decrease in the annual leave provision applicable to that individual.

2. 

 The amount to be settled in cash relating to performance of the Group and the individual for the financial year from 1 January to 31 December. The 
proportions of STI bonuses awarded and forfeited are set out on page 35.

3.  The cost to the Company, including any fringe benefits tax, for the provision of fully maintained cars, and other items.

4.  Contributions to superannuation.

5.  Long service leave accruals in accordance with relevant Australian Accounting Standards.

6. 

 The amount amortised as an expense in the financial year in accordance with Australian Accounting Standards, which require the value of long-term share-
based incentive grants to be amortised as an expense over the relevant future vesting periods. The amounts shown relate to unvested share and rights grants 
made in the current and past financial years. Subject to meeting the vesting conditions of the grants, the shares or rights will vest, or be forfeited, in future 
financial years.

7. 

 The reversal in the current financial year, in accordance with Australian Accounting Standards, previous years’ amortisation expense for long-term incentive 
shares granted in earlier years but which were forfeited in the current financial year because vesting conditions were not met.

8.  Total statutory remuneration is calculated and disclosed in accordance with the Corporations Act and Australian Accounting Standards.

9. 

 For information purposes and comparison with the total statutory remuneration, this column shows the executives’ remuneration which actually crystallised 
during the year, including salary, superannuation, leave entitlements paid and accrued, short-term incentives payable in respect of the financial year, the 
market value at vesting date of long-term incentive shares granted in previous years which vested during the year and other benefits, including termination 
benefits.

10.   Wee Leng Goh, Chief Executive Officer of Singapore Casket Company, received total remuneration of SG$448,630 (2015:SG$333,563), which has been 

converted to Australian dollars at the average exchange rate for the year of 0.9556 (2015: 0.9676).

11.   Graeme Rhind, Chief Operating Officer of New Zealand, received total remuneration of NZ$410,455 (2015:NZ$349,514), which has been converted to 

Australian dollars at the average exchange rate for the year of 0.9618 (2015: 0.9284).

12.  Andrew Smith stepped down as Chief Executive Officer on 30 April 2015 and is therefore no longer a KMP.

F.  Service Agreements

Chief Executive Officer

Remuneration and other terms of employment for the CEO, Martin Earp, have been formalised in a service agreement, which may be 
updated from time to time. The service agreement specifies that employment commenced on 30 March 2015, the role of CEO was 
assumed on 1 May 2015 and, subject to agreement to extend the term, the contract ends on 30 March 2018. The agreement provides for 
provision of salary, superannuation, short-term performance related cash bonuses, long-term performance related share-based bonuses 
and other benefits.

The total remuneration package is reviewed annually and the latest review effective from 1 January 2017 provides for Martin Earp’s 
remuneration as follows:

•  Total fixed remuneration (i.e. annual base salary, superannuation and motor vehicle) of $867,825 (“TFR”);

•  Short-term incentive bonus of up to $446,062, being 51.4% TFR; and

•  LTI award under the PLTIP to the value of $520,695, being 60.0% of TFR.

The STI opportunity will be subject to key performance conditions and weightings as follows:

•  EBITDA achievement (65% weighting) – with no STI earned until 95% of EBITDA budget is achieved at which level 50% of STI is 

payable, with no further payment until 100% budget achievement;

•  Culture programme roll out (15% weighting) – assessed by external consultant review of success; and

•  2017 Network and Brand Optimisation roll out (20% weighting)

The Board intends seeking the approval of shareholders at the next AGM for the CEO’s LTI awards.

The People, Culture & Remuneration Committee and Board have the discretion to provide additional performance incentives. Further details 
of the share-based remuneration are set out in Section G – Share-based Compensation.

Former Chief Executive

At the Annual General Meeting held on 20 May 2016, shareholders approved the cash settlement of long-term incentive shares subject to 
the satisfaction of the original vesting attaching to those rights. Accordingly, Mr Smith was paid a total of $157,000 before tax during 2016 
for the shares that would have otherwise vested and the STI approved at the same meeting.

38

Directors’ Report continuedThe relevant tests have been applied to the unvested grants that existed and a further 16,893 units will vest on 23 February 2017. Using 
the closing share price on 31 December 2016 that total value of the payment would be approximately $234,000. There are a further 24,257 
shares to be tested with 16,698 to be tested in February 2018 and 7,559 in February 2019.

Other Senior Executives

Remuneration and other terms of employment for each of the other Senior Executives are formalised in service agreements or letters of 
appointment as varied from time to time.

The senior executives’ total remuneration package is reviewed annually by the People, Culture & Remuneration Committee and Board and 
provides for remuneration to include:

•  TFR;

•  short-term incentive bonus averaging 42% of TFR with no retesting to recover any previous year shortfall; and

•  LTI awards averaging 38% of TFR.

Termination Arrangements for Senior Executives

Up to six months’ notice or payment in lieu of notice is generally required in the event of termination by the company. The company may 
terminate the employee immediately and without notice in the case of misconduct.

If the employee resigns, the employee must generally give six months’ notice.

Termination benefits are limited to statutory leave entitlements, unless determined otherwise by the People, Culture & Remuneration 
Committee and Board. Unless the Board exercises its discretion, upon termination for any reason, unvested LTI awards will be forfeited. 
The Board proposes putting a resolution dealing with termination benefit arrangements to shareholders at the next AGM. The approval 
sought will cover the following items:

•  payment in lieu of notice of termination under individual executive contracts of employment;

• 

the cash component of STI awards, at the Board’s discretion where the termination was not “for cause”;

•  at the discretion of the Board where the termination is due to retirement, death, total and permanent disability and bona fide 

redundancy, the option to allow LTI awards to remain on foot and be tested in line with the rules established at the time of grant; and

•  superannuation benefits.

Except for the CEO who is not subject to any post-employment restraints, other Senior Executives are generally subject to post-
employment restrictions for up to twelve months after employment termination without consideration paid for the restraint.

Non-executive directors

On appointment to the Board, all non-executive directors receive a letter of appointment, which summarises the Board policies and terms, 
including compensation, relevant to the office of director.

InvoCare Annual Report 2016  |  39

Remuneration report continued

G.  Share-based Compensation

Details of the LTI share and LTI share rights grants, vesting and forfeits for the Chief Executive Officer and other key management personnel 
are set out below.

Martin Earp

Phillip Friery

Josée Lemoine

Greg Bisset

Wee Leng Goh

Graeme Rhind

Year of grant

Final year 
vesting may 
occur (note1)

Number of 
shares or 
rights granted

Value at grant 
date (note 2)

Number 
vested  
during year

Total number 
vested

Vested %

2015

2016

2012

2013

2014

2015

2016

2016

2012

2013

2014

2015

2016

2012

2013

2014

2015

2016

2012

2013

2014

2015

2016

2020

2021

2017

2018

2019

2020

2021

2021

2017

2018

2019

2020

2021

2017

2018

2019

2020

2021

2017

2018

2019

2020

2021

17,410

10,617

8,098

9,617

9,483

8,079

6,644

2,931

16,088

12,212

12,044

10,260

7,457

5,081

4,124

4,607

4,074

4,155

4,536

3,464

4,011

3,422

2,858

$239,200

$128,250

$64,334

$105,140

$107,768

$111,001

$80,258

$35,410

$127,803

$133,525

$136,863

$140,969

$90,079

$39,432

$45,075

$52,336

$55,977

$49,259

$35,199

$37,862

$45,565

$47,018

$35,238

-

-

2,452

1,715

3,161

-

-

-

4,871

2,177

4,014

-

-

1,537

735

1,374

-

-

1,373

617

1,140

-

-

-

-

7,850

4,921

3,161

-

-

-

15,596

6,248

4,014

-

-

4,925

2,109

1,374

-

-

4,397

1,771

1,140

-

-

-

-

97%

51%

33%

-

-

-

97%

51%

33%

-

-

97%

51%

33%

-

-

97%

51%

33%

-

-

Maximum 
value yet to 
vest (note 3)

$239,200

$137,702

$1,970

$51,327

$71,818

$111,001

$86,173

$38,015

$3,914

$65,186

$91,221

$140,969

$96,717

$2,797

$33,890

$48,696

$57,375

$51,794

$2,371

$27,917

$40,896

$47,245

$38,398

1.  Under the terms of the respective year’s LTI grants, unvested shares or rights may vest in whole or in part in any year from 2016 up to the final year shown for 

each grant year.

2.  The value at grant date is based upon the share price at the time of grant. In accordance with Australian Accounting Standards, the original grant value of LTI 
shares is the amount amortised as an expense over the relevant future vesting periods. In the case of LTI rights 2016 and the overseas based Wee Leng Goh 
and Graeme Rhind, the amount expensed over the relevant future vesting periods takes account of value changes of the rights using the Black-Scholes / 
Merton valuation methodology.

3.  The maximum value of the original grant yet to vest. LTI shares are valued at original grant value. LTI rights for 2016 and for the overseas based Wee Leng Goh 
and Graeme Rhind are valued using the Black-Scholes / Merton valuation methodology. Performance conditions must be met before vesting and, if not, the 
minimum that will vest could be nil.

40

Directors’ Report continuedDetails of the LTI options grants, vesting and forfeits for the Chief Executive Officer and other key management personnel are set out below.

Martin Earp

Phillip Friery

Josée Lemoine

Greg Bisset

Wee Leng Goh

Graeme Rhind

Year of grant

Final year 
vesting may 
occur (note1)

Number 
of options 
granted

Value at grant 
date (note 2)

Number 
vested 
during year

Total number 
vested

Vested %

2016

2016

2016

2016

2016

2016

2021

2021

2021

2021

2021

2021

160,313

$384,750

33,441

14,754

37,533

20,946

14,416

$80,258

$35,410

$90,079

$49,259

$35,238

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maximum 
value yet to 
vest (note 3)

$537,049

$112,027

$49,426

$125,736

$67,771

$49,933

1.  Under the terms of the respective year’s LTI grants, unvested shares or rights may vest in whole or in part in any year from 2016 up to the final year shown for 

each grant year.

2.  The value at grant date is based upon the share price at the time of grant. In accordance with Australian Accounting Standards, the original grant value of LTI 
shares is the amount amortised as an expense over the relevant future vesting periods. In the case of LTI rights for the overseas based Wee Leng Goh and 
Graeme Rhind, the amount expensed over the relevant future vesting periods takes account of value changes of the rights using the Black-Scholes / Merton 
valuation methodology.

3.  The maximum value of the original grant yet to vest. LTI shares are valued at original grant value. LTI rights for 2016 and for the overseas based Wee Leng Goh 
and Graeme Rhind are valued using the Black-Scholes / Merton valuation methodology. Performance conditions must be met before vesting and, if not, the 
minimum that will vest could be nil.

The number of ordinary shares in the Company, or share appreciation rights, held during the year by each director of InvoCare Limited and 
other key management personnel are summarised in Note 7 on page 67.

H.  Use of remuneration consultants

During the year, the People, Culture & Remuneration Committee 
requested support from external consultants to provide 
remuneration benchmarks for selected Senior Executives and to 
understand best practice principles for remuneration report writing. 
This advice did not constitute a “remuneration recommendation” as 
defined in the Corporations Act 2001 (Cth).

The number of ordinary shares in the Company, or share 
appreciation rights, held during the year by each director of 
InvoCare Limited and other key management personnel are 
summarised in Note 7 on page 66.

Australian Firm

Assurance services

Taxation services

Other services

Non-Australian Firms

Taxation services

Other services

Total

$

26,350

51,250

69,500

63,763

17,144

228,007

Indemnifying officers or auditor

Auditor’s Independence Declaration

During the financial year, InvoCare paid a premium to insure 
directors and officers of the consolidated entity. The insurance 
policy specifically prohibits disclosure of the nature and liability 
covered and the amount of the premium paid.

No indemnity has been provided to the auditor of the Company in 
its capacity as auditor of the Company.

Proceedings on behalf of the company

No person has applied for leave of Court to bring proceedings on 
behalf of the Company or intervene in any proceedings to which 
the Company is a party for the purpose of taking responsibility on 
behalf of the Company for all or any part of those proceedings. The 
Company was not a party to any such proceedings during the year.

The copy of the auditor’s independence declaration as required under 
section 307C of the Corporations Act 2001 is set out on page 42.

Rounding of amounts

The Company is of a kind referred to in ASIC Corporations 
(Rounding in Financial / Directors’ Reports) Instrument 2016/191, 
issued by the Australian Securities and Investments Commission, 
relating to the “rounding off” of amounts in the Directors’ Report 
and Financial Report. Amounts in the Directors’ Report and 
Financial Report have been rounded off to the nearest thousand 
dollars (where rounding is applicable) in accordance with 
that instrument.

Signed in accordance with a resolution of the Board of Directors.

Non-audit services

The directors are satisfied that the provision of non-audit services 
during the year is compatible with the general standard of 
independence for auditors imposed by the Corporations Act 2001. 
The nature and scope of each type of non-audit service provided 
means that auditor independence was not compromised. 

The following fees for non-audit services were paid / payable to the 
external auditor (PricewaterhouseCoopers) during the year ended 
31 December 2016:

Richard Fisher 
Director   

Martin Earp 
Director

Dated this 23rd day of February 2017

InvoCare Annual Report 2016  |  41

 
 
 
 
Auditor’s Independence Declaration

As lead auditor for the audit of InvoCare Limited for the year ended 31 December 2016, I declare that to the best of my knowledge and 
belief, there have been:

a)  no contraventions of the auditor independence requirements of the Corporations Act 2001 in relation to the audit; and

b)  no contraventions of any applicable code of professional conduct in relation to the audit.

This declaration is in respect of InvoCare Limited and the entities it controlled during the period.

Brett Entwistle 
Partner 

PricewaterhouseCoopers

Sydney 
23 February 2017

PricewaterhouseCoopers, ABN 52 780 433 757 
Darling Park Tower 2, 201 Sussex Street, GPO BOX 2650, SYDNEY NSW 1171  
DX 77 Sydney, Australia 
T +61 2 8266 0000, F +61 2 8266 9999, www.pwc.com.au 

Liability limited by a scheme approved under Professional Standards Legislation. 

42

 
Consolidated Income Statement 

For the year ended 31 December 2016

Revenue from continuing operations

Finished goods, consumables and funeral disbursements

Employee benefits expense

Employee related and on-cost expenses

Advertising and public relations expenses

Occupancy and facilities expenses

Motor vehicle expenses

Other expenses

Depreciation and amortisation expenses

Intangible assets impairment charge

Cemetery land impairment reversal

Financial assets impairment charge

Finance costs

Interest income

Net gain on undelivered prepaid contracts

Acquisition related costs

Net gain on disposal of non-current assets

Profit before income tax

Income tax expense 

Profit from continuing activities

Profit for the year

Profit is attributable to:

Equity holders of InvoCare Limited

Non-controlling interests

Notes

4

2016 
$’000

460,834

(127,025)

(121,961)

2015 
$’000

445,941

(125,445)

(115,446)

5

5

5

5

5

15

6

(28,797)

(16,530)

(28,454)

(7,881)

(17,907)

112,279

(21,335)

(154)

-

-

(13,555)

964

22,928

(79)

(676)

100,372

(29,324)

71,048

71,048

70,949

99

71,048

(26,885)

(16,715)

(28,155)

(8,824)

(19,045)

105,426

(20,180)

-

5,400

(2,635)

(14,786)

722

7,527

(70)

312

81,716

(26,747)

54,969

54,969

54,844

125

54,969

Earnings per share for profit attributable to the ordinary equity holders of the Company

Basic earnings per share (cents per share)

Diluted earnings per share (cents per share)

11

11

64.7

64.6

50.1

50.1

The above Consolidated Income Statement should be read in conjunction with the accompanying notes.

InvoCare Annual Report 2016  |  43

Consolidated Statement of Comprehensive Income

For the year ended 31 December 2016

Profit for the year

Other comprehensive income

Items that may be reclassified to profit or loss

Changes in the fair value of cash flow hedges, net of tax

Changes in foreign currency translation reserve, net of tax

Other comprehensive income for the year, net of tax

Total comprehensive income for the year

Total comprehensive income for the year is attributable to:

Equity holders of InvoCare Limited

Non-controlling interests

Notes

26

26

2016 
$’000

71,048

2015 
$’000

54,969

1,048

1,083

2,131

73,179

73,080

99

73,179

1,179

(551)

628

55,597

55,472

125

55,597

The above Consolidated Statement of Comprehensive Income should be read in conjunction with the accompanying notes.

44

Consolidated Balance Sheet

For the year ended 31 December 2016

ASSETS

Current assets

Cash and cash equivalents

Trade and other receivables

Inventories

Prepaid contract funds under management

Property held for sale

Deferred selling costs

Total current assets

Non-current assets

Trade and other receivables

Other financial assets

Property, plant and equipment

Prepaid contract funds under management

Intangible assets

Deferred selling costs

Total non-current assets

Total assets

LIABILITIES

Current liabilities

Trade and other payables

Derivative financial instruments

Current tax liabilities

Prepaid contract liabilities

Deferred revenue

Provisions

Total current liabilities

Non-current liabilities

Trade and other payables

Borrowings

Derivative financial instruments

Deferred tax liabilities

Prepaid contract liabilities

Deferred revenue

Provisions

Total non-current liabilities

Total liabilities

Net assets

EQUITY

Contributed equity

Reserves

Retained profits

Parent entity interest

Non-controlling interests

Total equity

The above Consolidated Balance Sheet should be read in conjunction with the accompanying notes.

Notes

2016 
$’000

2015 
$’000

12

13

14

15

18 (c)

13

18

15

19

21

20

15

23

21

22

20

6 (d)

15

23

25

26

26

27

11,528

48,556

25,738

39,260

2,704

1,536

129,322

8,679

41,139

24,451

35,066

3,499

1,299

114,133

27,976

22,881

4

332,008

433,796

152,495

9,590

955,869

4

322,248

387,218

152,751

9,374

894,476

1,085,191

1,008,609

44,671

966

9,935

37,595

10,243

14,511

39,313

1,130

10,111

34,954

8,660

14,318

117,921

108,486

91

234,455

1,774

41,062

400,433

52,216

3,029

733,060

850,981

234,210

134,914

7,344

90,815

233,073

1,137

174

230,772

3,062

36,420

373,494

50,457

2,306

696,685

805,171

203,438

133,694

5,529

63,054

202,277

1,161

234,210

203,438

InvoCare Annual Report 2016  |  45

Consolidated Statement of Changes in Equity

For the year ended 31 December 2016

Attributable to Owners of InvoCare Limited

Balance at 1 January 2016

Total comprehensive income for the year

Transactions with owners in their capacity as owners:

Dividends paid

Deferred employee share plan shares vesting  
during the year

Transfer of shares from the deferred plan to  
the InvoCare Exempt Share Plan Trust

Employee shares – value of services

Balance at 31 December 2016

Balance at 1 January 2015

Total comprehensive income for the year

Transactions with owners in their capacity as owners:

Dividends paid

Deferred employee share plan shares vesting  
during the year

Transfer of shares from the deferred plan to  
the InvoCare Exempt Share Plan Trust

Employee shares – value of services

Balance at 31 December 2015

10

26

25

26

10

26

25

26

Notes

Contributed 
equity 
$’000

133,694

Retained 
profits 
$’000

Non 
controlling 
interests 
$’000

Total 

Total equity 
$’000

63,054

202,277

1,161

203,438

70,949

73,080

99

73,179

Reserves 
$’000

5,529

2,131

-

(43,188)

(43,188)

(123)

(43,311)

-

-

866

(866)

-

-

-

-

354

550

90,815

233,073

48,367

186,805

-

550

7,344

6,756

628

54,844

55,472

-

-

-

-

354

550

1,137

1,154

125

234,210

187,959

55,597

354

-

134,914

131,682

-

-

-

(40,157)

(40,157)

(118)

(40,275)

1,684

(1,684)

328

-

133,694

-

(171)

5,529

-

-

-

-

328

(171)

-

-

-

-

328

(171)

63,054

202,277

1,161

203,438

The above Consolidated Statement of Changes in Equity should be read in conjunction with the accompanying notes.

46

Consolidated Statement of Cash Flows

For the year ended 31 December 2016

Cash flows from operating activities

Receipts from customers (including GST)

Payments to suppliers and employees (including GST)

Other revenue

Interest received

Finance costs

Income tax paid

Net cash inflow from operating activities

Cash flows from investing activities

Proceeds from sale of property, plant and equipment

31

Purchase of subsidiaries and other businesses including acquisition costs, net of cash acquired

Purchase of property, plant and equipment 

Payments to funds for pre-paid contract sales

Receipts from funds for pre-paid contracts performed

Net cash outflow from investing activities

Cash flows from financing activities

Proceeds from borrowings

Repayment of borrowings

Payment of dividends – InvoCare Limited shareholders 

Dividends paid to non-controlling interests in subsidiaries

Net cash outflow from financing activities

Net increase in cash and cash equivalents

Cash and cash equivalents at the beginning of the year

Effects of exchange rate changes on cash and cash equivalents

Cash and cash equivalents at the end of the year

12

The above Consolidated Statement of Cash Flows should be read in conjunction with the accompanying notes.

Notes

2016 
$’000

2015 
$’000

508,492

489,769

(400,828)

(395,007)

9,359

117,023

25

(13,233)

(25,319)

78,496

4,510

(1,270)

(30,321)

(46,669)

39,253

(34,497)

84,735

(82,500)

(43,188)

(123)

7,856

102,618

83

(14,380)

(23,690)

64,631

1,138

(7,076)

(22,035)

(35,338)

37,022

(26,289)

45,023

(44,953)

(40,157)

(118)

(41,076)

(40,205)

2,923

8,679

(74)

11,528

(1,863)

10,488

54

8,679

InvoCare Annual Report 2016  |  47

Notes to the Consolidated Financial Statements

For the year ended 31 December 2016

Note 1:  Summary of Significant Accounting Policies

consistency with the policies adopted by the Group.

The principal accounting policies adopted in the preparation of 
the financial report are set out below. These policies have been 
consistently applied to all the years presented, unless otherwise 
stated. The financial statements are for the consolidated entity 
consisting of InvoCare Limited and its subsidiaries.

(a)  Basis of preparation

This general purpose financial report has been prepared in 
accordance with Australian Accounting Standards, other 
authoritative pronouncements of the Australian Accounting 
Standards Board, Urgent Issues Group Interpretations and the 
Corporations Act 2001.

(i)  Compliance with IFRS

The consolidated financial statements and notes of InvoCare 
Limited also comply with International Financial Reporting 
Standards (“IFRS”) as issued by the International Accounting 
Standards Board (“IASB”).

(ii)  Historical cost convention

These financial statements have been prepared on an accruals 
basis under the historical cost convention, as modified by the 
revaluation to fair value of financial assets and liabilities (including 
derivative instruments).

(iii)  Critical accounting estimates

The preparation of financial statements in conformity with IFRS 
requires the use of certain critical accounting estimates. It also 
requires the exercise of judgement in the process of applying the 
Group’s accounting policies. The areas involving a higher degree 
of judgement or complexity, or areas where assumptions and 
estimates are significant to the financial statements are disclosed at 
Note 37. 

(iv)  Comparatives

Where necessary, comparatives have been reclassified and 
repositioned for consistency with current year disclosures. 

(b)  Principles of consolidation

(i)  Subsidiaries

The consolidated financial statements incorporate the assets 
and liabilities of all subsidiaries of InvoCare Limited (“Company’’ 
or “parent entity’’) as at 31 December 2016 and the results of all 
subsidiaries for the year then ended. InvoCare Limited and its 
subsidiaries are together referred to in this financial report as the 
Group or the consolidated entity.

Subsidiaries are all entities (including structured entities) over 
which the Group has control. The Group controls an entity when 
the Group is exposed to, or has rights to, variable returns from its 
involvement with the entity and has the ability to affect those returns 
through its power to direct the activities of the entity.

Subsidiaries are fully consolidated from the date on which control 
is transferred to the Group. They are deconsolidated from the date 
that control ceases. The purchase method of accounting is used 
to account for the acquisition of subsidiaries by the Group (refer to 
Note 1(i)).

Intercompany transactions, balances and unrealised gains on 
transactions between Group companies are eliminated. Unrealised 
losses are also eliminated unless the transaction provides evidence 
of the impairment of the asset transferred. Accounting policies 
of subsidiaries have been changed where necessary to ensure 

48

Non-controlling interests in the results and equity of subsidiaries are 
shown separately in the consolidated statement of comprehensive 
income and balance sheet, respectively.

(ii)  Employee share trust

The Group has formed a trust to administer the InvoCare Exempt 
Employee Share Plan and the InvoCare Deferred Employee Share 
Plan. These trusts are consolidated, as the substance of the 
relationship is that the trust is controlled by the Group. Shares held 
by the InvoCare Deferred Employee Share Plan Trust are disclosed 
as treasury shares and deducted from contributed equity.

(iii)  Associates

Associates are entites over which the Group has significant 
influence but not control or joint control, generally accompanying 
a shareholding between 20% and 50% of the voting rights. 
Investments in associates are accounted for using the equity 
method of accounting, after intially being recognised at cost.

The Group’s share of its associates’ post-acquisition profits or 
losses and its share of post-acqusition movements in reserves 
is recognised in the statement of comprehensive income. The 
cumulative post-acquisition movements are adjusted against 
the carrying amount of the investment. Dividends received from 
associates are recognised as a reduction in the carrying amount of 
the investment.

If the Group’s share of losses in an associate equals or exceeds 
its interest in the associate, including any other unsecured long-
term receivables, the Group does not recognise further losses, 
unless it has incurred obligations or made payments on behalf of 
the associate.

Unrealised gains on transactions between the Group and its 
associates are eliminated to the extent of the Group’s interest 
in the associates. Unrealised losses are also eliminated unless 
the transaction provides evidence of an impairment of the asset 
transferred. Accounting policies of associates have been changed 
where necessary to ensure consistency with the policies adopted 
by the Group.

(c)  Segment reporting

Operating segments are reported in a manner consistent with the 
internal reporting provided to the chief operating decision maker. 
This reporting is based on the operational location of the business 
because different economic and cultural factors impact growth and 
profitability of the segment.

(d)  Foreign currency translation

(i)  Functional and presentation currency

Items included in the financial statements of each of the Group’s 
entities are measured using the currency of the primary economic 
environment in which the entity operates (“the functional 
currency”). The consolidated financial statements are presented 
in Australian dollars, which is InvoCare Limited’s functional and 
presentation currency.

(ii)  Transactions and balances

Foreign currency transactions are translated into the functional 
currency using the exchange rates prevailing at the dates of the 
transactions. Foreign exchange gains and losses resulting from the 
settlement of such transactions and from the translation at year end 
exchange rates of monetary assets and liabilities denominated in 
foreign currencies are recognised in the income statement, except 
when they are deferred in equity as qualifying cash flow hedges and 

Note 1: 

 Summary of Significant Accounting Policies 
continued

(d)  Foreign currency translation continued

qualifying net investment hedges or are attributable to part of the 
net investment in a foreign operation.

(iii)  Group companies

•  The results and financial positions of all the Group entities (none 

of which has the currency of a hyperinflationary economy) 
that have a functional currency different from the presentation 
currency are translated into the presentation currency as 
follows:

•  assets and liabilities for each balance sheet presented are 

translated at the closing rate at the date of that balance sheet;

• 

income and expenses for each income statement are translated 
at average exchange rates (unless this is not a reasonable 
approximation of the cumulative effect of the rates prevailing on 
the transaction dates, in which case income and expenses are 
translated at the dates of the transactions); and

•  all resulting exchange differences are recognised in other 

comprehensive income.

On consolidation, exchange differences arising from the translation 
of any net investment in foreign entities, and of borrowings 
and other financial instruments designated as hedges of such 
investments, are recognised in other comprehensive income. When 
a foreign operation is sold or any borrowings forming part of the 
net investment are repaid, a proportionate share of such exchange 
differences will be recognised in the income statement, as part of 
the gain or loss on sale where applicable.

Goodwill and fair value adjustments arising on the acquisition of 
a foreign entity are treated as assets and liabilities of the foreign 
entities and translated at the closing rate.

(e)  Revenue recognition

Revenue is recognised to the extent that it is probable that the 
economic benefits will flow to the entity and the revenue can 
be reliably measured. Revenue is measured at the fair value of 
the consideration received or receivable. Amounts disclosed as 
revenue are net of returns, allowances, duties and taxes paid.

Revenue is recognised when the funeral, burial, cremation or other 
services are performed or the goods supplied.

Revenues relating to undelivered memorials and merchandise are 
deferred until delivered or made ready for use. Minor items such as 
plaques, ash containers and vases where actual deliveries are not 
individually tracked are released to revenue over 15 years.

The Group enters into prepaid contracts to provide funeral, burial 
and cremation services in the future and funds received are placed 
in trust and are not recognised as revenue until the service is 
performed. Refer to Note 1(n).

Interest income is recognised using the effective interest method.

Dividends are recognised as revenue when the right to receive 
payments is established.

(f)  Deferred selling costs

(g)  Income tax

The income tax expense or revenue for the period is the tax 
payable on the current period’s taxable income based on the 
national income tax rate for each jurisdiction adjusted by changes 
in deferred tax assets and liabilities attributable to temporary 
differences and unused tax losses.

Deferred income tax is provided in full, using the liability method, on 
temporary differences arising between the tax bases of assets and 
liabilities and their carrying amounts in the consolidated financial 
statements. However, the deferred income tax is not accounted 
for if it arises from initial recognition of an asset or liability in a 
transaction other than a business combination that at the time of 
the transaction affects neither accounting nor taxable profit or loss. 
Deferred income tax is determined using tax rates (and laws) that 
have been enacted or substantially enacted by the balance sheet 
date and are expected to apply when the related deferred income 
tax asset is realised or the deferred income tax liability is settled.

Deferred tax assets are recognised for deductible temporary 
differences and unused tax losses only if it is probable that future 
taxable amounts will be available to utilise those temporary 
differences and losses. Deferred tax liabilities and assets are not 
recognised for temporary differences between the carrying amount 
and tax bases of investments in controlled entities where the parent 
entity is able to control the timing of the reversal of the temporary 
differences and it is probable that the differences will not reverse in 
the foreseeable future.

Deferred tax assets and liabilities are offset when there is a 
legally enforceable right to offset current tax assets and liabilities 
and when the deferred tax balances relate to the same taxation 
authority. Current tax assets and tax liabilities are offset where the 
entity has a legally enforceable right to offset and intends either to 
settle on a net basis, or to realise the asset and settle the liability 
simultaneously.

Current and deferred tax balances attributable to amounts 
recognised directly in equity are also recognised in equity.

(h)  Leases

Leases of property, plant and equipment where the Group has 
substantially all the risks and rewards of ownership are classified as 
finance leases.

Leases in which a significant portion of the risks and rewards of 
ownership are retained by the lessor are classified as operating 
leases. Payments made under operating leases (net of any 
incentives received from the lessor) are charged to the income 
statement on a straight-line basis over the period of the lease. 
Lease income from operating leases is recognised in income on a 
straight-line basis over the lease term.

(i)  Business combinations and acquisitions of assets

The purchase method of accounting is used to account for all 
acquisitions of assets (including business combinations) regardless 
of whether equity instruments or other assets are acquired. 
Cost is measured as the fair value of the assets given, shares 
issued or liabilities incurred or assumed at the date of exchange. 
Where equity instruments are issued in an acquisition, the value 
of the instruments is their published market price as at the date 
of exchange. Transaction costs arising on the issue of equity 
instruments are recognised directly in equity.

Selling costs applicable to prepaid funeral service contracts, net of 
any administrative fees recovered, are expensed when incurred. Direct 
selling costs applicable to deferred revenue on undelivered memorials 
and merchandise are deferred until the revenue is recognised.

Identifiable assets acquired and liabilities and contingent liabilities 
assumed in a business combination are measured initially at their 
fair values at the acquisition date, irrespective of the extent of any 
non-controlling interest. The excess of the cost of acquisition over 

InvoCare Annual Report 2016  |  49

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 1: 

 Summary of Significant Accounting Policies 
continued

(i)   Business combinations and acquisitions of assets 

Continued

the fair value of the Group’s share of the identifiable net assets 
acquired is recorded as goodwill (refer to Note 1(p)). If the cost of 
acquisition is less than the fair value of the net identifiable assets of 
the subsidiary acquired, the difference is recognised directly in the 
statement of comprehensive income, but only after a reassessment 
of the identification and measurement of the net assets acquired.

Where settlement of any part of cash consideration is deferred, 
the amounts payable in the future are discounted to their present 
value as at the date of acquisition. The discount rate used is the 
entity’s incremental borrowing rate, being the rate at which a similar 
borrowing could be obtained from an independent financier under 
comparable terms and conditions. Any variations in the initial 
estimates of deferred consideration and the final amount payable 
are remeasured through the statement of comprehensive income.

Contingent consideration is classified either as equity or a financial 
liability. Amounts classified as a financial liability are subsequently 
remeasured to fair value with changes in fair value recognised in 
profit or loss.

The indirect costs of completing business combinations are 
recorded in the statement of comprehensive income.

(j)  Impairment of assets

Assets that have an indefinite useful life are not subject to 
amortisation and are tested annually for impairment or more 
frequently if events or changes in circumstances indicate that the 
carrying amount may not be recoverable. Assets that are subject 
to depreciation or amortisation are reviewed for impairment 
whenever events or changes in circumstances indicate that the 
carrying amount may not be recoverable. An impairment loss is 
recognised for the amount by which the asset’s carrying amount 
exceeds its recoverable amount. The recoverable amount is the 
higher of an asset’s fair value less costs to sell and value in use. For 
the purposes of assessing impairment, assets are grouped at the 
lowest levels for which there are separately identifiable cash flows 
(cash-generating units). Non-financial assets other than goodwill 
that suffered impairment are reviewed for possible reversals of the 
impairment at each reporting date.

(k)  Cash and cash equivalents

Cash and cash equivalents include cash on hand, deposits held 
at call with financial institutions, other short-term, highly liquid 
investments with original maturities of three months or less that are 
readily convertible to known amounts of cash and which are subject 
to an insignificant risk of changes in value, and bank overdrafts. Any 
bank overdrafts are shown within borrowings in current liabilities on 
the balance sheet.

(l)  Receivables

Trade receivables are recognised initially at fair value and 
subsequently measured at amortised cost, less provision for 
doubtful receivables.

Trade receivables are usually due for settlement no more than 30-
days from the date of recognition, except where extended payment 
terms (up to a maximum of 60-months) have been made available 
on cemetery or crematorium contracts for sale of interment or 
inurnment rights and associated memorials and other merchandise. 
Receivables arising from cemetery or crematorium contracts which 
are initially expected to be collected over a period exceeding Twelve 

50

months are recognised as non-current receivables and measured 
as the net present value of estimated future cash receipts, 
discounted at an imputed effective interest rate. Upon initial 
recognition of the contract receivables, any undelivered portion of 
the contracts is included in deferred revenue until delivery.

The carrying amount of the asset is reduced through the use of 
a provision for doubtful receivables account and the amount of 
the loss is recognised in the statement of comprehensive income 
within “other expenses”. When a trade receivable is uncollectable, 
it is written off against the provision account for trade receivables. 
Subsequent recoveries of amounts previously written off are 
credited against sundry revenue in the statement of comprehensive 
income. Details of the impaired receivables, provision account 
movements and other details are included in Notes 2 and 13.

(m) Inventories

Inventories are stated at the lower of cost and net realisable 
value. Cost comprises direct materials and, where appropriate, a 
proportion of variable and fixed overhead. Costs are assigned to 
individual items of inventory predominantly on the basis of weighted 
average cost. Net realisable value is the estimated selling price in 
the ordinary course of business less the estimated costs necessary 
to make the sale.

(n)  Prepaid contracts

Prepaid contracts are tripartite agreements whereby the Group 
agrees to deliver a specified funeral, cremation or burial service at 
the time of need and the beneficiary invests the current price of the 
service to be delivered with a financial institution and conditionally 
assigns the benefit to the Group. The Group records the value of 
the invested funds as an asset and revalues the invested funds to 
fair value at the end of each reporting period. The Group initially 
recognises a liability at the current selling price of the service to be 
delivered and increases this liability to reflect the change in selling 
prices to reflect the best estimate of the expenditure required to 
settle the obligation at the end of each reporting period.

When the service is delivered, the liability is derecognised. The 
initially recorded liability amount is included in revenue and the price 
increases recognised since initial recognition are recorded as a 
reduction in the cost of service delivery.

(o)  Property, plant and equipment

Property, plant and equipment are carried at historical cost less 
depreciation or amortisation. Historical cost includes expenditure 
that is directly attributable to the acquisition of the items.

Subsequent costs are included in the asset’s carrying amount or 
recognised as a separate asset, as appropriate, only when it is 
probable that future economic benefits associated with the item 
will flow to the Group and the cost of the item can be measured 
reliably. Repairs, maintenance and minor renewals are charged 
to the income statement during the financial period in which they 
are incurred.

Cemetery land is carried at cost less accumulated amortisation and 
impairment write-downs. The consolidated entity sells interment 
and inurnment rights while retaining title to the property. Cemetery 
land is amortised, as the right to each plot or space is sold, to write 
off the net cost of the land over the period in which it is utilised and 
an economic benefit has been received. Other freehold land is not 
depreciated or amortised.

Depreciation of other assets is calculated using the straight-line 
method to allocate their cost or revalued amounts, net of their 
residual values, over their estimated useful lives, as follows:

Note 1: 

 Summary of Significant Accounting Policies 
continued

•  hedges of the risks associated with the cash flows of 

recognised assets and liabilities and highly probable forecast 
transactions (cash flow hedges); or

(o)  Property, plant and equipment continued

•  Buildings 

40 years

•  Plant and equipment 

3-10 years

The cost of improvements to or on leasehold properties is 
amortised over the unexpired period of the lease or the estimated 
useful life of the improvement to the consolidated entity, whichever 
is shorter. The assets’ residual values and useful lives are reviewed, 
and adjusted if appropriate, at each balance sheet date. Gains 
and losses on disposals are determined by comparing proceeds 
with the carrying amount. Gains and losses are included in the 
income statement.

(p)  Intangible assets

(i)  Goodwill

Goodwill represents the excess of the cost of an acquisition over 
the fair value of the Group’s share of the net identifiable assets 
of the acquired subsidiary at the date of acquisition. Goodwill on 
acquisitions of subsidiaries is included in intangible assets. Goodwill 
acquired in business combinations is not amortised. Instead, 
goodwill is tested for impairment annually or more frequently 
if events or changes in circumstances indicate that it might be 
impaired, and is carried at cost less accumulated impairment 
losses (Note 19).

(ii)  Trademarks and brand names

Trademarks and brand names have a finite useful life and are 
carried at cost less accumulated amortisation and impairment 
losses. Amortisation is calculated using the straight-line method 
to allocate the cost of trademarks and brand names over their 
estimated useful lives of 10-years.

(q)  Trade and other payables

Trade and other payables represent liabilities for goods and 
services provided to the Group prior to the end of the financial 
year, which had not been settled at balance date. The amounts are 
unsecured and are usually paid within 60-days of recognition.

(r)  Borrowings

Borrowings are initially recognised at fair value, net of transaction 
costs incurred. Borrowings are subsequently measured at 
amortised cost. Any difference between the proceeds (net of 
transaction costs) and the redemption amount is recognised in 
the income statement over the period of the borrowings using the 
effective interest rate method.

Borrowings are classified as current liabilities unless the Group has 
an unconditional right to defer settlement of the liability for at least 
Twelve months after the balance sheet date.

Refer to Notes 2 and 22 for further information on borrowings.

(s)  Derivative financial instruments

The Group uses derivative financial instruments such as cross 
currency and interest rate swaps to hedge its risks associated 
with exchange and interest rate fluctuations. Derivatives are initially 
recognised at fair value on the date a derivative contract is entered 
into and are subsequently remeasured to their fair value at each 
reporting date. The accounting for subsequent changes in fair value 
depends on whether the derivative is designated as a hedging 
instrument, and if so, the nature of the item being hedged. The 
Group designates certain derivatives as either:

•  hedges of a net investment in a foreign operation.

The Group documents at inception the relationship between 
hedging instruments and hedged items, as well as its risk 
management objective and strategy for undertaking various hedge 
transactions. The Group also documents its assessment of whether 
the derivatives that are used in hedging transactions have been, 
and will continue to be, highly effective in offsetting changes in fair 
values or cash flows or hedged items.

The fair value of interest rate swap contracts is calculated as the 
present value of the estimated future cash flows. The fair value of 
forward exchange contracts is determined using forward exchange 
market rates at the balance sheet date. The fair values of derivative 
financial instruments used for hedging purposes are disclosed in 
Note 20. Movements in the hedging reserve in shareholders’ equity 
are shown in Note 26. The full fair value of a hedging derivative is 
classified as a non-current asset or liability when the remaining 
maturity of the hedged item is more than 12-months; it is classified 
as a current asset or liability when the remaining maturity of the 
hedged item is less than 12-months. 

Hedges that meet the strict criteria for hedge accounting are 
accounted for as follows:

(i)  Cash flow hedges

The effective portion of changes in the fair value of derivatives that 
are designated and qualify as cash flow hedges is recognised 
in equity in the hedging reserve. The gain or loss relating to the 
ineffective portion is recognised immediately in the statement of 
comprehensive income within finance costs.

Amounts accumulated in equity are recycled in the statement of 
comprehensive income within finance costs in the periods when the 
hedged item affects profit or loss (for instance when the forecast 
sale that is hedged takes place).

When a hedging instrument expires, is sold or terminated, or when 
a hedge no longer meets the criteria for hedge accounting, any 
cumulative gain or loss existing in equity at that time remains in 
equity and is recognised when the forecast transaction is ultimately 
recognised in the income statement.

When a forecast transaction is no longer expected to occur, the 
cumulative gain or loss that was reported in equity is immediately 
transferred to the income statement.

(ii)  Hedges of a net investment

Hedges of a net investment in a foreign operation, including a 
hedge of a monetary item that is accounted for as part of the net 
investment, are accounted for in a similar way to cash flow hedges. 
Gains or losses on the hedging instrument relating to the effective 
portion of the hedge are recognised directly in equity while any 
gains or losses relating to the ineffective portion are recognised in 
the income statement. On disposal of the foreign operation, the 
cumulative value of any such gains or losses recognised directly in 
equity is transferred to the income statement.

(t)  Employee benefits

(i)  Wages and salaries, annual leave and sick leave

Liabilities for wages and salaries, including non-monetary benefits, 
annual leave and accumulating sick leave expected to be settled 
within 12-months of the reporting date are recognised in other 
payables and provision for employee benefits in respect of 
employees’ services up to the reporting date and are measured at 

InvoCare Annual Report 2016  |  51

 
Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 1: 

 Summary of Significant Accounting Policies 
continued

any, is recognised in the statement of comprehensive income with a 
corresponding adjustment to equity.

(t)  Employee benefits continued

(u)  Contributed equity

the amounts expected to be paid when the liabilities are settled, 
including appropriate on-costs. Liabilities for non-accumulating sick 
leave are recognised when the leave is taken and measured at the 
rates paid or payable.

(ii)  Long service leave

The liability for long service leave is recognised in the provision 
for employee benefits and is measured as the present value of 
expected future payments to be made in respect of services 
provided by employees up to the reporting date, including 
appropriate on-costs. Consideration is given to expected future 
wage and salary levels, experience of employee departures and 
periods of service. Expected future payments are discounted using 
market yields at the reporting date on corporate bonds with terms 
to maturity and currency that match, as closely as possible, the 
estimated future cash outflows.

(iii)  Bonus plans

The Group recognises a liability in other payables and an expense 
for bonus plans when there is no realistic alternative but to settle 
the liability and at least one of the following conditions is met:

• 

• 

there are formal terms in the plan for determining the amount of 
the benefit; 

the amounts to be paid are determined before the time of 
completion of the financial report; or

•  past practices give clear evidence of a constructive obligation.

(iv)  Retirement benefits

Employees of the Group are entitled to benefits on retirement, 
disability or death from the Group sponsored defined contribution 
superannuation plans. Fixed statutory contributions are made 
by the Group to these plans and are recognised as an expense 
as they become payable. The Group’s liability is limited to 
these contributions.

(v)  Share-based payments

The Group provides benefits to certain employees, including key 
management personnel, in the form of share-based payments, 
whereby employees render services in exchange for shares, share 
appreciation rights or options over shares. Details of the employee 
share, share appreciation or option plans are set out in Note 8.

The cost of equity-settled transactions with employees is measured 
by reference to the fair value of the equity instruments at the date 
granted. Cash settled share based payments are valued at each 
reporting date using a Black Scholes valuation technique. Increases 
or decreases in value are recorded as part of employee benefits 
expense. The cost is recognised as an employee benefit expense 
in the income statement, with a corresponding increase in equity, 
over the period during which the performance and / or service 
conditions are fulfilled (the vesting period), ending on the date on 
which the relevant employees become unconditionally entitled to 
the award (the vesting date).

At each balance sheet date, the Group revises its estimate of the 
number of awards that are expected to vest. The employee benefit 
expense recognised each period takes into account the most 
recent estimate. The impact of the revision to original estimates, if 

52

Ordinary shares are classified as equity. Incremental costs directly 
attributable to the issue of new shares or options are shown in 
equity as a deduction, net of tax, from the proceeds. Incremental 
costs directly attributable to the issue of new shares or options 
for the acquisition of a business are included in the cost of the 
acquisition as part of the purchase consideration.

(v)  Dividends

Provision is made for the amount of any dividend declared being 
appropriately authorised and no longer at the discretion of the 
Company on or before the end of the financial year but not 
distributed at balance date.

(w) Earnings per share

Basic earnings per share is calculated by dividing the profit 
attributable to equity holders of the Company, excluding any costs 
of servicing equity other than ordinary shares, by the weighted 
average number of ordinary shares outstanding during the 
financial year.

Diluted earnings per share adjusts the figures used in the 
determination of basic earnings per share to take into account 
the after income tax effect of interest and other financing costs 
associated with dilutive potential ordinary shares and the weighted 
average number of shares assumed to have been issued for no 
consideration in relation to dilutive potential ordinary shares.

(x)  Goods and Services Tax (“GST”)

Revenues, expenses and assets are recognised net of the amount 
of the GST, except where the amount of the GST incurred is not 
recoverable from the taxing authority. In these circumstances, the 
GST is recognised as part of the cost of acquisition of the asset or 
as part of an item of the expense. Receivables and payables in the 
balance sheet are shown inclusive of GST. 

Cash flows are presented in the statement of cash flows on a gross 
basis and the GST component of cash flows arising from investing 
and financing activities, which is recoverable from or payable to the 
taxing authority, are presented as operating cash flows.

(y)  Parent entity financial information

The financial information for the parent entity, InvoCare Limited, 
disclosed in Note 35 has been prepared on the same basis as 
the consolidated financial statements, except investments in 
subsidiaries and associates which are accounted for at cost in the 
financial statements of InvoCare Limited. Dividends received from 
associates are recognised as a reduction in the carrying value of 
the investment in associates.

(z)  Rounding of amounts

The Company is of a kind referred to in ASIC Corporations 
(Rounding in Financial / Directors’ Reports) Instrument 2016/191, 
issued by the Australian Securities and Investments Commission, 
relating to the “rounding off” of amounts in the Directors’ Report 
and Financial Report. Amounts in the Directors’ Report and 
Financial Report have been rounded off to the nearest thousand 
dollars (where rounding is applicable) in accordance with 
that instrument.

Note 1: 

 Summary of Significant Accounting Policies 
continued

(aa) New accounting standards and interpretations

Certain new accounting standards and interpretations have been 
published that are not mandatory for 31 December 2016 reporting 
periods. The Group’s assessments of the impacts of these new 
standards and interpretations are set out below.

(ii) AASB 9 Financial Instruments 

AASB 9 Financial Instruments addresses the classification, 
measurement and derecognition of financial assets and financial 
liabilities, introduces new rules for hedge accounting and a 
new impairment model for financial assets. The standard is not 
applicable until 1 January 2018. After a detailed assessment, 
management believes that the new standard is unlikely to have a 
material impact on the Group’s current accounting practices.

(i) AASB 15 Revenue from Contracts with Customers 

(iii) AASB 16 Leases

AASB 16 was issued in February 2016. It will result in almost all 
leases being recognised on the balance sheet, as the distinction 
between operating and finance leases is removed. Under the new 
standard, an asset (the right to use the leased item) and a financial 
liability to pay rentals are recognised. The only exceptions are short-
term and low-value leases. The standard is not applicable until 
1 January 2019 but is available for early adoption.

The standard will affect primarily the accounting for the group’s 
operating leases. As at the reporting date, the group has non-
cancellable operating lease commitments of $44,089,000. 
However, the group has not yet determined to what extent these 
commitments will result in the recognition of an asset and a liability 
for future payments and how this will affect the group’s profit and 
classification of cash flows.

A preliminary analysis of AASB 15 Revenue from Contracts with 
Customers has been completed. This has demonstrated that with 
the exception of the accounting for Prepaid Contracts no other 
material changes are expected to result. In regards to Prepaid 
Contracts, given the time frame between contract inception and 
contract redemption, financing will be recognised on the contract 
liability. The objective of this being to adjust the consideration paid 
so that revenue is recognised at an amount that reflects the price 
that a customer would have paid for the services if the customer 
had paid cash for those services when provided. This differs from 
the current practice of recognising revenue at the consideration 
paid by the customer at contract inception. Further, costs will be 
recognised for providing the services as incurred unless they qualify 
for capitalisation as a fulfilment or acquisition cost.

The Group currently recognise revenue for 10% of Prepaid Contract 
value at inception as compensation for the cost of marketing 
/ preparing the contract, however, under the new standard, 
mobilisation and sales / marketing efforts would not qualify as a 
distinct service provided to the customer. As such, the revenue will 
be deferred until the service is provided. Certain of the associated 
mobilisation and fulfilment costs may be allowed to be capitalised.

The Group is continuing its analysis of the changes to enable the 
expected financial impacts to be quantified.

InvoCare Annual Report 2016  |  53

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 2:  Financial Risk Management

The Group’s activities expose it to a variety of financial risks: market risk (including currency risk, cash flow interest rate risk, price risk and 
fair value interest rate risk), credit risk and liquidity risk. The Group’s overall risk management programme focuses on the unpredictability 
of financial markets and seeks to minimise potential adverse effects on the financial performance of the Group. The Group uses derivative 
financial instruments such as interest rate swaps to hedge risk exposures. The Group uses different methods to measure different types 
of risks to which it is exposed. These methods include sensitivity analysis in the case of interest rate, foreign exchange and price risk and 
ageing analysis for credit risk.

Strategic risk management is carried out by the Board of Directors. The Audit, Risk & Compliance Committee, which operate under policies 
approved by the Board, is responsible for operational and financial risk management, respectively. These policies provide written principles 
for overall risk management, as well as policies covering specific areas such as interest rate risk and currency risk.

The Group holds the following financial assets and liabilities:

Financial assets

Cash and cash equivalents

Trade and other receivables*

Prepaid contract funds under management

Other financial assets

Financial liabilities

Trade and other payables^

Borrowings

Derivative financial instruments

2016 
$’000

11,528

68,277

2015 
$’000

8,679

55,759

473,056

422,284

4

4

552,865

486,726

43,965

234,455

2,740

281,160

39,487

230,772

4,192

274,451

* excluding prepayments and security deposits / ^ excluding unamortised balance of compensation received in relation to a leased premises

(a)  Market risk

(i)  Cash flow and fair value interest rate risk

The Group’s main interest rate risk arises from long-term borrowings. All borrowings are initially at variable interest rates determined by 
a margin over the reference rate based on the Group’s leverage ratio. Borrowings issued at variable rates expose the Group to cash flow 
interest rate risk. The broad policy of the Group to keep 75% of debt, measured by individual currency, on fixed interest rates over the next 
twelve months by entering into interest rate swap contracts. The policy, however, provides flexibility to reduce the level of coverage in low 
interest rate currency or when the interest rate outlook is relatively benign. The Group has entered into interest rate swap contracts under which 
it receives interest at variable rates and pays interest at fixed rates. The bank loans of the Group outstanding during the year had an effective 
average interest rate of 4.64% (2015: 5.38%) inclusive of swaps and margins but excluding establishment fees.

At balance date, interest rate swaps for 71% (2015: 64%) of borrowings were in place. Of these interest rate swaps 28% (2015: 19%) were 
denominated in New Zealand dollar fixed interest instruments, with the balance denominated in Australian dollars. As at 31 December 2016 
the weighted average fixed interest rate payable on the interest rate swaps is 3.45% (2015: 4.38%) and the weighted average variable rate 
receivable as at 31 December 2016 is 1.85% (2015: 2.44%).

The following variable rate borrowings and interest rate swap contracts are outstanding:

31 December 2016

31 December 2015

Weighted average 
interest rate

Balance $’000 Weighted average  
interest rate

Balance $’000

Bank loans

Interest rate swaps (notional principal)

Net exposure to cash flow interest rate risk

4.64%

3.45%

235,181

166,787

401,968

5.38%

4.38%

238,819

148,124

386,943

54

Note 2:  Financial Risk Management continued

(a)  Market risk continued

(i)  Cash flow and fair value interest rate risk continued

The notional principal amounts, including forward start interest rate swap contracts, and periods of expiry of the interest rate swap 
contracts are as follows:

Less than one year

One to two years

Two to three years

Three to four years

Four to five years

2016 
$’000

60,000

31,191

30,000

75,596

30,000

2015 
$’000

60,000

60,000

28,110

30,000

30,000

226,787

208,110

These contracts require settlement of net interest receivable or payable each 90-days. The settlement dates coincide with the dates on 
which interest is payable on the underlying debt.

As a consequence, the Group is exposed to interest rate risks on that portion of total borrowings not swapped to fixed rates and to 
potential movements in the margin due to changes in the Group’s leverage ratio. An increase of 100 basis points in Australian and New 
Zealand rates (2015: 100 basis points) and 50 basis points in Singapore (2015: 50 basis points) in the interest rate would result in additional 
interest expense after tax of $415,000 (2015: $395,000). A decrease of 100 basis points in Australian and New Zealand rates (2015: 100 
basis points) and 50 basis points in Singapore (2015: 50 basis points) in the interest rate would result in an after tax gain of $415,000 (2015: 
$395,000). Where possible, borrowings are made in the same country as the operation being funded to provide a natural hedge against 
currency volatility. Where this is not possible, other techniques, such as foreign currency bank accounts, are used to mitigate the profit and 
loss volatility due to currency movements.

Due to the use of floating to fixed interest rate swaps, the Group has fixed interest commitments and the changes in the fair value of the 
future cash flows of these derivatives are recognised in equity to the extent that the derivative remains effective in accordance with AASB 
139 Financial Instruments: Recognition and Measurement.

The interest rate swap contracts were all judged to be effective at 31 December 2016 and the movements in the fair value of these 
instruments have been quarantined in equity. If interest rates decline by 100 basis points (2015: 100 basis points) a further $1,144,000 (2015: 
$1,179,000) net of tax would have been charged to equity and a 100 basis points increase in interest rates would have resulted in a credit to 
equity of $1,144,000 (2015: $1,179,000) net of tax.

The overall impact on the Group has been summarised on page 60.

The Group’s cash and cash equivalents held in Australia are interest bearing. At 31 December 2016 the weighted average interest rate was 
0.00% (2015: 0.67%). If interest rates changed by 100 basis points (2015: 100 basis points) the Group’s after tax result would increase or 
decrease by $53,000 (2015: $44,000).

(ii)  Foreign exchange risk

The Group rarely undertakes significant commercial transactions in currencies other than in the functional currency of the operating entity.

Foreign exchange risks arise from recognised assets and liabilities that are denominated in a currency other than the Group’s functional 
currency, the Australian dollar. The major foreign exchange risk relates to the investments in controlled entities in New Zealand, Singapore, 
the USA and north Asia. This exposes the Group to foreign currency risk on the assets and liabilities. Borrowings have been made in New 
Zealand and Singapore dollars to provide a natural hedge against the risk of changes in exchange rates. 

The Group’s exposure to foreign currency risk at the end of the reporting period, expressed in Australian dollars, was as follows:

New Zealand Dollars

Singapore Dollars

New Zealand Dollars

Singapore Dollars

Borrowings

Derivatives

53,381

1,132

25,800

-

41,696

1,126

26,136

-

2016 
$’000

2015 
$’000

InvoCare Annual Report 2016  |  55

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 2:  Financial Risk Management continued

(a)  Market risk continued

(ii)  Foreign exchange risk continued

The Group has no significant unhedged foreign exchange exposures at 31 December 2016. The Singapore dollar borrowing is undertaken 
in Australia and designated as the hedge of a net investment in a subsidiary. The New Zealand dollar borrowings are undertaken in New 
Zealand.

(iii)  Price risk

The Group is the ultimate beneficiary of funds invested in various prepaid contract trusts, as described in Note 1 (n). There are a significant 
number of trusts in existence with various investment profiles. 

Accordingly, the Group’s future income is sensitive to the price risk relating to the investment returns of these funds under management. 
These funds are invested in a range of asset classes with different price risk variables including cash, fixed interest, Australian and 
international equities, hybrids and direct and indirect property. Based on the asset allocation as at 31 December 2016 and 31 December 
2015 the following changes in investment returns are reasonably probable. 

Asset class

Equities (plus or minus 10%)

Property (plus or minus 3%)

  Cash and fixed interest (no price risk)

31 December 2016

31 December 2015

Increase

Decrease

Increase

Decrease

6,150

4,541

-

10,691

(6,150)

(4,541)

-

(10,691)

7,179

3,294

-

10,473

(7,179)

(3,294)

-

10,473

The returns of these funds are recognised in the income statement. An estimated 50% of the funds are expected to be realised over the 
next 10 years and 90% over about 25 years. In any one year approximately 14% of all Australian funeral services performed by InvoCare 
have been prepaid; a proportion that has been reasonably constant for many years and is not expected to significantly change in the 
short term.

InvoCare monitors the asset allocations and investment performance at least quarterly and makes representations, where possible, to those 
in control of the trusts to mitigate price risks and enhance the returns, which will ultimately impact InvoCare’s future results.

As the funds are held in trust for relatively long periods, investment strategies take a long-term view for those trusts not restricted to more 
conservative, capital guaranteed assets. Historically, equities have provided the best long-term returns although the instability of the equity 
markets has caused a substantial shift in the investment bias towards more conservative property, cash, and fixed interest investments. 
When considering investment strategies the life cycle of the fund is considered so that funds that are closer to the end of their expected life 
take a more conservation investment stance than those funds continuing to receive new funds.

The asset allocation at year-end of prepaid contract funds under management is as follows:

Equities

Property

Cash and fixed interest

2016  
%

13

32

55

2015  
%

17

26

57

Approximately 85% of InvoCare’s prepaid funds under management are with Over Fifty Guardian Friendly Society.

Other than disclosed above, the Group does not hold any investments in equities, which are not equity accounted, or commodities and is 
therefore not subject to price risk.

(b)  Credit risk

Credit risk is managed on a Group basis. Credit risk arises from cash and cash equivalents, derivative financial instruments and deposits 
with banks and financial institutions, as well as credit exposures to customers, including outstanding receivables and committed 
transactions. For banks and financial institutions, only independently rated parties with a minimum rating of AA- are accepted.

Credit risks in relation to customers are highly dispersed and without concentration on any particular region or sector. Funeral homes 
attempt to collect deposits at the time the service is commissioned both as a sign of good faith and in order to cover out-of-pocket 
expenses. Cemetery and crematorium products are generally not delivered prior to the receipt of all or substantially all of the amounts due.

56

 
 
Note 2:  Financial Risk Management continued

(b)  Credit risk continued

(i) 

Impaired receivables

The total amount of the provision for doubtful receivables was $2,281,000 (2015: $2,268,000). As at 31 December 2016, receivables 
with a nominal value of $2,945,000 (2015: $3,050,000) had been specifically identified internally or referred to the Group’s independent 
debt collection agent and hence were considered to be impaired. The amount of the provision for doubtful receivables was calculated by 
applying the historical debt collector’s recovery ratio to all debtors over 90-days overdue.

The movement in the provision for impaired receivables is set out in Note 13 – Trade and Other Receivables.

(ii)  Receivables past due but not impaired

As of 31 December 2016, trade receivables of $11,928,000 (2015: $8,745,000) were past due but had not been referred to external debt 
collection agents and hence were considered not to be impaired. These relate to customers where there is no current evidence of an 
inability or unwillingness to settle the amount due but where payment has been delayed. The Group’s own collection activity, which varies 
based on the nature and relative age of the debt, is routinely applied to all past due accounts. When these activities do not result in a 
successful outcome, the debt is referred to external debt collection agencies.

The ageing of receivables past due but not impaired follows:

One to three months overdue

Over three months overdue

(iii)  Other receivables

2016 
$’000

6,163

8,711

2015 
$’000

4,365

4,381

These amounts generally arise from transactions outside the normal operating activities of the Group. Interest is generally not charged on 
the amounts involved although collateral is generally obtained for larger amounts receivable.

(iv)  Interest rate risks

The Group has no exposure to interest rate risk in respect of receivables as they are non-interest bearing.

(c)  Liquidity risk

Prudent liquidity management implies maintaining sufficient cash and marketable securities, the availability of funding through an adequate 
amount of committed credit facilities and the ability to close out market positions. Due to the relatively stable nature of the Group’s 
business, management aims to maintain a large portion of committed credit lines on a long-term basis.

The Group’s borrowings are unsecured but subject to negative pledges and the Group has complied with these covenants throughout and 
at the end of the year. Details of the Group’s facilities are as follows:

InvoCare Annual Report 2016  |  57

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 2:  Financial Risk Management continued

(c)  Liquidity risk continued

Finance facilities available

Unrestricted access was available at balance date to the following lines of credit:

Total facilities

-  unsecured loan facility expiring in two to five years

-  working capital facility expiring within one year

Used at balance date

-  unsecured loan facility

-  working capital facility

Unused at balance date

-  unsecured loan facility

-  working capital facility

2016 
$’000

2015 
$’000

290,000

290,000

9,442

9,685

299,442

299,685

235,203

231,832

1,621

2,416

236,824

234,248

54,797

7,821

62,618

58,168

7,269

65,437

The tables below analyse the Group’s financial liabilities into the relevant maturity groupings based on their contractual terms. Trade and 
other payables and borrowings are non-derivative liabilities.

31 December 2016

Trade and other payables

Borrowings

Derivatives

31 December 2015

Trade and other payables

Borrowings

Derivatives

Less than  
one year 
$’000

44,671

-

-

Less than  
one year 
$’000

39,313

-

1,130

Two to  
three Years 
$’000

91

153,892

2,225

Two to  
three Years 
$’000

174

163,332

2,978

More than  
three Years 
$’000

-

81,311

515

More than  
three Years 
$’000

-

68,500

84

Total  
$’000

44,762

235,203

2,740

Total 
$’000

39,487

231,832

4,192

The Group’s external debt financing is provided by four major banks in Australia and their New Zealand operations, where relevant, through 
bi-lateral revolver debt facilities totalling $290 million, $120 million expiring in December 2020 and $170 million expiring in December 2018.

The facilities agreements’ covenant ratios are calculated on a rolling 12-month basis and have been met at 31 December 2016. The ratio of 
Net Debt to EBITDA (adjusted for acquisitions) must be no greater than 3.5 and the ratio of EBITDA to net interest must be greater than 3.0.

(d)  Capital risk management

The Group’s capital management objectives and strategies seek to maximise total shareholder returns, while maintaining a capital structure 
with acceptable debt and financial risk.

The capital management goals can be broadly described as:

•  manage the amount of equity and the expectation of returns – including dividend distribution policy, dividend reinvestment and share 

buy-back policies;

•  maintain debt and gearing that is prudent, cost effective, supports operational needs and provides flexibility for growth and 

development; and

•  avoid excessive exposure to interest rate fluctuations and debt refinancing risk.

58

Note 2:  Financial Risk Management continued

(d)  Capital risk management continued

The goals are actively managed by the use of quantifiable measures. These measures and relevant comments are as follows:

•  Maximising shareholder returns: Earnings per share (EPS) is a key measure and for 2016, basic EPS was 64.7 cents (2015: 50.1 cents). 
Operating EPS, which excludes gains and losses on the disposal or impairment of non-current assets and on undelivered prepaid 
contracts and non-controlling interests, was 50.4 cents (2015: 45.1 cents). Importantly, senior management of the Group have long-term 
incentives linked to EPS growth, thus aligning employee and shareholder interests. Total compound annual shareholder return, being 
the sum of cash dividends and share price growth, has exceeded 18% (2015:19%) per annum since the Company listed in December 
2003, except for 2008 when global equity market values declined, although InvoCare’s share price did not fall as significantly as the rest 
of the market. A shareholder investing $1.00 in the initial public offering (IPO) would have enjoyed a total return of $8.40 or 840% (2015: 
$7.25 or 725%) up to 31 December 2016.

•  Maintaining a minimum ordinary dividend payout ratio of at least 75% of operating earnings after tax. For each of the years since listing, 

the Group has distributed ordinary dividends in excess of this payout ratio. The aggregate of the interim and final 2016 dividends 
represents a payout ratio of 85% (2015: 85%) of operating earnings after tax.

•  Monitoring participation in the Dividend Reinvestment Plan: Up to 14% of the Company’s shareholders have participated in the DRP 

since it was first activated in October 2006.

•  Confirming compliance with the debt covenant ratios, as defined in the facility agreements, through bi-annual calculations. The Group 

has complied with its banking covenants as follows:

 о Interest cover (EBITDA/Net Interest Expense) must be greater than 3.00:1.

 о Leverage ratio (Net Debt/Adjusted EBITDA) must not be greater than 3.50:1.

•  Maintaining an optimal leverage ratio: The optimal capital structure, which has the lowest cost of capital, is indicatively at a leverage 
ratio (i.e. Net Debt / EBITDA) of between 3:1 and 5:1. The Group can sustain and service higher levels of debt than the amount at 
balance date. Where the capacity exists, debt financing will be used for small acquisitions and capital expenditure. In the absence of 
opportunities to invest in growing the business, the Group will consider applying excess debt capacity to make returns to shareholders.

•  Maintaining floating to fixed base interest rate swaps for at least 75% of debt principal in Australia and New Zealand. At 31 December 

2016 the proportion of debt hedged was 78% (2015: 72%). The hedge contracts extend to the second half of 2020.

•  Managing refinancing risk: The Group’s borrowing facilities were renewed during 2015 and have been split into two tranches across 

four banks in order to reduce refinancing risk. During 2017, the tranche currently expiring in December 2018 will be renegotiated and the 
overall value of the facility increased to ensure the Group’s growth plans are appropriately funded.

InvoCare Annual Report 2016  |  59

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 2:  Financial Risk Management continued

(e)  Summarised sensitivity analysis

The following table summarises the sensitivity of the Group’s financial assets and financial liabilities to interest rate risk and foreign 
exchange risk net of applicable income tax.

4

4

-

-

-

-

Interest rate risk

Foreign exchange risk

- 100 basis points

+ 100 basis points

- 10%

+ 10%

Profit 
$’000

Equity 
$’000

Profit 
$’000

Equity 
$’000

Profit 
$’000

Equity 
$’000

Profit 
$’000

Equity 
$’000

Carrying 
amount 
$’000

31 December 2016

Financial assets

Cash and cash equivalents

Accounts receivable

Prepaid contract funds under 
management

Other financial assets

Financial liabilities

11,528

68,274

(53)

-

473,056

(2,760)

Trade and other payables

43,965

Borrowings

Derivatives

234,455

(415)

2,740

-

Total increase / (decrease)

(3,228)

-

-

-

-

-

-

53

-

2,760

-

-

415

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(285)

3,606

233

(3,386)

1,144

1,144

-

(1,144)

-

(3,606)

-

3,386

3,228

(1,144)

(285)

-

233

-

Interest rate risk

Foreign exchange risk

- 100 basis points

+ 100 basis points

- 10%

+ 10%

Profit 
$’000

Equity 
$’000

Profit 
$’000

Equity 
$’000

Profit 
$’000

Equity 
$’000

Profit 
$’000

Equity 
$’000

Carrying 
amount 
$’000

8,679

55,759

(44)

-

422,284

(1,385)

230,772

(395)

4,192

-

(1,824)

1,179

1,179

-

-

-

-

-

-

44

-

1,385

-

-

395

-

1,824

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-

-

-

-

(133)

1,444

109

(1,432)

(1,179)

(1,179)

-

(1,444)

(133)

-

-

109

1,432

2

31 December 2015

Financial assets

Cash and cash equivalents

Accounts receivable

Prepaid contract funds under 
management

Other financial assets

Financial liabilities

Borrowings

Derivatives

Total increase / (decrease)

(f)  Fair value estimation

Trade and other payables

39,487

The fair value of financial assets and financial liabilities must be estimated for recognition and measurement or for disclosure purposes. The 
fair value of derivatives, which are recorded on the balance sheet, are measured using the cumulative dollar offset method.

This section explains the judgements and estimates made in determining the fair values of the financial instruments that are recognised and 
measured at fair value in the financial statements. To provide an indication about the reliability of the inputs used in determining fair value, 
the Group has classified its financial instruments into the three levels prescribed under the accounting standards as detailed below:

a.  quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1);

b.  inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (as prices) or indirectly 

(derived from prices) (Level 2); and

c.  inputs for the asset or liability that are not based on observable market data (unobservable inputs) (Level 3).

The fair value of contingent consideration is calculated as the present value of the expected cash flows using a discount rate that reflects 
the incremental costs of borrowing used to fund the acquisition. If the discount rate was increased by 10% the contingent consideration 
would reduce by $1,000 (2015: $1,000). Similarly, a 10% decrease in the discount rate results in an increase in contingent consideration of 
$1,000 (2015: $1,000).

60

Note 2:  Financial Risk Management continued

(f)  Fair value estimation continued

Level 2

Prepaid contract funds under management

Derivatives financial instruments

Level 3

Contingent consideration

2016 
$’000

2015 
$’000

473,056

(2,740)

422,284

(4,192)

(283)

(1,457)

Effective 31 December 2016 prepaid contract funds under management assets have been classified as Level 2 as they are not publically 
traded. As this is a modification in the application of levels compared to prior years, comparatives have been restated to reflect the change 
in classification methodology. Management believes that this modification results in a better representation of the classification of levels as it 
reflects levels for the actual asset held by the Plan, (the fund), instead of the underlying investments held by the fund.

No financial instruments or derivatives are held for trading. The contingent consideration represents expected future payments for business 
acquisitions, which are subject to performance hurdles. The carrying value is calculated by discounting the expected future payments to 
their present value using the current interest rate on the Group’s borrowings. 

The carrying value less impairment provisions for trade receivables and payables is a reasonable approximation of their fair values due 
to the short-term nature of trade receivables. Non-current trade receivables are discounted to their fair value in accordance with the 
accounting policy outlined in Note 1(l).

Note 3:  Segment Information

(a)  Description of segments

The operating segments should be based on the management reporting regularly reviewed by the CEO. This reporting is based on the 
operational location of the business because different economic and cultural factors impact the growth and profitability of the segments.

(b)  Segment information provided to the Chief Executive Officer (“CEO”)

The segment information provided to the CEO for reportable segments to 31 December 2016 and 31 December 2015 is outlined below.

Revenue from external customers

Other revenue (excluding interest income)

Operating expenses

Operating EBITDA

Depreciation and amortisation

Intangible assets impairment charge

Finance costs

Interest income

Income tax expense

Total goodwill

Total assets

Total liabilities

Australian 
Operations

Singapore 
Operations

2016 
$’000

386,924

9,010

2016 
$’000

17,236

463

New 
Zealand 
Operations

2016 
$’000

44,246

210

(297,818)

(9,543)

(35,461)

98,116

(18,103)

-

(10,527)

935

(27,695)

85,780

944,820

759,677

8,156

(530)

-

(652)

-

(1,028)

13,992

42,414

28,776

8,995

(2,510)

(154)

(2,376)

27

(590)

46,380

93,841

61,889

Other 

Operations Consolidated

2016 
$’000

2,253

492

(5,733)

(2,988)

(192)

-

-

2

(11)

1,721

4,116

639

2016 
$’000

450,659

10,175

(348,555)

112,279

(21,335)

(154)

(13,555)

964

(29,324)

147,873

1,085,191

850,981

InvoCare Annual Report 2016  |  61

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 3:  Segment Information continued

(b)  Segment information provided to the Chief Executive Officer (“CEO”) continued

Revenue from external customers

Other revenue (excluding interest income)

Operating expenses

Operating EBITDA

Depreciation and amortisation

Cemetery land impairment reversal

Financial assets impairment charge

Finance costs

Interest income

Income tax expense

Total goodwill

Total assets

Total liabilities

Australian 
Operations

Singapore 
Operations

New 
Zealand 
Operations

Other 

Operations Consolidated

2015 
$’000

374,080

8,367

(289,895)

92,552

(17,090)

5,400

(2,635)

(11,831)

661

(25,343)

85,780

886,448

725,160

2015 
$’000

16,525

397

(8,951)

7,971

(635)

-

-

(789)

-

(930)

14,168

38,181

28,802

2015 
$’000

44,337

704

(36,398)

8,643

(2,304)

-

-

(2,165)

61

(457)

45,323

80,286

50,697

2015 
$’000

1,429

102

(5,271)

(3,740)

(151)

-

-

(1)

-

(17)

1,704

3,694

512

2015 
$’000

436,371

9,570

(340,515)

105,426

(20,180)

5,400

(2,635)

(14,786)

722

(26,747)

146,975

1,008,609

805,171

Operating EBITDA of $112,279,000 (2015: $105,426,000) is reconciled to profit before tax on the face of the Consolidated 
Income Statement.

(c)  Segment information – accounting policies

The consolidated entity operates in one industry, being the funeral industry, with significant operations in Australia, New Zealand and 
Singapore and smaller operations in Hong Kong and the USA.

Segment revenues, expenses, assets and liabilities are those that are directly attributable to a segment and the relevant portion that can be 
allocated to the segment on a reasonable basis. Segment assets include all assets used by a segment and consist primarily of operating 
cash, receivables, inventories, property, plant and equipment and goodwill and other intangible assets, net of related provisions. Segment 
liabilities consist primarily of trade and other creditors and employee benefits and, in the case of Singapore, include an allocation of the 
long-term borrowings raised in Australia to fund the investment in Singapore. New Zealand has long-term borrowings which are arranged 
in New Zealand but with the support of Australia. Group’s operations in Hong Kong and the USA have been aggregated under “Other 
Operations” in the tables above due to their relatively small size.

Note 4:  Revenue from Continuing Operations

Sales revenue

Sale of goods

Services revenue

Other revenue

Rent

Administration fees

Sundry revenue

2016 
$’000

190,216

260,443

450,659

357

6,914

2,904

10,175

2015 
$’000

178,707

257,664

436,371

345

5,623

3,602

9,570

Total revenue from continuing operations

460,834

445,941

62

 
 
 
 
 
 
Note 5:  Expenses

Profit before income tax includes the following specific expenses:

Depreciation

Buildings

Property, plant and equipment

Total depreciation

Amortisation of non-current assets

  Cemetery land

Leasehold land and buildings

Leasehold improvements

Brand names

Total amortisation

Total depreciation and amortisation

Impairment of other assets

  Cemetery land impairment reversal

Intangible assets impairment charge

Financial assets impairment charge

Total depreciation, amortisation and impairment

Finance costs

Interest paid and payable

  Other finance costs

Total financing costs

Impairment losses – financial assets

Trade receivables

Rental expense

  Operating lease rental – minimum lease payments

Defined contribution superannuation expense

2016 
$’000

2015 
$’000

4,436

14,323

18,759

540

176

660

1,200

2,576

21,335

-

154

-

21,489

11,469

2,086

13,555

4,382

13,394

17,776

389

176

567

1,272

2,404

20,180

(5,400)

-

2,635

17,415

12,739

2,047

14,786

649

923

11,439

8,824

11,422

8,396

InvoCare Annual Report 2016  |  63

 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 6: 

Income Tax

(a) Income tax expense

Current tax

Deferred tax

Under / (over) provided in prior years

Income tax expense attributable to continuing operations

(b) Reconciliation of income tax expense to prima facie tax payable

Prima facie tax at 30% (2015: 30%) on profit before tax

Tax effect of amounts which are not deductible/(taxable) in calculation of taxable income

2016 
$’000

25,344

4,259

(279)

29,324

2016 
$’000

30,112

Impact of previously unrecognised capital losses offsetting capital gains and unrecognised capital losses

(118)

Impact of the eliminations of translation gains / (losses) on intercompany balances in foreign currencies

Impact of impairment of financial assets

Acquisition costs not deductible

Revenue losses not recognised

Other items (net)

Difference in overseas tax rates

Under / (over) provision in prior years

Income tax expense

(c) Tax expense relating to items of other comprehensive income

Cash flow hedges

30

43

-

794

(319)

30,542

(939)

(279)

29,324

2016 
$’000

410

2015 
$’000

24,207

1,406

1,134

26,747

2015 
$’000

24,515

(48)

(123)

790

27

1,358

308

26,827

(1,214)

1,134

26,747

2015 
$’000

552

64

 
 
 
 
Note 6: 

Income Tax continued

(d) Deferred tax liability

The deferred tax liability balances comprised temporary differences attributable to:

Amounts recognised in profit and loss:

Cemetery land

Property, plant and equipment

Deferred selling costs

Prepayments and other

Brand names

Prepaid contracts

Provisions

Receivables

Accruals and other

Amounts recognised directly in equity:

Cash flow hedge reserve

The net movement in the deferred tax liability is as follows:

Balance at the beginning of the year

Net charge to income statement – current period

Net charge (credit) to income statement – prior periods

Amounts recognised due to business combinations net of businesses subsequently sold

Amounts recognised directly in equity

Effect of movements in exchange rates

Balance at the end of the year

Deferred tax (assets) to be settled within 12 months

Deferred tax liabilities to be settled after 12 months

(e) Tax losses

2016 
$’000

2015 
$’000

29,389

29,524

4,109

3,338

364

1,350

10,508

(5,889)

(229)

(1,068)

(810)

41,062

36,420

4,259

(41)

-

410

14

41,062

(1,481)

42,543

41,062

5,208

3,202

960

1,675

1,621

(2,892)

(770)

(898)

(1,210)

36,420

32,275

1,406

602

1,481

552

104

36,420

(2,326)

38,746

36,420

The Group has no unutilised Australian capital losses (2015: $120,000 benefit) at the corporate tax rate of 30% (2015: 30%). The Group has 
unutilised revenue losses with a potential benefit of US$5,800,000 (2015: US$3,266,000) in foreign jurisdictions although recovery of these 
losses is highly unlikely.

InvoCare Annual Report 2016  |  65

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 7:  Key Management Personnel Disclosures

(a) Key management personnel compensation

Short-term employee benefits

Post-employment benefits

Other long-term benefits

Share-based payments

2016 
$

2015 
$

3,786,464

3,602,155

179,086

33,240

829,975

164,935

28,003

382,299

4,828,765

4,177,392

Detailed remuneration disclosures are provided in the Remuneration Report on pages 30 to 41. 

(b) Equity instrument disclosures relating to key management personnel

(i)  Shares and share appreciation rights provided as remuneration

Details of shares and share appreciation rights provided as remuneration, together with terms and conditions of the shares and share 
appreciation rights, can be found in the Remuneration Report starting on pages 30 to 41. 

For details of the share options issued please refer to Note 8: Share based payments on page 67.

(ii)  Holdings of shares and share appreciation rights

The number of ordinary shares in the Company, or share appreciation rights in the case of overseas based key management personnel, 
held during the financial year by each director of InvoCare Limited and other key management personnel of the Group, including indirectly 
by their personally related parties or by the trustee of the InvoCare Deferred Employee Share Plan, are set out below. During the year, 
Long-term Incentive (“LTI”) shares or LTI rights were granted to other key management personnel under the terms of the InvoCare Deferred 
Employee Share Plan the details of which are outlined in Note 8.

Balance at start  
of the year

Granted during year 
as compensation

Other changes 
during year

Balance at  
end of the year

Non-executive Directors 

Richard Fisher

Christine Clifton

Richard Davis

Gary Stead

Joycelyn Morton

Executive Directors

Martin Earp 

Other key management personnel

Phillip Friery 

Josée Lemoine

Greg Bisset 

Wee Leng Goh 

Graeme Rhind 

17,389

112,961

561,607

6,500

6,000

17,410

64,411

-

79,294

13,125

11,255

-

-

-

-

-

525

-

(40,000)

115

2,205

10,617

1,518

6,644

2,931

7,457

4,155

2,858

(19,181)

-

(18,749)

(3,646)

(3,130)

17,914

112,961

521,607

6,615

8,205

29,545

51,874

2,931

68,002

13,634

10,983

66

Note 7:  Key Management Personnel Disclosures continued

(b) Equity instrument disclosures relating to key management personnel continued 

(iii)  Share options

The number of share options in the Company held during the financial year by key management personnel of the Group are set out below:

Balance at start  
of the year

Granted during year 
as compensation

Other changes 
during year

Balance at  
end of the year

Executive Directors

Martin Earp 

Other key management personnel

Phillip Friery 

Josée Lemoine 

Greg Bisset 

Wee Leng Goh 

Graeme Rhind 

-

-

-

-

-

-

160,313

33,441

14,754

37,533

20,946

14,416

-

-

-

-

-

-

160,313

33,441

14,754

37,533

20,946

14,416

(c)  Loans to key management personnel

There were no loans to directors of the Company or other key management personnel.

(d)  Other transactions with key management personnel

There were no transactions with key management personnel of the Group, including their personally related parties, during 2016 or 2015.

Note 8:  Share-based Payments

The Group provides benefits to employees (including Key Management Personnel) through share-based incentives. Four plans are currently 
in operation.

(a)  Performance Long-term Incentive Plan (“PLTIP”)

This plan provides share rights and options to senior staff and is heavily weighted towards options so employees are incentivised to 
maximise shareholder value in the longer term. The plan was introduced during 2016 and is described more fully in the Remuneration 
Report. For senior staff it replaces the schemes previously used and more fully described below. As the plan permits settlement in either 
equity or cash, at the Board’s discretion, it is treated as a cash-settled plan. The fair value of the instruments in the plan was determined at 
31 December 2016 based on the following inputs.

Share price at Grant Date

Share Price at 31 December 2016

Exercise Price

Annualised Risk Free Rate

Volatility

Compound Dividend Yield

Fair Value at 31 December 2016

Options

$12.08

$13.87

$12.08

2.76%

25.00%

3.00%

$3.35

Rights

$12.08

$13.87

-

2.76%

25.00%

3.00%

$12.97

The determination of fair value does not include an adjustment for performance or service conditions.

(b)  Deferred Employee Share Plan (“DESP”)

This plan introduced in 2007 is settled by the transfer of equity instruments to participants upon vesting. The required ordinary shares 
are purchased on market around the time of the grant and held by the Deferred Employee Share Plan Trust. In the event that the Trust 
has sufficient ordinary shares, due to forfeits, new grants are valued at the VWAP of ordinary shares traded during the first 10-days of the 
Trading Window that immediately follows the announcement of the full-year results for the full year.

(c)  Share Appreciation Rights (“SARs”)

For overseas based employees, where settlement in equity can present challenges, cash settled SARs are offered. The fair value of these 
rights is determined on the same basis as the PLTIP Rights adjusted for the dividend rights which attach.

InvoCare Annual Report 2016  |  67

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 8:  Share-based Payments continued

(d)  Exempt Employee Share Plan (“EESP”)

Australian based permanent employees with more than six-months service and a salary less than $180,000 per annum are annually offered 
the opportunity to acquire $1,000 worth of InvoCare Limited shares via a salary sacrifice arrangement as permitted by Australian Taxation 
Legislation. During 2016, 344 employees accepted the offer and at 31 December 2016 a further $179,271 was remaining to be collected via 
payroll deductions.

(e)  Expense

Long-term incentive bonus expense

 (f)  Awards Outstanding

Outstanding at the beginning of the year

Granted during the year

Vested during the year

Forfeited during the year

Balance at the end of the year

Note 9:  Remuneration of Auditors

2016 
$’000

1,656

2015 
$’000

261

PLTIP 
Options

-

PLTIP 
Rights

-

504,270

108,782

-

(5,399)

498,871

-

(1,073)

107,709

DESP

SARs

310,266

17,544

(88,485)

(37,293)

202,032

41,268

384

(11,918)

-

29,734

During the year, the following fees were paid or payable for services provided by the auditor  
of the parent entity, its related practices and non-related audit firms.

(a) Audit services

PricewaterhouseCoopers – Australian firm

Audit and review of financial reports

PricewaterhouseCoopers – non-Australian firm

Audit and review of financial reports

Non-PricewaterhouseCoopers – Singaporean firm

Audit and review of financial reports

Total remuneration for audit services

(b) Non-audit services

PricewaterhouseCoopers – Australian firm

Assurance services

Taxation services

  Other Services

PricewaterhouseCoopers – non-Australian firms

Taxation services

  Other services

Non-PricewaterhouseCoopers – Singaporean firm

  Other services

Total remuneration for non-audit services

2016 
$

2015 
$

400,900

416,900

29,935

-

31,008

461,843

31,460

448,360

26,350

51,250

69,500

63,763

17,144

23,617

80,506

16,666

48,391

485

16,206

244,213

13,157

182,822

It is the Company’s policy to employ PricewaterhouseCoopers on assignments additional to their statutory audit duties where 
PricewaterhouseCoopers’ expertise and experience with the consolidated entity are important and auditor independence is not 
compromised. These assignments are principally tax advice and advisory services, or where PricewaterhouseCoopers is awarded 
assignments on a competitive basis. It is the Company’s policy to seek competitive tenders for any major consulting projects.

68

 
 
 
 
 
 
Note 10:  Dividends

Dividends paid

2016 
$’000

2015 
$’000

Final ordinary dividend for the year ended 31 December 2015 of 22.25 cents (2014: 20.75 cents) per fully paid 
share paid on 8 April 2016 (2014: 2 April 2015), fully franked based on tax paid at 30% (2014: 30%)

24,482

22,827

Interim ordinary dividend for the year ended 31 December 2016 of 17.00 cents (2015: 15.75 cents) per share 
paid on 7 October 2016 (2015: 9 October 2015), fully franked based on tax paid at 30% (2015: 30%)

Dividends paid to members of InvoCare Limited

On 16 June 2016 and 12 December 2016 (2015: 20 July 2015) dividend totalling 15.45 cents (2015: 14.75 
cents) per fully paid share, fully franked based on tax paid at 30%, was paid to non-controlling interests.

Dividends not recognised at year end

In addition to the above dividends, since the year end, the directors recommended the payment of a final 
dividend to InvoCare Limited shareholders of 25.50 cents (2015: 22.25 cents) per fully paid ordinary share, 
fully franked based on tax paid at 30%. The aggregate amount of the proposed dividend, expected to be 
paid on 7 April 2017 out of 2016 profits, but not recognised as a liability at year end is:

Franking credit balance

The amounts of franking credits available for subsequent financial years are:

Franking account balance at the end of the financial year

Franking credits that will arise from the payment of income tax payable at the end of the financial year

Reduction in franking account resulting from payment of proposed final dividend of 25.50 cents  
(2015: 22.25 cents)

Note 11:  Earnings per Share

Reconciliation of Earnings to Profit and Loss

Profit from ordinary activities after income tax

Less profit attributable to non-controlling interests

Profit used to calculate basic and diluted EPS

Weighted average number of shares used as the denominator

Weighted average number of ordinary shares used as the denominator in calculating  
basic earnings per share

Weighted average number of ordinary shares used as the denominator in calculating diluted  
earnings per share

Earnings per share for profit attributable to the ordinary equity holders of the Company

Basic earnings per share (cents per share)

Diluted earnings per share (cents per share)

18,706

43,188

123

43,311

17,330

40,157

118

40,275

28,058

24,482

28,120

28,120

4,227

8,563

(12,025)

20,322

(10,492)

26,191

2016 
$’000

2015 
$’000

71,048

(99)

70,949

54,969

(125)

54,844

2016 
Number

2015 
Number

109,671,454

109,533,561

109,906,820

109,533,561

2016 
cents

64.7

64.6

2015 
cents

50.1

50.1

InvoCare Annual Report 2016  |  69

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 12:  Cash and Cash Equivalents

Cash on hand

Cash at bank

Cash at bank attracts floating interest rate of 0.00% (2015: 0.75%)

Note 13:  Trade and Other Receivables

Current

Trade receivables

Provision for doubtful receivables

Prepayments

Other receivables

Non-current

Trade receivables

Provision for doubtful receivables

Security deposits

(a) Impaired receivables

Movements in the provision for impairment of receivables are as follows:

As at 1 January

Provision for impairment recognised during the year

Receivables written off as uncollectible

As at 31 December

Note 14:  Inventories

Current

Finished goods – at cost
Work in progress – at cost

70

2016 
$’000

87

11,441

11,528

2015 
$’000

83

8,596

8,679

2016 
$’000

2015 
$’000

43,786

(2,279)

5,758

1,291

48,556

35,737

(2,265)

6,138

1,529

41,139

26,772

22,290

(2)

1,206

27,976

(4)

595

22,881

2016 
$’000

2,269

649

(637)

2,281

2015 
$’000

2,230

923

(884)

2,269

2016 
$’000

2015 
$’000

24,641
1,097

25,738

22,487
1,964

24,451

 
 
Note 15:  Prepaid Contracts

(a) Income statement impact of undelivered prepaid contracts

Gain on prepaid contract funds under management

Change in provision for prepaid contract liabilities

Net gain on undelivered prepaid contracts

(b) Movements in prepaid contract funds under management

Balance at the beginning of the year

Sale of new prepaid contracts

Initial recognition of contracts paid by instalment

Redemption of prepaid contract funds following service delivery

Increase in fair value of contract funds under management

Balance at the end of the year

(c) Movements in prepaid contract liabilities

Balance at the beginning of the year

Sale of new prepaid contracts

Initial recognition of contracts paid by instalment

Decrease following delivery of services

Increase due to re-evaluation of delivery obligation

Balance at the end of the year

2016 
$’000

39,426

(16,498)

22,928

2015 
$’000

19,790

(12,263)

7,527

2016 
$’000

2015 
$’000

422,284

400,967

46,669

3,930

(39,253)

39,426

473,056

35,338

3,211

(37,022)

19,790

422,284

2016 
$’000

2015 
$’000

408,448

393,841

46,669

3,930

(37,517)

16,498

438,028

35,338

3,211

(36,205)

12,263

408,448

(d)  Classification of prepaid funds under management and liabilities

The current and non-current portions of the prepaid contract assets and liabilities are disclosed separately to more clearly reflect the 
expected pattern of usage associated with the timing of actual contract redemptions.

(e)  Nature of contracts under management and liabilities

Prepaid contracts are tripartite agreements, currently entered into and performed in Australia only, whereby InvoCare agrees to deliver a 
specified funeral service, cremation or burial at the time of need and the beneficiary invests the current price of the service to be delivered 
with a financial institution and conditionally assigns the benefit to InvoCare. InvoCare records the value of the invested funds as an asset 
and revalues the invested funds to fair value at the end of each reporting period. InvoCare also records a liability at the current selling price 
of the service to be delivered and adjusts this liability for the change in selling prices during the period.

The assignment of the benefit of the invested funds to InvoCare, in most cases, only becomes unconditional when InvoCare demonstrates 
that it has delivered the service specified. InvoCare receives the investment returns as well as the initial investment when the service has 
been delivered.

As generally required by law, most of the funds are controlled by trustees who are independent of InvoCare.

InvoCare permits, on request, contracts to be paid by instalments over periods not exceeding three years. In some instances these 
contracts are never fully paid. If, during the three-year period the contract becomes at-need, the family is given the option of either paying 
outstanding instalments and receiving the contracted services at the original fixed price or using the amount paid as a part payment of 
the at-need service. If the contract is not fully paid after three years InvoCare only permits the family to use the amounts paid as a partial 
payment of the at-need services. At the end of the year the total balance of amounts received from instalment payments for incomplete 
contracts was $6,977,000 (2015: $6,797,000). These funds and the relevant liability are recognised when the contract has been fully paid.

During the year the non-cash fair value movements (i.e. investment earnings) of $39.4 million in prepaid contract funds under management 
(2015: $19.8 million) was greater than the non-cash growth due to selling price increases of $16.5 million in the liability for future service 
delivery obligations (2015: $12.3 million).

InvoCare Annual Report 2016  |  71

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 16:  Interests in Other Entities: Subsidiaries

(a)  Interests in subsidiaries

Set out below are the Group’s principal trading subsidiaries at 31 December 2016. Unless otherwise stated, the subsidiaries as listed below 
have share capital consisting solely of ordinary shares, which are held directly by the Group, and the proportion of ownership interests held 
equals to the voting rights held by the Group. The country of incorporation or registration is also their principal place of business.

Name of entity

InvoCare Australia Pty Limited

Bledisloe Australia Pty Ltd

InvoCare New Zealand Limited

Country of incorporation

Principal activities

Australia

Australia

New Zealand

Funeral services provider 

Funeral services provider 

Funeral services provider 

Funeral services provider 

Singapore Casket Company (Private) Limited

Singapore

Ownership interest  
held by the Group

2016 
%

100

100

100

100

2015 
%

100

100

100

100

Shares in subsidiaries are carried at cost and relate to InvoCare Limited’s ownership interest in InvoCare Australia Pty Limited, InvoCare 
(Singapore) Pty Limited, InvoCare New Zealand Limited, InvoCare Hong Kong Limited and InvoCare USA, Inc. All shares held are 
ordinary shares.

InvoCare Australia Pty Limited, InvoCare (Singapore) Pty Limited and Bledisloe Australia Pty Ltd have been granted relief from the necessity 
to prepare financial reports in accordance with Class Order 98/1418 issued by the Australian Securities and Investments Commission. For 
further information refer to Note 32.

During 2016 Bledisloe New Zealand Limited was renamed InvoCare New Zealand Limited and InvoCare New Zealand Limited was renamed 
InvoCare Holdings NZ Limited.

(b)  Significant restrictions

Other than those imposed by the legislative provisions in the respective country of incorporation, for the subsidiaries listed above, the 
Group has no significant restriction on its ability to access or use assets and settle liabilities.

(c)  Subsidiaries with non-controlling interests (“NCI”)

One subsidiary, Macquarie Memorial Park Pty Limited, has non-controlling interests of 16.86% (2015: 16.86%). During the year dividends 
totalling $123,000 were paid to non-controlling interests (2015: $118,000).

72

Note 17:  Interests in Other Entities: Associates

(a)  Interests in associates

(i) 

 Set out below is the associate of the Group at 31 December 2016. The entity listed below has share capital consisting solely of ordinary 
shares, which are held directly by the Group. The country of incorporation or registration is also its principal place of business, and the 
proportion of ownership interest is the same as the proportion of voting rights held. The interest held in this entity is not material to the 
Group.

Name of entity

Country of 
incorporation

Nature of 
relationship

Measurement 
method

HeavenAddress Pte. Ltd

Singapore

Associate

Equity method

2016 
%

34.59

2015 
%

34.59

2016 
$’000

-

2015 
$’000

-

% of ownership interest

Carrying Amount

HeavenAddress Pte. Ltd offers online memorial services to allow families and communities to celebrate the life of a loved one.

(ii) Commitments and contingent liabilities in respect of associates:

The Group has no commitments or contingent liabilities in respect of its associates at 31 December 2016 (2015: Nil).

(b)  Impairment

As at 31 December 2015 the recoverable amount of the Group’s investment in its associate was nil as a result of impairment write-downs 
in 2015 and 2014. The decision to impair this investment was made after considering the business performance to date, its future cash 
projections and the risks associated with a start-up operation. A review of the associate’s performance in 2016 was carried out and no 
reversal of previous impairment write-down was deemed necessary.

The recoverable amount is based on value-in-use calculations whereby cash flow projections provided by the associate’s management 
have been discounted to present value using selected discount rates. Cash projections, which covered an initial three-year period, have 
then been extrapolated using estimated growth rates of 3% for both revenues and expenses.  

Sensitivities were conducted on a number of variables including revenue growth and discount rates. Given the start-up nature of the 
business, more weight was placed on the existing business than on future opportunities when developing growth scenarios. A pre-tax rate 
of 17.8% (2015: 17.8%) was used to discount the cash projections. This is higher than the 10.9% rate used for valuing existing business 
assets and reflects the greater risk associated with a start-up investment. From these scenarios Management has selected a mid-point 
which it believes is in a range of possible future outcomes. The Group will continue to monitor its investment in the associate for indicators 
of any future impairment reversals.

InvoCare Annual Report 2016  |  73

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 18:  Property, Plant and Equipment

Cemetery 
land 
$’000

Freehold 
land  
$’000

Buildings 
$’000

111,588

85,164

137,741

Leasehold 
land and 
buildings 
$’000

4,534

(3,005)

-

Leasehold 
improvements 
$’000

Plant and 
equipment 
$’000

Total 
$’000

7,510

128,857

475,394

(3,268)

(81,593)

(148,770)

-

-

(4,376)

85,164

84,236

1,529

4,242

47,264

322,248

85,422

84,727

1,343

5,249

55,348

332,008

-

-

(176)

(10)

1,343

4,534

(3,191)

-

2,220

(586)

24,869

(2,534)

32,950

(3,795)

(660)

(14,323)

(20,135)

33

72

740

5,249

55,348

332,008

8,859

143,712

497,240

(3,610)

(88,364)

(160,856)

-

-

(4,376)

4,534

(2,821)

-

1,713

-

-

-

6,622

(2,820)

-

118,779

454,135

(73,443)

(136,015)

-

(9,776)

3,802

45,336

308,344

1,027

15,399

22,215

-

(19)

336

(385)

6,679

(827)

-

(4,382)

(176)

(567)

(13,394)

(13,508)

226

-

(44)

(800)

(8)

-

(1)

-

(28)

-

145

(800)

99,813

85,164

84,236

1,529

4,242

47,264

322,248

111,588

85,164

137,741

(53,505)

-

4,534

(3,005)

-

1,529

7,510

128,857

475,394

(3,268)

(81,593)

(148,770)

-

-

(4,376)

4,242

47,264

322,248

85,164

84,236

At 1 January 2016

Cost

Accumulated depreciation / amortisation

Impairment write-downs

Net book amount

Year ended 31 December 2016

Additions

Disposals

Depreciation / amortisation &  
impairment charge

Effect of movement in exchange rates

Closing net book amount

At 31 December 2016

Cost

Accumulated depreciation / amortisation

Impairment write-downs

Net book amount

At 1 January 2015

Cost

Accumulated depreciation / amortisation

Impairment write-downs

Net book amount

Year ended 31 December 2015

Additions

Business combinations

Disposals

Depreciation / amortisation & impairment 
charge

Effect of movement in exchange rates

Transfers / reclassifications

Closing net book amount

At 31 December 2015

Cost

(7,399)

(4,376)

99,813

550

-

(540)

96

(7,939)

(4,376)

99,919

(7,010)

(9,776)

91,193

25

3,584

-

5,011

-

-

99,919

85,422

84,727

112,234

85,422

107,979

83,959

-

-

(53,505)

-

-

-

-

5,311

(675)

(4,436)

258

291

142,479

(57,752)

-

132,262

(49,921)

-

83,959

82,341

746

433

(200)

5,018

2,326

(223)

-

-

-

-

-

-

Accumulated depreciation / amortisation

Impairment write-downs

Net book amount

(7,399)

(4,376)

99,813

74

Note 18:  Property, Plant and Equipment continued

(a)  Assets in the course of construction

The carrying amounts of assets disclosed above include the following expenditure recognised in relation to property, plant and equipment 
which is in the course of construction:

Freehold buildings

Leasehold improvements

Plant and equipment

Cemetery land

Total assets in the course of construction

(b)  Impairment

2016 
$’000

694

521

514

543

2,272

2015 
$’000

2,008

700

1,721

-

4,429

All impaired cemetery and crematorium sites were reassessed at 31 December 2016 using the same methodology as previously applied 
and no change to the impairment provision was deemed necessary. 

The following table summarises the impairment losses/reversals along with the recoverable amount estimates for the individual sites for 
2016 and 2015:

Site Name

Allambe Gardens Memorial Park, Queensland

Mt Thompson Memorial Gardens, Queensland

Tweed Heads Memorial Gardens, New South Wales

Impairment Loss / (Reversal)

Recoverable Amount Estimates

2016 
$’000

-

-

-

-

2015 
$’000

(3,000)

(2,400)

-

(5,400)

2016 
$’000

17,500

15,300

2,100

34,900

2015 
$’000

17,500

15,300

2,100

34,900

The impairment losses recognised over the years may be reversed in future years. The Group has no impairment at other cemetery and 
crematorium sites, or of other property, plant and equipment assets. The total recoverable amount of the Group’s assets is well in excess of 
carrying value.

The recoverable amount of cash-generating units is based on value-in-use calculations. These calculations use cash flow projections based 
on financial estimates approved by management based on past performance and future expectations. The cash flows cover an initial five-
year period and are then extrapolated beyond five years using estimated growth rates of 4% in revenues and 3% in expenses which are not 
inconsistent with historical trends and forecasts included in reports prepared by market analysts. A sensitivity analysis has been conducted 
on the impaired sites by moving the underlying assumptions both up and down 10%. This analysis demonstrates that changing the 
assumptions is unlikely to result in a material change in the currently recognised impairment losses. Management considers that a +/- 10% 
shift is within the reasonably possible range of long-term outcomes. The pre-tax discount rate used was 10.9% (2015: 10.9%), reflecting the 
risk estimates for the business as a whole.

(c)  Property held for sale

During 2015 a review of the Group’s property requirements in New South Wales, Australia and the North Island of New Zealand identified 
parcels of land and buildings which were no longer strategically significant to the Group’s long-term growth and being actively marketed. 
Accordingly they have been classified as held for sale. 

InvoCare Annual Report 2016  |  75

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 19:  Intangible Assets

At 1 January 2016

Cost

Accumulated amortisation

Net book amount

Year ended 31 December 2016

Impairment write-downs

Effect of movement in exchange rates

Amortisation charge

Net book amount

At 31 December 2016

Cost

Accumulated amortisation

Net book amount

At 1 January 2015

Cost

Accumulated amortisation

Net book amount

Year ended 31 December 2015

Acquisition of subsidiary / businesses

Effect of movement in exchange rates

Amortisation charge

Net book amount

At 31 December 2015

Cost

Accumulated amortisation

Net book amount

(a)  Impairment test for goodwill

Goodwill 
$’000

Brand name 
$’000

Total 
$’000

146,975

-

146,975

(154)

1,051

-

147,872

147,872

-

147,872

145,390

-

145,390

1,536

49

-

146,975

146,975

-

146,975

12,909

(7,133)

5,776

-

47

(1,200)

4,623

12,991

(8,368)

4,623

12,922

(5,832)

7,090

-

(42)

(1,272)

5,776

12,909

(7,133)

5,776

159,884

(7,133)

152,751

(154)

1,098

(1,200)

152,495

160,863

(8,368)

152,495

158,312

(5,832)

152,480

1,536

7

(1,272)

152,751

159,884

(7,133)

152,751

For the Group’s Australian-based operations, goodwill cannot be allocated on a non-arbitrary basis to individual Cash-generating Units 
(“CGU”s) due to the significant history of numerous acquisitions, especially during the years 1993 to 1999, and resulting post-acquisition 
business integration activities and operational changes over many years. The New Zealand, Singapore and USA operations are separate 
CGUs and the associated goodwill arising from that acquisition has been allocated to the single New Zealand, Singapore or USA CGU. As 
a result, the lowest level within the Group at which goodwill is monitored for management purposes comprises the grouping of all CGUs 
within a country of operation. The recoverable amounts of the total of Australian, New Zealand, Singapore and USA CGUs are based on 
value-in-use calculations. These calculations use cash flow projections based on approved financial estimates covering a five-year period. 
Cash flows beyond the five-year period have been extrapolated using estimated growth rates. The assessment also considered the 
reasonable possible long-term shift in key assumptions, which will not cause further impairment.

During 2016, a strategic decision was made to close a previously acquired small business in New Zealand as it no longer fits the Group’s 
long-term strategy. As a result, $154,000 in goodwill recognised in the prior years in relation to this acquisition was fully impaired. 

(b)  Key assumptions used for value-in-use calculations

Budgeted cash flows have been based on past performance and expectations for the future. The growth rates of 4% in revenue and 3% in 
expense projections are not inconsistent with historical trends and forecasts included in reports prepared by market analysts. The pre-tax 
discount rate used for assessing the carrying value of goodwill in each CGU was 10.9% (2015: 10.9%), reflecting the risk estimates for the 
business as a whole. Sensitivity analysis indicates significant headroom exists in the value-in-use calculations for Australia, New Zealand, 
Singapore and USA compared to the carrying value of goodwill.

76

Note 20: Derivative Financial Instruments

Current liabilities

Interest rate swap contracts – cash flow hedges

Non-current liabilities

Interest rate swap contracts – cash flow hedges

2016 
$’000

2015 
$’000

966

966

1,774

1,774

1,130

1,130

3,062

3,062

Full details of the derivatives being used by the Group and the risks and ageing of the existing derivatives are set out in Note 2 – Financial 
risk management.

Note 21:  Trade and Other Payables

Current

Trade payables

Sundry payables and accrued expenses

Deferred cash settlement for business interests acquired

Non-current

Deferred cash settlement for business interests acquired

2016 
$’000

2015 
$’000

32,683

11,796

192

44,671

91

91

26,446

11,583

1,284

39,313

174

174

Full details of the risks and currency exposure of trade and other payables are set out in Note 2 – Financial Risk Management. 

Note 22: Borrowings

Long-term borrowings

Borrowings are represented by:

Principal amount of bank loans – unsecured

Loan establishment costs

Full details of the risks, ageing and available facilities are set out in Note 2 – Financial Risk Management.

2016 
$’000

2015 
$’000

235,203

(748)

234,455

231,833

(1,061)

230,772

InvoCare Annual Report 2016  |  77

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 23: Provisions for Employee Benefits

Current

Employee benefits

Non-current

Liability for long service leave

(a) Employee numbers

Number of full-time equivalent employees

(b)  Superannuation plan

2016 
$’000

2015 
$’000

14,511

14,318

3,029

2,306

2016 
Number

2015 
Number

1,566

1,557

The Company contributes to accumulation-type employee superannuation plans in accordance with statutory requirements.

Note 24:  Current Liabilities expected to be settled within twelve months

The amounts included in current liabilities, which are expected to be settled within twelve months, are set out below.

Trade and other payables

Current tax liabilities

Prepaid contract liabilities

Deferred revenue

Employee benefits

Total current liability

Expected to settle  
within twelve months

2016 
$’000

44,671

9,935

37,595

10,243

14,511

2015 
$’000

39,313

10,111

34,954

8,660

14,318

2016 
$’000

44,671

9,935

37,595

10,243

8,476

2015 
$’000

39,313

10,111

34,954

8,660

8,031

116,955

107,356

110,920

101,069

The amounts expected to be settled within twelve months have been calculated based on the historical settlement patterns. 

78

Note 25: Contributed Equity

Fully paid ordinary shares

2016 
$’000

2015 
$’000

134,914

133,694

2016 
Number

2016 
$’000

2015 
Number

2015 
$’000

Ordinary shares

Balance at the beginning of the financial year

Total contributed equity

Treasury shares (note 25 (b))

110,030,298

110,030,298

(331,724)

136,858

136,858

(1,944)

110,030,298

110,030,298

(444,300)

Total consolidated contributed equity

109,698,574

134,914

109,585,998

(a)  Ordinary shares

136,858

136,858

(3,164)

133,694

Ordinary shares entitle the holder to participate in dividends and the proceeds on winding up of the Company in proportion to the number 
of and amounts paid on the shares held. On a show of hands every holder of ordinary shares present at a meeting in person or by proxy, is 
entitled to one vote, and upon a poll each share is entitled to one vote.

InvoCare Annual Report 2016  |  79

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 25: Contributed Equity continued

(b)  Treasury shares

Treasury shares are shares in InvoCare Limited that are held by the InvoCare Deferred Employee Share Plan Trust for the purpose of issuing 
shares under the InvoCare Deferred Employee Share Plan, as set out in Note 8.

Date

1 January 2015

25 February 2015

30 April 2015

30 April 2015

Details

Balance

Shares vested

Shares vested

Forfeit of shares on termination of employment

22 May 2015 to 3 July 2015

Forfeit of shares on termination of employment

6 July 2015

Transfer of shares to members of the Exempt Employee Share Plan

6 August 2015 to 14 December 2015

Forfeit of shares on termination of employment

31 December 2015

Shares provisionally forfeited but not yet de-allocation by the Trustee

31 December 2015

18 January 2016

25 February 2016

26 February 2016

8 April 2016

11 April 2016

01 July 2016

18 July 2016

31 July 2016

1 August 2016

26 August 2016

1 December 2016

7 December 2016

16 December 2016

30 December 2016

31 December 2016

31 December 2016

Unallocated shares held by the Trustee

Balance

Forfeit of shares on termination of employment

Shares vested

Forfeit of shares on termination of employment

Forfeit of shares on termination of employment

Forfeit of shares on termination of employment

Forfeit of shares on termination of employment

Forfeit of shares on termination of employment

Shares vested

Transfer of shares to members of the Exempt Employee Share Plan

Forfeit of shares on termination of employment

Forfeit of shares on termination of employment

Forfeit of shares on termination of employment

Forfeit of shares on termination of employment

Forfeit of shares on termination of employment

Movement in unallocated shares held by the Trustee

Number  
of shares

661,978

(133,614)

(57,334)

(50,513)

(4,006)

(26,730)

(1,681)

(76,996)

133,196

444,300

(13,186)

(88,481)

(972)

(811)

(2,701)

(259)

(11,787)

(364)

(24,081)

(810)

(1,158)

(1,662)

(3,599)

(348)

37,643

$’000

5,176

(988)

(695)

(627)

(41)

(328)

(20)

(737)

1,424

3,164

(144)

(861)

(11)

(9)

(31)

(2)

(136)

(5)

(354)

(9)

(14)

(21)

(41)

(5)

423

Balance

331,724

1,944

(c)  Dividend reinvestment plan

During 2006, the Company activated its Dividend Reinvestment Plan under which holders of ordinary shares may elect to have all or part of 
their dividend entitlements satisfied in ordinary shares rather than by being paid in cash.

80

Note 26: Reserves and Retained Profits

(a) Reserves

Share-based payments reserve

Hedging reserve – cash flow hedge reserve

Foreign currency translation reserve

Movements:

Share-based payments reserve

Balance at the beginning of the year

Deferred employee share plan expense

Vesting of deferred employee share plan shares

Balance at the end of the year

Hedging reserve

Balance at the beginning of the year

Revaluation to fair value – gross

Deferred tax

Balance at the end of the year

Foreign currency translation reserve

Balance at the beginning of the year

  Currency translation differences

Balance at the end of the year

(b) Retained profits

Movements in retained profits were as follows:

Balance at the beginning of the year

  Net profit for the year

Dividends paid during the year

Balance at the end of the year

(c)  Nature and purpose of reserves

(i)  Share-based payments reserve

2016  
$’000

2015 
$’000

1,849

(1,844)

7,339

7,344

2,165

550

(866)

1,849

(2,892)

1,467

(419)

(1,844)

6,256

1,083

7,339

2,165

(2,892)

6,256

5,529

4,020

(171)

(1,684)

2,165

(4,071)

1,731

(552)

(2,892)

6,807

(551)

6,256

63,054

70,949

(43,188)

90,815

48,367

54,844

(40,157)

63,054

The share-based payments reserve is used to recognise the expensed portion of shares granted to employees under the terms of the 
Australian Deferred Employee Share Plan.

(ii)  Hedging reserve – cash flow hedge reserve

The hedging reserve is used to record gains or losses on hedging instruments that are cash flow hedges which are recognised directly in 
equity. Amounts are recognised in profit and loss when the associated hedged transaction affects the profit and loss.

(iii)  Foreign currency translation reserve

Exchange differences arising on translation of the foreign controlled entities and from the hedging of the net investment in foreign 
operations are taken to the foreign currency translation reserve as set out in Notes 1(d) and 1(s). The reserve is recognised in the profit and 
loss when the net investment is sold.

InvoCare Annual Report 2016  |  81

 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 27:  Non-Controlling Interests

Reconciliation of non-controlling interests in controlled entities:

Share capital

Retained earnings

Balance at the beginning of the year

Add share of operating earnings

Less dividends paid

  Closing balance of retained earnings

Reserves

Balance at the end of the year

Note 28: Capital and Leasing Commitments

(a)  Operating lease commitments

Non-cancellable operating leases contracted for at the reporting date but not capitalised  
in the financial statements:

Payable – minimum lease payments

-  not later than 12 months

-  between 12 months and five years

-  greater than five years

2016  
$’000

2015 
$’000

800

800

262

99

(123)

238

99

1,137

255

125

(118)

262

99

1,161

2016 
$’000

2015 
$’000

11,289

24,353

8,447

44,089

11,828

30,530

11,045

53,403

During the year a lease for premises located at 181 Miller Street, North Sydney, which was compulsorily acquired by Transport for NSW 
as part of the Sydney Metro project, was rescinded and appropriate compensation received. As a consequence lease commitments 
totalling $3,483,000 for periods after 31 December 2016, included in the 2015 comparative have been removed from the lease 
commitments disclosed.

Non-cancellable operating leases contracted for at the reporting date but not capitalised in the financial statements include the following:

Not later than 12 months

Between 12 months and five years

Greater than five years

Property 
$’000

Equipment 
$’000

11,018

23,891

8,447

43,356

271

462

-

733

Total 
$’000

11,289

24,353

8,447

44,089

82

 
 
 
 
Note 28: Capital and Leasing Commitments continued

The Group leases premises, motor vehicles and sundry office equipment under non-cancellable operating leases with terms generally from 
one to five years. The Rookwood Crematorium lease expires in 2025. The Great Southern Garden of Remembrance lease expires in 2047 
with an option to renew for a further 50 years.

(a)  Capital expenditure commitments

Capital expenditure commitments contracted or conditionally contracted at the reporting date but not 
recognised as liabilities payable:

Building purchase – within one year

Building extensions and refurbishments – within one year

Plant and equipment purchases – within one year

(b)  Other expenditure commitments

Documentary letters of credit outstanding at balance date payable:

-  within one year

Note 29: Business Combinations

Tuckers Funeral & Bereavement Services 

2016 
$’000

2015 
$’000

6,600

705

528

-

2,539

5,345

113

129

On 10 December 2012, a subsidiary InvoCare Australia Pty Limited completed the acquisition of Tuckers Funeral & Bereavement Services 
Pty Ltd and Geelong Mortuary Transfer Services Pty Ltd together with the property assets owned by a party related to the vendors 
(“Tuckers”). Tuckers has been operating since 1883, and is recognised to be one of the largest regional funeral directors in Australia. The 
company operates in the state of Victoria and its main facilities are located in Geelong West, with additional chapels and offices located in 
Grovedale, Lara and Barrabool Hills. 

Included in the purchase consideration was $2.1 million in future payments to be paid if predetermined revenue targets are achieved in each 
of the next three calendar years. The predetermined revenue target was achieved in 2015 and as a result a payment, representing the final 
instalment of future payments, of $900,000 was made during the year. 

Harewood Memorial Gardens and Crematorium / Cremation Society of Canterbury 

On 22 July 2015, a subsidiary, InvoCare New Zealand (formerly Bledisloe New Zealand Limited), completed the acquisition of the cemetery 
and cremation assets of Harewood Memorial Gardens and Crematorium Limited and Cremation Society of Canterbury Limited (“Harewood”) 
which have operated crematoria in the Christchurch market for over 70 years. 

Retention amount of $286,000, included in the purchase consideration, was paid in January 2016.

Note 30: Contingent Liabilities and Contingent Assets

The Group had contingent liabilities at 31 December 2016 in respect of bank guarantees  
given for leased premises of controlled entities to a maximum of:

2016 
$’000

2015 
$’000

1,510

2,287

For information about the deed of cross guarantee given by InvoCare Limited, InvoCare Australia Pty Limited, InvoCare (Singapore) 
Pty Limited, Bledone Pty Ltd and Bledisloe Australia Pty Ltd, refer to Note 32.

No liability was recognised by the consolidated entity in relation to the guarantees as the fair value of the guarantees is immaterial.

InvoCare Annual Report 2016  |  83

 
 
 
 
Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 31: Cash Flow Information

Reconciliation of cash flow from operations with profit from ordinary activities after income tax

Profit from ordinary activities after income tax

Non-cash items in profit from ordinary activities

Depreciation, amortisation and impairment

Reversal of impairment loss

Share-based payments expense

Loan establishment costs

Imputed interest from deferred purchase consideration

  Net (gain) / loss on disposal of property, plant and equipment 

Unrealised (gain) on prepaid contracts

  Other prepaid contract movements

Business acquisition costs classified in investing activities

Changes in assets and liabilities, net of the effects of purchase and disposal of subsidiaries 

(Increase) / decrease in trade and other receivables

(Increase) / decrease in inventories 

(Increase) / decrease in deferred selling expenses

Increase / (decrease) in trade and other payables 

Increase / (decrease) in deferred revenue

Increase / (decrease) in income taxes payable 

Increase / (decrease) in deferred taxes

Increase / (decrease) in provisions 

2016 
$’000

2015 
$’000

70,949

54,844

21,489

-

1,656

384

10

676

(22,928)

1,814

79

(12,512)

(1,287)

(453)

5,276

3,343

(176)

4,642

5,534

78,496

22,815

(5,400)

779

366

56

(312)

(7,527)

837

71

(8,403)

(2,138)

(816)

2,136

6,049

748

4,145

(3,619)

64,631

84

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note 32: Deed of Cross Guarantee

InvoCare Limited, InvoCare Australia Pty Limited and InvoCare (Singapore) Pty Limited entered into a Deed of Cross Guarantee on 11 
December 2006 under which each company guarantees the debts of the others. Effective from 15 June 2011 Bledone Pty Ltd and 
Bledisloe Australia Pty Ltd became parties to this Deed of Cross Guarantee. By entering into the deed, the wholly-owned entities have been 
relieved from the requirement to prepare a Financial Report and Directors’ Report under Class Order 98/1418 (as amended) issued by the 
Australian Securities and Investments Commission.

The above companies represent a “Closed Group” for the purposes of the Class Order, and as there are no other parties to the Deed of 
Cross Guarantee that are controlled by InvoCare Limited, they also represent the “Extended Closed Group”.

Set out below is a consolidated income statement, statement of comprehensive income, summary of movements in consolidated retained 
earnings and balance sheet for the year ended 31 December 2016 of the Closed Group.

(a)  Consolidated income statement, statement of comprehensive income, and a summary of movements in consolidated retained 

profits of the Closed Group

Consolidated income statement of the Closed Group

Revenue from continuing operations

Finished goods and consumables used

Employee benefits expense

Employee related and on-cost expenses

Advertising and public relations expenses

Occupancy and facilities expenses

Motor vehicle expenses

Other expenses

Depreciation, impairment and amortisation expenses

Reversal of impairment loss

Finance costs

Interest income

Net gain / (loss) on prepaid contracts

Acquisition costs

Inter-segment revenue

Net gain / (loss) on disposal of non-current assets

Profit before income tax

Income tax expense

Profit for the year

Changes in the fair value of cash flow hedges, net of tax

Changes in foreign currency translation reserve, net of tax

Other comprehensive income for the year, net of tax

Total comprehensive income for the year

Summary of movements in consolidated retained profits of the Closed Group

Retained profits at the beginning of the financial year

Profit for the year

Dividends paid

Retained profits at the end of the financial year

2016 
$’000

2015 
$’000

369,619

(99,743)

(94,572)

(24,300)

(11,745)

(21,348)

(6,297)

(13,418)

98,196

(16,545)

-

(11,106)

932

22,928

(53)

2,095

(445)

96,002

(25,785)

70,217

1,015

331

1,346

71,563

68,390

70,217

(43,188)

95,419

358,727

(97,652)

(90,059)

(22,218)

(11,629)

(21,145)

(7,307)

(14,550)

94,167

(15,448)

2,823

(12,543)

649

7,527

9

2,341

507

80,032

(22,548)

57,484

1,662

(1,255)

407

57,891

51,063

57,484

(40,157)

68,390

InvoCare Annual Report 2016  |  85

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 32: Deed of Cross Guarantee continued

(b)  Balance sheet of the Closed Group

Current assets

Cash and cash equivalents

Trade and other receivables

Inventories

Prepaid contract funds under management

Property held for sale

Deferred selling costs

Total current assets

Non-current assets

Trade and other receivables

Shares in subsidiaries

Property, plant and equipment

Prepaid contract funds under management

Intangible assets

Deferred selling costs

Total non-current assets

Total assets

Current liabilities

Trade and other payables

Derivative financial instruments

Current tax liabilities

Prepaid contract liabilities

Deferred revenue

Provisions for employee benefits

Total current liabilities

Non-current liabilities

Long-term borrowings

Derivative financial instruments

Deferred tax liabilities

Prepaid contract liabilities

Deferred revenue

Provisions for employee benefits

Total non-current liabilities

Total liabilities

Net assets

Equity

Contributed equity

Reserves

Retained profits/(Accumulated losses)

Total equity

86

2016 
$’000

2015 
$’000

1,219

42,226

22,059

39,260

2,519

1,537

108,820

44,344

138,789

259,577

433,796

11,238

9,068

896,812

1,005,632

37,177

966

8,409

37,379

10,243

13,109

107,283

559

35,309

21,997

35,066

3,320

1,299

97,550

47,126

136,425

252,774

387,218

11,418

8,857

843,818

941,368

32,594

1,130

7,304

34,700

8,660

13,061

97,449

181,064

189,076

685

36,242

400,433

49,317

2,861

670,602

777,885

227,747

1,936

31,313

373,494

47,559

2,074

645,452

742,901

198,467

134,914

133,694

(2,586)

95,419

227,747

(3,617)

68,390

198,467

Note 33: Events after the Balance Sheet Date

Subsequent to the balance date a strategic decision was made to execute an orderly closure of the Group’s USA funeral operations after 
a detailed review of its performance to date. Management expects to incur approximately $700,000 in costs associated with the closure. 
Other than this no significant subsequent events, not otherwise disclosed, have occurred since 31 December 2016.

Note 34: Related Party Transactions

(a)  Parent entity

The ultimate parent entity within and for the Group is InvoCare Limited.

(b)  Subsidiaries

Interests in subsidiaries material to the Group are set out in Note 16.

(c)  Directors and key management personnel

Disclosures relating to directors and key management personnel are set out in Note 7.

(d)  Transactions with related parties

Transactions with other related parties

  Contributions to superannuation funds on behalf of employees

8,823,797

8,395,542

(e)  Guarantees and other matters

Under the terms of common terms deed executed on 20 December 2013 and amended on 22 December 2015, InvoCare Limited and its 
material wholly-owned entities (the “Guarantors”) have individually guaranteed to the financiers the due and punctual payment in full of 
any liabilities or obligations under the debt facilities provided under the terms of individual Facility Agreements. The Guarantors have also 
indemnified the financiers against any loss or damage suffered by the financiers arising from any failure by a borrower or any Guarantor to 
satisfy the obligations.

2016 
$

2015 
$

InvoCare Annual Report 2016  |  87

Notes to the Consolidated Financial Statements continued

For the year ended 31 December 2016

Note 35: Parent Entity Financial Information

(a)  Summary financial information

The individual financial statements for the parent entity show the following aggregate amounts.

Balance sheet

Current assets

Total assets

Current liabilities

Total liabilities

Shareholders’ equity

Contributed equity

Reserves

Share-based payments

  Hedging reserve – cash flow hedge reserve

Foreign currency translation reserve

Retained earnings

Total shareholders’ equity

Profit for the year after tax

Total comprehensive income for the year

(b)  Contingent liabilities of the parent entity

The parent entity had contingent liabilities at 31 December 2016 in respect of bank guarantees given for 
leased premises of controlled entities to a maximum of:

2016 
$’000

2015 
$’000

131

404,463

9,898

165,373

188

381,571

8,782

173,044

134,914

133,694

1,849

(1,156)

1,080

102,403

239,090

71,831

73,604

2,165

(2,171)

1,080

73,759

208,527

53,174

53,224

2016 
$’000

2015 
$’000

1,510

2,287

No liability was recognised by the parent entity or the consolidated entity in relation to the guarantees as the fair value of the guarantees 
is immaterial.

(c)  Contractual commitments for the acquisition of property, plant or equipment

The parent entity has no contractual commitments for the acquisition of property, plant or equipment at 31 December 2016  
(31 December 2015: Nil).

(d)  Tax consolidation legislation

InvoCare Limited and its wholly-owned Australian controlled entities implemented the tax consolidation legislation from 1 January 2004. 

On adoption of the tax consolidation legislation, the entities in the tax consolidated group entered into a tax sharing and funding agreement 
which, in the opinion of the directors, limits the joint and several liability of the wholly-owned entities in the case of a default by the head 
entity InvoCare Limited.

This agreement was updated on 5 June 2007 and provides that the wholly-owned entities will continue to fully compensate InvoCare 
Limited for any current tax payable assumed and be compensated by InvoCare Limited for any current tax receivable and deferred tax 
assets relating to unused tax losses or unused tax credits that are transferred to InvoCare Limited under the tax consolidation legislation.

The amounts receivable or payable under the tax funding agreement are due upon receipt of the funding advice from the head entity, 
which is issued as soon as practicable after the end of each financial year. InvoCare Australia Pty Limited, as permitted by the tax funding 
agreement, acts on behalf of InvoCare Limited for the purpose of meeting its obligations to make tax payments, or receive refunds, and 
reimburses, or is compensated by, that entity through the intercompany loan account for amounts of tax paid, or received, except for the 
tax allocated to that entity.

88

 
 
Note 36: Economic Dependence

The parent entity depends on dividend and interest income from, and management fees charged to, its controlled entities to source 
the payment of future dividends and fund its operating costs and debt service obligations as borrower under the bank loan facility 
agreements. The parent entity’s financial position is sound, notwithstanding a net current liability situation being shown in the balance 
sheet. Adequate cash resources are available to enable it to meet its obligations as and when they fall due, through either drawing on 
unused finance facilities, which at the reporting date amounted to $62,618,000 as outlined in Note 2(c), or by on-demand repayment of 
intercompany advances.

Note 37:  Critical Accounting Estimates and Judgements

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of 
future events that are believed to be reasonable under the circumstances.

The Group makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, seldom equal 
the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying 
amounts of assets and liabilities within the next financial year are discussed below.

(i)  Estimated impairment of goodwill

The Group tests annually whether goodwill has suffered any impairment, in accordance with the accounting policy stated in Note 1(p). The 
recoverable amounts of cash-generating units have been determined based on value-in-use calculations. These calculations require the 
use of assumptions. Refer to Note 19 for details of these assumptions and the potential impact of changes to the assumptions.

(ii)  Estimated impairment of other non-financial assets and cash-generating units

The Group annually considers if events or changes in circumstances indicate that the carrying amount of other assets or cash-generating 
units may not be recoverable. Similarly, at each reporting date, assets or cash-generating units that suffered a previous impairment are 
reviewed for possible reversals of the impairment. The recoverable amounts are determined based on value-in-use calculations, which 
require the use of assumptions. Refer to Notes 17 and 18 for details of these assumptions.

(iii) Timing of recognition of deferred plaque and miscellaneous merchandise revenue

Prepaid cemetery / crematorium plaque and miscellaneous merchandise sales are currently brought to account over an assumed 15-year 
period. Unredeemed merchandise sales (included within deferred revenue on the balance sheet) total $46.5 million at 31 December 2016 
(2015: $44.0 million).

The 15-year period is based on the actuarially assessed average period between a customer entering into a prepaid funeral plan and the 
contract becoming at-need. The actual history of a prepaid cemetery / crematorium contract may differ from the profile of a prepaid funeral 
plan; however, in the absence of more specific data being available, the funeral data has been applied.

The average 15-year period is an assumption only and therefore subject to uncertainty. It is possible that there will remain unperformed 
contracts at the end of the 15-year amortisation period, yet all revenue will have been recognised. Offsetting this is the likelihood that 
contracts performed during the 15-year period will have unrecognised revenue.

Actual redemptions information is being collated for a sample of sites in order to determine a more accurate historical pattern of cemetery/
crematorium prepaid sale redemptions. The information collated to date suggests there is no material misstatement of revenue using the 
assumed 15 years period. The impact of recognising revenue over five years less (or five years more) than 15 years would be to increase 
annual revenue by approximately $3.3 million (decrease by $1.6 million).

Note 38: Company Details

InvoCare Limited is a company limited by shares, incorporated and domiciled in Australia.

The registered office and principal place of business of the Company is:

Level 2, 40 Miller Street 
North Sydney NSW 2060

Note 39: Authorisation of the Financial Report

This financial report was authorised for issue by the directors on 23 February 2017. The Company has the power to amend and reissue 
this report.

InvoCare Annual Report 2016  |  89

Directors’ Declaration

In the directors’ opinion:

(a)  the financial statements and notes set out on pages 42 to 90 are in accordance with the Corporations Act 2001, including:

(i) 

 complying with Accounting Standards, the Corporations Regulations 2001 and other mandatory professional reporting 
requirements; and

(ii)   giving a true and fair view of the Company’s and consolidated entity’s financial position as at 31 December 2016 and of their 

performance for the financial year ended on that date; and

(b)  there are reasonable grounds to believe that the Company will be able to pay its debts as and when they become due and payable; and

(c)  at the date of this declaration, there are reasonable grounds to believe that the members of the Extended Closed Group identified in 
Note 32 will be able to meet any obligations or liabilities to which they are, or may become, subject by virtue of the deed of cross guarantee 
described in Note 32.

Note 1(a) confirms that the financial statements also comply with International Financial Reporting Standards as issued by the International 
Accounting Standards Board.

The directors have been given the declarations by the Chief Executive Officer and Chief Financial Officer required by section 295A of the 
Corporations Act 2001.

This declaration is made in accordance with a resolution of the directors.

Richard Fisher 
Director   

Sydney 
23 February 2017 

Martin Earp 

 Director

90

 
 
 
 
 
 
 
 
 
Independent Auditor’s Report

To the Shareholders of InvoCare Limited

Report on the audit of the financial report 

Our opinion 

In our opinion:

The accompanying financial report of InvoCare Limited (the Company) and its controlled entities (together the Group) is in accordance with 
the Corporations Act 2001, including: 

(a)   giving a true and fair view of the Group’s financial position as at 31 December 2016 and of its financial performance for the year then 

ended

(b)   complying with Australian Accounting Standards and the Corporations Regulations 2001.

What we have audited

The Group’s financial report comprises:

the consolidated balance sheet as at 31 December 2016

the consolidated income statement for the year then ended

the consolidated statement of comprehensive income for the year then ended

the consolidated statement of changes in equity for the year then ended

the consolidated statement of cash flows for the year then ended

the notes to the consolidated financial statements, which include a summary of significant accounting policies

the directors’ declaration

Basis for opinion 

We conducted our audit in accordance with Australian Auditing Standards. Our responsibilities under those standards are further described 
in the Auditor’s responsibilities for the audit of the financial report section of our report. 

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

Independence

We are independent of the Group in accordance with the auditor independence requirements of the Corporations Act 2001 and the  
ethical requirements of the Accounting Professional and Ethical Standards Board’s APES 110 Code of Ethics for Professional Accountants 
(the Code) that are relevant to our audit of the financial report in Australia. We have also fulfilled our other ethical responsibilities in 
accordance with the Code.

Our audit approach

An audit is designed to provide reasonable assurance about whether the financial report is free from material misstatement. Misstatements 
may arise due to fraud or error. They are considered material if individually or in aggregate, they could reasonably be expected to influence 
the economic decisions of users taken on the basis of the financial report.

We tailored the scope of our audit to ensure that we performed enough work to be able to give an opinion on the financial report as a 
whole, taking into account the geographic and management structure of the Group, its accounting processes and controls and the industry 
in which it operates. 

PricewaterhouseCoopers, ABN 52 780 433 757 
Darling Park Tower 2, 201 Sussex Street, GPO BOX 2650, SYDNEY NSW 1171  
DX 77 Sydney, Australia 
T +61 2 8266 0000, F +61 2 8266 9999, www.pwc.com.au 

Liability limited by a scheme approved under Professional Standards Legislation. 

InvoCare Annual Report 2016  |  91

 
Independent Auditor’s Report continied

To the Shareholders of InvoCare Limited

Materiality

Audit scope

Key audit matters

•  Amongst other relevant topics, we 
communicated the following key 
audit matters to the Audit and Risk 
Committee:

 о Cemetery land impairment and 

reversal assessment

 о Accounting for prepaid funeral 

contracts

 о Revenue recognition 

They are further described in the Key audit 
matters section of our report.

•  For the purpose of our audit we used 
overall Group materiality of $5 million, 
which represents 5% of the Group’s 
profit before tax. 

•  We applied this threshold, together with 
qualitative considerations, to determine 
the scope of our audit and the 
nature, timing and extent of our audit 
procedures and to evaluate the effect of 
misstatements on the financial report as 
a whole.

•  We chose Group profit before tax 

because, in our view, it is the metric 
against which the performance of the 
Group is most commonly measured 
by users. 

•  There is no common materiality 

threshold within the funeral services 
industry so we selected 5% which 
is within the range of acceptable 
quantitative profit related materiality 
thresholds used for publicly 
listed entities.

•  Our audit focused on where the 

directors made subjective judgements; 
for example, significant accounting 
estimates involving assumptions and 
inherently uncertain future events.

•  The Group has operations within 

Australia, New Zealand, Singapore, 
Hong Kong and the USA, with the 
accounting functions led from the head 
office in Sydney, Australia. 

•  We conducted audits of the financial 
information of the Australian and New 
Zealand operations given their financial 
significance to the Group. As shown 
in note 3 of the Financial Report, the 
Australian and New Zealand operations 
account for 96% of revenue and 95% of 
Operating EBITDA of the Group.

•  The scale of operations in other 

territories is, in our view, insignificant 
to the overall results of the Group, 
and as such, we performed specific 
risk-focused audit procedures over 
those operations. 

Key audit matters 

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial report for 
the current period. The key audit matters were addressed in the context of our audit of the financial report as a whole, and in forming our 
opinion thereon, and we do not provide a separate opinion on these matters. Further, any commentary on the outcomes of a particular 
audit procedure is made in that context.

92

Key audit matter

How our audit addressed the Key audit matter

Cemetery land impairment and reversal assessment

Refer to Note 1(j), Note 18(b) and Note 37(ii).

We focused on this area due to the size of the Cemetery land 
balance (historical cost of $112.2 million as at 31 December 2016) 
and because the directors’ assessment of the ‘value in use’ of 
the Group’s Cash Generating Units (CGU’s – typically defined 
as physical Cemetery / Crematoria locations) involves significant 
judgements about the future results of the business and the 
discount rates applied to future cash flow forecasts.

In particular, we focused our audit effort on the carrying value of 
previously impaired sites at Allambe Gardens Memorial Park, Mount 
Thompson Memorial Gardens and Tweed Heads Memorial Gardens 
(each of which was previously impaired but no change in carrying 
value in the current year).

The Allambe and Mount Thompson sites in South Eastern 
Queensland recognised impairment losses in 2004 and 2006 as a 
result of increased competition in the region, but each have shown 
steady improvement in business performance and outlook since 
2013 and have recognised reversals of impairment in 2013, 2014 
and 2015. Tweed Heads was impaired by $1.2 million in 2013 and 
its carrying value is being closely monitored for further indicators of 
impairment or reversal of impairment. 

The remaining Cemetery land values have been assessed for 
internal and external indicators of impairment, and based on 
this assessment no indicators of impairment were identified by 
the Group. 

To evaluate the composition of the Group’s future cash flow forecasts 
and the process by which they were drawn up, we:

•  Developed an independent range of possible alternative inputs 
for revenue growth rate, expected death rate and weighted 
average cost of capital that could have been used. We found 
them to be consistent with the rates and assumptions used by 
the Group. 

•  Compared the prior year cash flow forecast to current year 
actual results to consider whether any forecasts included 
assumptions that, with hindsight, had been inaccurate. We 
found that the assumptions and expectations within the 
forecast were materially consistent with the actual results.

•  Agreed some of the forecast inputs, such as revenue growth 

rate, expected death rate and weighted average cost of capital 
used in the valuation model to Board approved budgets.

•  Considered whether all relevant locations for impairment testing 

had been identified, by considering both the Group’s own 
internal assessment and our own independent assessment of 
potential indicators for impairment. No new or different locations 
were identified for additional focus.

For Allambe, Mount Thompson and Tweed Heads, we also:

•  Compared long-term growth rates used by the Group to 

economic and industry forecasts and found that they were 
consistent.

•  Assessed the discount rate used by the Group by forming an 

independent expectation of what the weighted average cost of 
capital would be with reference to comparable organisations 
and independent broker reports. 

We challenged the Group on the adequacy of their sensitivity 
calculations over all their CGUs by varying critical inputs into the 
valuation model by plus or minus 10% and assessing how the 
calculations would change. We determined that the calculations were 
most sensitive to assumptions for revenue growth rates and discount 
rates and as such, focused our testing on these assumptions. We 
found that these assumptions were consistently applied and in line 
with our expectations, which were based on historical experience 
and industry performance.

InvoCare Annual Report 2016  |  93

Independent Auditor’s Report continued

To the Shareholders of InvoCare Limited

Key audit matter

How our audit addressed the Key audit matter

Accounting for prepaid funeral contracts

For the asset value invested, we:

Refer to note 1(n) and note 15.

The Group enters into prepaid funeral contracts whereby they 
agree to deliver a specified funeral, cremation or burial service 
at the time of need. The beneficiary invests the current price 
of the service to be delivered with a financial institution and 
conditionally assigns the benefit to the Group. For each prepaid 
funeral contract, the Group records an asset for the value of the 
funds invested (funds under management) and a liability to deliver 
the services. 

As at 31 December 2016, InvoCare had recorded $473.1 million of 
funds under management and $438.0 million of contract liabilities.

We focused on prepaid funeral contracts due to the:

•  Size of the asset and liability balances

•  Agreed the balances recorded to statements and confirmation 
balances received from independent custodians indicating that 
assets were recorded accurately and in the correct period. 

For the liability recognised, we:

•  Considered whether the Group’s methodology used to measure 

prepaid contract liabilities had been consistently applied

•  Tested the mathematical accuracy of the calculations used in 

the application of price increases on service delivery obligations

•  Selected a sample of new contracts issued and contract 

redemptions and compared the date and value to that recorded 
by the Group. We found the sample tested to be accurate and 
recorded or redeemed in the correct period.

For the revenue recognised, we:

•  Significant time difference that may arise between receipt 

of cash from customers and the subsequent recognition of 
revenue on the delivery of services (redemption date) 

•  Potential for deliberate manipulation or error in the timing of 

recording revenue arising from the:

•  Compared the redemption dates and values for a sample of 

prepaid funeral contracts against the dates and values at which 
the revenue had been recorded. We found that the revenue 
had been recorded accurately and in the correct period for the 
sample tested.

 о high volume of transactions, contracts (over 80,000 
contracts) and different asset management trusts 
(29 trusts)

 о manual translation, into the accounting records, of the 

assets balances held in the trusts 

Revenue recognition (other than prepaid funeral contracts – 
refer key audit matter 2 above)

Refer to note 1(e) and note 4

We focused on the recognition of revenue as revenue is comprised 
of a number of different streams, some of which can be complex 
(specifically, large memorials e.g. Crypts or multiple plot sales, timing 
of deferred plaque and miscellaneous merchandise revenue and 
payments by instalment). Complexity can arise from a significant 
difference between the timing of receipt of cash from customers 
and the subsequent recognition of revenue from funeral service and 
memorial delivery. 

Due to the manual processes and calculations for the different 
elements of a funeral service and memorial, the high number 
of different revenue sources and the recognition of these in the 
accounting records, additional audit effort has been applied.

Other information 

We assessed the design of the manual and IT controls over revenue 
systems to consider whether they had been implemented effectively. 
This included testing key Inventory and Accounts Receivable 
reconciliations at 31 December 2016 by agreeing material reconciling 
items to supporting documents. We found the controls were suitable 
for the purpose of our audit.

For a sample of revenue transactions, we compared the delivery 
dates against the date on which the revenue had been recorded. 
We found that revenue had been recorded accurately in the correct 
period and in accordance with the Group’s accounting policy for the 
sample tested.

The directors are responsible for the other information. The other information included in the Group’s annual report for the year ended 
31 December 2016 comprises the Directors Report (but does not include the financial report and our auditor’s report thereon), which we 
obtained prior to the date of this auditor’s report. The other information also includes the Performance Highlights, Chairman’s Message, 
Chief Executive Officer’s Review, Shareholder Information and InvoCare Locations, which are expected to be made available to us after the 
date of this auditor’s report. 

94

Our opinion on the consolidated financial statements does not cover the other information and we do not and will not express any form of 
assurance conclusion thereon. 

In connection with our audit of the financial report, our responsibility is to read the other information identified above and, in doing so, 
consider whether the other information is materially inconsistent with the financial report or our knowledge obtained in the audit, or 
otherwise appears to be materially misstated. 

If, based on the work we have performed on the other information that we obtained prior to the date of this auditor’s report, we conclude 
that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. 

When we read the other information not yet received as identified above, if we conclude that there is a material misstatement therein, we are 
required to communicate the matter to the directors and use our professional judgement to determine the appropriate action to take.

Responsibilities of the directors for the financial report

The directors of the Company are responsible for the preparation of the financial report that gives a true and fair view in accordance with 
Australian Accounting Standards and the Corporations Act 2001, and for such internal control as the directors determine is necessary to enable 
the preparation of the financial report that gives a true and fair view and is free from material misstatement, whether due to fraud or error. 

In preparing the financial report, the directors are responsible for assessing the ability of the Group to continue as a going concern, 
disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either 
intend to liquidate the Group or to cease operations, or has no realistic alternative but to do so. 

Auditor’s responsibilities for the audit of the financial report

Our objectives are to obtain reasonable assurance about whether the financial report as a whole is free from material misstatement, 
whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, 
but is not a guarantee that an audit conducted in accordance with the Australian Auditing Standards will always detect a material 
misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they 
could reasonably be expected to influence the economic decisions of users taken on the basis of the financial report. 

A further description of our responsibilities for the audit of the financial report is located at the Auditing and Assurance Standards Board 
website at: http://www.auasb.gov.au/auditors_files/ar2.pdf. This description forms part of our auditor’s report.

Report on the remuneration report 

Our opinion on the remuneration report

We have audited the remuneration report included in pages 30 to 41 of the directors’ report for the year ended 31 December 2016.

In our opinion, the remuneration report of InvoCare Limited, for the year ended 31 December 2016 complies with section 300A of the 
Corporations Act 2001. 

Responsibilities 

The directors of the Company are responsible for the preparation and presentation of the remuneration report in accordance with section 
300A of the Corporations Act 2001. Our responsibility is to express an opinion on the Remuneration Report, based on our audit conducted 
in accordance with Australian Auditing Standards. 

PricewaterhouseCoopers

Brett Entwistle 
Partner  

23 February 2017 

InvoCare Annual Report 2016  |  95

 
Shareholder Information

Shares and options as at 13 March 2017

Shares on issue
Options on issue

Distribution of shareholders as at 13 March 2017

1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over

Number
110,030,298
 498,871 

Percentage 
%
3.76%
18.17%
9.51%
13.61%
54.95%
100.00%

Number of 
shareholders
8,200
8,376
1,432
686
40
18,734

Number  
of shares
4,132,303
19,995,974
10,466,761
14,973,896
60,461,364
110,030,298

There were 235 holders of less than a marketable parcel of ordinary shares (being 35 based on a price of $14.17 on 13 March 2017) who 
hold a total of 2,108 ordinary shares.

Equity security holders

Number  
of shares

Percentage 
%

Largest 20 holders of ordinary shares at 13 March 2017
1.  HSBC Custody Nominees (Australia) Limited
2.  J P Morgan Nominees Australia Limited
3.  Citicorp Nominees Pty Limited
4.  National Nominees Limited 
5.  Argo Investments Limited 
6.  Milton Corporation Limited 
7.  BKI Investment Company Limited 
8.  BNP Paribas Nominees Pty Ltd (Drp)
9.  Australia Foundation Investment Company Limited
10. Australian United Investment Company Limited
11.  IOOF Investment Management Limited (IPS Super A/C)
12. AET SFS Pty Ltd (InvoCare Share Plans)
13. Warbont Nominees Pty Ltd
14. BNP Paribas Noms Pty Ltd
15. Mr Richard Hugh Davis
16. Netwealth Investment Limited
17.  Gwynvill Trading Pty Ltd
18. CS Fourth Nominees Pty Limited
19. HSBC Custody Nominees (Australia) Investments Limited - A/C 2
20. Navigator Australia Ltd (MLC Investment Sett A/C)
Total for top 20

Substantial holders

Substantial holders in the Company as at 13 March 2017 are set out below:
JCP Investment Partners Ltd
Mondrian Investment Partners Limited

Voting Rights

The voting rights attaching to each class of security are set out below:

Ordinary Shares

23,128,873 
10,482,864 
6,229,479 
3,616,686 
2,082,191 
1,950,914 
1,358,474 
1,329,168 
1,150,000 
1,000,000 
687,675 
686,880 
631,776 
602,125 
521,607 
508,618 
415,643 
 376,328 
 374,069 
 340,815 
 57,474,185 

21.02%
9.53%
5.66%
3.29%
1.89%
1.77%
1.23%
1.21%
1.05%
0.91%
0.62%
0.62%
0.57%
0.55%
0.47%
0.46%
0.38%
0.34%
0.34%
0.31%
52.23%

Number of  
shares held

Percentage 
%

 6,726,849 
 12,007,408 

6.11%
10.91%

On a show of hands, each member present in person and each other person present as a proxy of a member has one vote. On a poll, each 
member present in person has one vote for each fully paid share held by the member and each person present as a proxy of a member has 
one vote for each fully paid share held by the member that the proxy represents.

96

Glossary

AASB

ABS

ACCC

AIFRS

ASX

ASX Corporate 
Governance Principles and 
Recommendations

Cemetery

CGU

Australian Accounting Standards Board

Australian Bureau of Statistics

Australian Competition & Consumer Commission

The Australian equivalents to International Reporting Standards for annual reporting periods 
beginning on or after 1 January 2005

Australian Securities Exchange which is the operating brand of ASX Limited

The eight essential corporate governance principles and best practice recommendations of the ASX 
Corporate Governance Council 3rd Edition 2014

A place for burials and memorialisation

A cash-generating unit which is the smallest identifiable group of assets that independently generates 
cash in flows

Condolence Lounge

A facility for family and friends to gather at after the funeral service – usually offering a catering service

Constitution

Crematorium

The Constitution of the Company

A place for cremations and memorialisation

Crypts

DRP

EBITDA

EEO

EPS

Above ground burial facilities

Dividend Reinvestment Plan

Earnings Before Interest, Tax, Depreciation and Amortisation

Equal Employment Opportunity

Earnings Per Share

Funeral Arrangement

The process in which the funeral service is planned and necessary documentation prepared

Funeral Home

The InvoCare location where a funeral can be arranged and where some services can be conducted

Memorial or Memorialisation

The physical marker or tribute to the life of the deceased

Memorial Park

An InvoCare location offering cremation, burial and memorialisation services

Operating Earnings

Prepaid Cemetery and 
Crematorium Services

Earnings before the net gain/(loss) on undelivered prepaid contracts, asset sales gains/ (losses), 
minority interests and any other unusual items as disclosed in the relevant reconciliations.

Cemetery and crematorium services that have been arranged and paid for in advance

Prepaid Funeral Fund

The fund where prepaid funeral monies are held in trust until the funeral service is provided

Volume

A term that refers to the number of funeral services, burials and cremations performed

InvoCare Annual Report 2016  |  97

InvoCare Locations

Contemporary – Australia and New Zealand

New South Wales

Queensland

Victoria

South Australia

New Zealand

Blackwell Funerals
(est 1940)
Aberfoyle Park
Glenside
Paradise
Payneham
Prospect
Rosewater
Torrensville

Tasmania

Turnbull Family
Funerals (est 1936)
North Hobart

New Zealand

South Island
John Rhind Funeral
Directors (est 1881)
Christchurch
Kaiapoi

Academy Funeral
Services (est 1982)
Christchurch

Geoffrey T Sowman
(est 1869)
Blenheim

Sowman Memorials
Blenheim

George Hartnett
Funerals (est 1947)
Albany Creek
Cleveland
Holland Park
Kelvin Grove
Redcliffe
Sandgate
Wynnum

Metropolitan  
Funerals (est 1941)
Aspley
Cleveland
Mt Gravatt
Petrie
Redcliffe
Southport
Springwood
Toowong
Wynnum

Other Providers

Drysdale Funerals
(est 1983)
Nambour
Tewantin

Somerville Funerals
(est 1932)
Nerang
Southport

City Funeral Services
(est 1959)
Mackay

Gatton Funerals
(est 1983)
Gatton

Hiram Philp Funerals
(est 1903)
Toowoomba

Mackay Funerals
(est 1884)
Mackay

Burkin Svendsens
(est 1884)
Cairns

Beaudesert Funeral
Services (est 1980)
Beaudesert

Le Pine including
Le Pine Heritage
(est 1891)
Box Hill
Camberwell
Croydon
Dandenong
Eltham
Ferntree Gully
Footscray West
Glen Waverley
Greensborough
Healesville
Ivanhoe
Kew East
Lilydale
Mordialloc
Oakleigh
Pakenham

Le Pine Asian 
Funerals
Glen Waverley
West Footscray

W D Rose (est 1884)
Brighton
Burwood
Cheltenham

Joseph Allison
(est 1853)
Brunswick
Essendon

Other Providers
Mulqueen Funerals
(est 1932)
Coburg

Southern Cross
(est 1998)
Noble Park

Tuckers Funeral  
& Bereavement 
Service (est 1883)
Geelong West
Grovedale
Highton
Lara

Werribee Funerals
Werribee

Charles Crawford
& Son
Melton

North Island
Forrest Funeral
Services (est 1978)
Browns Bay
Orewa

Fountain’s Funeral
Services (est 1956)
Manurewa 
Papakura

Sibuns Funeral
Directors (est 1913)
Remuera

H Morris Funerals
(est 1933)
Northcote

Lychgate Funeral
Home (est 1876)
Johnsonville
Karori
Wellington

Resthaven Funerals
(est 2000)
Howick 
Manurewa

Gee & Hickton
(est 1946)
Lower Hutt
Porirua
Upper Hutt
Akatarawa 
Crematorium

James R Hill 
(est 1965)
Hamilton

Pellows Funeral
Directors (est 1963)
Hamilton

Elliotts Funeral
Services (est 1967)
Kati Kati
Mt Maunganui
Tauranga

Beth Shan Funeral
Directors (est 1977)
Hastings
Napier

Cleggs Funeral
Services (est 1919)
Hawera

Vospers (est 1933)
New Plymouth

Wairarapa Funeral
Services (est 1938)
Masterton

Guardian Funeral 
Providers 
Guardian Funerals
Ballina
Bankstown
Blacktown
Bondi Junction
Burwood
Campbelltown
Casino
Cremorne
Hurstville
Leppington
Lidcombe
Lismore
Merrylands
Minchinbury
North Ryde
Parramatta
Rockdale
Roseville Chase
Warrawee

Hansen & Cole
Funerals (est 1936)
Bulli
Kembla Grange
Wollongong

J W Chandler 
Funerals (est 1885)
Richmond
Windsor

Boland Funerals
(est 1962)
Maroubra

Tobin Brothers
Funerals (est 1946)
Queanbeyan

Australian Capital
Territory

Tobin Brothers 
Funerals (est 1946)
Belconnen
Kingston
Tuggeranong

Other Providers
Allan Drew Funerals
(est 1985)
Castle Hill
Rouse Hill

Ann Wilson Funerals
(est 1995)
Dee Why
Mona Vale

David Lloyd Funerals
(est 1885)
Adamstown
Belmont
Beresfield
Toronto

Liberty Funerals
(est 1994)
Chatswood
Granville

Universal Chung 
Wah
(est 1955)
Fairfield

W N Bull (est 1892)
Newtown
Parramatta

Western
Australia

Purslowe Funerals
(est 1907)

Midland
North Perth
Fremantle
Victoria Park
Wangara

Other Providers
Oakwood Funerals
(est 1999)
Booragoon
Rockingham

Chipper Funerals
(est 1889)
Mandurah
Myaree
Rockingham
Subiaco

Christian Funerals
(est 1978)
Maylands

98

New South Wales

Queensland

Victoria

South Australia

Western Australia

Simplicity Funerals (est 1979)+

Balgowlah 
Bankstown 
Bateau Bay 
Chatswood 
Erina 
Hornsby 
Liverpool 
Mascot 
Miranda 
Newcastle* 
Newtown
Northern Rivers*

Penrith
Randwick
Ryde
Smithfield
South Sydney*
Toukley East
Tweed Heads
Woy Woy
Wyong

ACT

Canberra*

* Mobile Arranger + Incorporate Value Funerals

Bayswater
Carnegie
Frankston
Pascoe Vale
Reservoir
Sunshine
Werribee

Buranda
Brisbane North*
Gold Coast*
Ipswich
Kedron
Logan
Parkwood
Robina
Strathpine*
Sunshine Coast*

Black Forest
Brahma Lodge
Enfield
Gawler
Gawler and  
Barrossa Valley*
Morphett Vale
South Adelaide*
Victor Harbor

Tasmania

Hobart*

Joondalup
Kelmscott
Mandurah
Osborne Park
Southern Region*

New Zealand

Nelson
Christchurch
New Lynn
Royal Oak
Sydenham
Wellington*

New South Wales

Queensland

Victoria

South Australia

Western Australia

White Lady Funerals (est 1987)

Bankstown
Belmont
Bondi Junction
Bulli
Camden
Charlestown
Charmhaven
Eastwood
Five Dock
Liverpool
Mayfield
Mosman

Narrabeen
Northern Rivers
Pennant Hills
Penrith 
Queanbeyan
Rockdale
Roseville
Salamanda
Sutherland
Toronto
Tweed Heads
Wyoming

Ashmore
Cairns
Caloundra
Chelmer
Clayfield
Kelvin Grove
Miami
Morningside
Nambour
Tanah Merah
Warana

Burwood
Doncaster
Epping
Glen Huntly
Heathmont
Heidelberg
Mornington
North Essendon
Rosebud
South Melbourne

Singapore

Singapore Casket Company (est 1920)

Simplicity Casket Company (est 2009)

Lavender Street
Mount Vernon

Sin Ming Drive

Hillcrest
Glenside
Plympton

Operating  
as Mareena  
Purslowe Funerals

Fremantle
Midland
Mandurah
North Perth
Subiaco
Victoria Park
Wangara

Tasmania

North Hobart

Australian Capital 
Territory

Belconnen
Kingston
Tuggeranong

USA

Macera Crematory
San Diego

Cemeteries and Crematoria

New South Wales

Queensland

Castlebrook Memorial Park (est 1973)
Forest Lawn Memorial Park (est 1962)
Lake Macquarie Memorial Park (est 1994)
Lakeside Memorial Park (est 1964)
Lung Po Shan Information Centre (est 2000)
Newcastle Memorial Park (est 1936)
Northern Suburbs Memorial Gardens and
Crematorium (est 1933)
Pinegrove Memorial Park (est 1962)
Po Fook Shan Information Centre (est 2002)
Rookwood Memorial Gardens and
Crematorium (est 1925)
Tweed Heads Memorial Gardens &  
Crematorium (est 1971)

Rouse Hill
Leppington
Ryhope
Dapto
Haymarket
Beresfield
North Ryde

Minchinbury
Cabramatta
Rookwood
Necropolis
Tweed Heads

Albany Creek Memorial Park(est 1964)
Allambe Memorial Park &  
Crematorium (est 1968)
Great Southern Memorial Gardens &  
Crematorium (est 1997)
Mt Thompson Memorial Gardens &  
Crematorium (est 1934)
Toowoomba Garden of Remembrance &  
Crematorium (est 1966)

New Zealand

Harewood Memorial Gardens &  
Crematorium (est 1963)
Woodlawn Memorial Gardens &  
Crematorium (est 1936)

Bridgeman Downs
Nerang

Carbrook

Holland Park

Toowoomba

Christchurch

Christchurch

InvoCare Annual Report 2016  |  99

Corporate Information

InvoCare Limited
ABN 42 096 437 393

Directors
Richard Fisher (Chairman)
Martin Earp (Managing Director
and Chief Executive Officer)
Richard Davis (Non-executive Director)
Joycelyn Morton (Non-executive 
Director)
Gary Stead (Non-executive Director)
Robyn Stubbs (Non-executive Director)

Company Secretary
Phillip Friery

Registered Office
Level 2, 40 Miller Street
North Sydney NSW 2060
Telephone: 02 9978 5200
Facsimile: 02 9978 5299
Website: www.invocare.com.au

Share Registry
Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Toll free: 1300 854 911
Facsimile: 02 9287 0303

Stock Exchange Listing
InvoCare Limited is a company
limited by shares that is incorporated
and domiciled in Australia.
InvoCare Limited’s shares are listed
on the Australian Securities Exchange
only. ASX code is IVC.

Auditors
PricewaterhouseCoopers
One International Towers Sydney
Watermans Quay, Barangaroo
Sydney NSW 2000

Solicitors
Addisons Lawyers
Level 12
60 Carrington Street
Sydney NSW 2000

Anthony Harper Lawyers
Level 15, Chorus House
66 Wyndham Street
Auckland New Zealand

Bankers
Australia and New Zealand
Banking Group Limited
242 Pitt Street
Sydney NSW 2000

ANZ Bank New Zealand Limited
ANZ Centre
23–29 Albert Street
Auckland New Zealand

Commonwealth Bank of Australia
201 Sussex Street
Sydney NSW 2000

HSBC Bank Australia Limited
Tower 1 - International Towers Sydney
100 Barangaroo Avenue
Sydney NSW 2000

The Hongkong and Shanghai
Banking Corporation
1 Queen Street
Auckland New Zealand

Westpac Banking Corporation
275 Kent Street
Sydney NSW 2000

Westpac New Zealand Limited
16 Takutai Square
Auckland New Zealand

100

Contents

1 

2 

4 

Performance Highlights

Chairman’s Message

 Chief Executive Offi  cer’s 

Review

6 

Community Activities

8  Management Team

9 

Financial Report

10  Director’s Report

25 

 Corporate Governance 

Statement

30  Remuneration Report

42 

 Auditor’s Independence 

Declaration

90  Director’s Declaration

91 

Independent Auditor’s Report

96  Shareholder Information

97  Glossary

98 

InvoCare Locations

100  Corporate Information

Our Mission

“We’re here to support our 

clients, their families and 

friends, at a pivotal time in 

their lives. We do this by being 

compassionate, exceeding 

expectations and delivering 

outstanding service.”

I

N

V

O

C

A

R

E

L

I

M

I

T

E

D

A

N

N

U

A

L

R

E

P

O

R

T

2

0

1

6

invocare.com.au

2016 Annual Report